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1 IRON(II)-CATALYZED INTERMOLECULAR AMINO-OXYGENATION OF OLEFINS*  
Abstract 
In this chapter, a highly efficient and selective iron (II)-catalyzed intermolecular olefin amino-
oxygenation reaction is described. This process goes through an iron-nitrenoid intermediate, which 
generated by the N−O bond cleavage of a functionalized hydroxylamine.† In this reaction, an easy-prepared 
and bench-stable hydroxylamine derivative is used as the source of both nitrogen and oxygen 
functionalities. A broad range of synthetically valuable unfunctionalized olefins is excellent candidates for 
this reaction and many of them are incompatible with existing amino-oxygenation methods. With this 
method, simple and unfunctionalized olefins can be converted to vicinal amino alcohols regioselectively 
and diastereoselectively.  
1.1 Introduction 
Vicinal amino alcohols are important structural motifs in many pharmaceuticals, biologically active 
molecules and synthetically valuable building blocks (Figure 1.1). Therefore, direct olefin 
difunctionalization that can introduce both amino groups and hydroxyl groups simultaneously are highly 
desired and well-studied in the last few decades.   
 
Figure 1.1 Representative nitrogen containing pharmaceuticals 
Sharpless and coworkers discovered the first osmium-catalyzed racemic olefin aminohydroxylation 
reaction in 1970s and they further developed the asymmetric reaction (with ee approaching 90% or higher) 
                                                 
* This chemistry was carried out with collaboration with the following co-workers: Lu, D.F. and Jia, Z.X. 
† Contents in this chapter were published in: (1) Lu, D. F.; Zhu, C. -L.; Jia, Z. X.; Xu, H. J. Am. Chem. Soc. 2014, 
136, 13186–13189; (2) Zhu, C.-L.; Lu, D.-F.; Sears, J. D.; Jia, Z.-X.; Xu, H. Synthesis 2016, 48, 3031–3041. 
2 
in 1990s.1,2 (Scheme 1.1A) The Sharpless’ aminohydroxylation is a powerful tool even today.  However, 
this transformation is not perfect and there are quite a few intrinsic limitations associated with this process. 
The first limitation is regioselectivity. In most cases, the Sharpless aminohydroxylation always gives a pair 
of regio isomers, and often times the ratio is about 1 to 1. In addition to that, this transformation suffered 
from its limited substrate scope. A large number of synthetic valuable olefins with labile C-H bonds are not 
even compatible with the racemic Sharpless aminohydroxylation reactions. In spite of its limitations, the 
osmium–based Sharpless aminohydroxylation continues to be a prevalent stereospecific method for olefin 
amino-oxygenation. To overcome these limitations, many other amino hydroxylation strategies and 
approaches have been developed to achieve broader substrate scope and better regioselectivity.3-9 In 
addition to those precious late-transition-metal catalyzed methods, sustainable and less expensive first-row 
transition metal catalyzed amino-oxygenation reactions emerged with great interest. (Scheme 1.1B) 
Chemler and coworkers developed copper-catalyzed olefin amino-oxygenation and other 
difunctionalization methods;4,5,10,11Yoon’s groups developed Cu- and Fe-catalyzed amino hydroxylation 
with sulfonyl oxaziridine reagent.3,6-8 Complementary regioselectivity could be achieved under specific 
reaction conditions.  One of the great strength of Yoon’s method is its asymmetric version is uniquely 
effective for terminal olefins, however, the enantioselective variant of this method is ineffective for internal 
olefins because of lack of reactivity. In addition to that, because of the highly electrophilic nature of this 
sulfonyl oxaziridine reagent, a number of synthetically valuable olefins with sensitive groups are not 
compatible with this method, including cyclopentadiene, indene, enol ether, allyl silane and glycal. 
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Scheme 1.1 Selected previous approaches for olefin aminohydroxylation 
Given all these great discoveries, we like to develop new first-row transition metal-catalyzed olefin 
amino-oxygenation methods, which have a broader substrate scope and improved or complementary regio- 
and stereoselectivity to other existing methods. In particular, we have a long-standing interest in iron 
catalyzed olefin difunctionalization, but the intermolecular olefin amino-oxygenation mediated by iron 
catalyst has not been reported in the literature. Unlike the rhodium nitrenoid catalyzed olefin amination 
reactions,12-15 the iron nitrenoid will more likely to add to olefins through step-wise radical addition 
pathways, because iron has a greater crystal field splitting energy than rhodium and usually in high-spin 
state.16-23 Therefore, the discrepancy between iron nitrenoid and rhodium nitrenoid opens the way for us to 
explore its new reactivity. Our group have previously discovered iron-catalyzed intramolecular amino-
oxygenation and amino-fluorination reactions of olefins with functionalized hydroxylamines (Scheme 
1.2A).24-26  The mechanistic studies indicate that an iron nitrenoid is a reactive intermediate within both 
transformations and their stereo selectivity can be controlled by ligands.27-29 
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Scheme 1.2 Iron-catalyzed olefin amino-oxygenation with functionalized hydroxylamines 
We started an intermolecular olefin amino-oxygenation with the same catalyst, same solvent and a similar 
oxidant that are previously used in the intramolecular amino-oxygenation. To our surprise, no desired 
product was detected from this system, and olefin substrate was recovered. To balance the catalyst reactivity 
and stability, we studied a range of new oxidants, iron catalyst and ligands. After lots of exploration, we 
discovered an intermolecular olefin amino-oxygenation method based upon N−O bond cleavage and redox 
iron catalysis that can convert a broad range of simple and unfunctionalized olefins to vicinal amino alcohol 
derivatives efficiently and selectively. In this transformation, a bench-stable hydroxylamine derivative is 
applied as both the amination reagent and oxidant (Scheme 1.2B). 
Compared to the existing iron-catalyzed olefin amino-oxygenation method with sulfonyl oxaziridines, this 
method has a few advantages.7,8 Firstly, we observed significant asymmetric induction with internal olefins 
in this method, while the sulfonyl oxaziridine-based asymmetric approach is uniquely effective for terminal 
olefins. Secondly, this method tolerates a variety of synthetically valuable olefins with sensitive functional 
groups, such as cyclopentadiene, allyl silanes, indene, enol ethers and glycals, which are all incompatible 
with the existing iron-catalyzed olefin amino-oxygenation method with sulfonyl oxaziridines.7,8 
Additionally, this method will afford amino alcohol derivatives with improved or complementary 
regioselectivity to other existing amino-oxygenation methods.  
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1.2 Results and discussions 
 Catalyst discovery 
To achieve the proposed intermolecular amino-oxygenation, we chose styrene 1.1 as a model 
substrate for catalyst discovery (Table 1.1). Styrene was selected in the initial study for a few reasons: (1) 
it is commercially available and less expensive; (2) the relatively compact size will favor intermolecular 
reactions to take place; (3) the benzylic position is known to stabilize both carbocation or carboradical 
intermediate generated during the reaction process; (4) it is UV active but not very volatile, which makes it 
convenient to monitor the reaction progress with TLC technique. Iron (II) catalyst with N,N′-bi-dentate 
ligands work very well in our previously reported intramolecular aminohydroxylation reactions.  However, 
our initial attempts with Fe(OTf)2–N,N′-bi-dentate ligands failed in the intermolecular reaction due to the 
lack of reactivity (entries 7–9). We subsequently studied a range of ligands and found that the nitrogen-
based tri-dentate bisoxazoline tetramethyl PyBOX ligand L1 is uniquely effective. With a range of 
functionalized hydroxyl amines (1.2a–1.2d, entries 1–4), the Fe(OTf)2–L1 complex catalyzes an styrene 
amino-oxygenation affording an alkoxyl oxazoline 1.3 and a protected amino alcohol 1.4 (a direct 
aminohydroxylation product) product. Good to excellent combined yields were obtained in these 
transformation with complementary regioselectivity to the osmium-based methods.1 Fortunately, both 
alkoxyl oxazoline and amino alcohol could be readily converted to the same oxazolidinone building block 
with high yield through simple hydrolysis procedures. Furthermore, we noted that the electronic nature of 
oxidants affects the reactivity greatly. From ethoxy carbamate, tert-butoxy carbamate, to trichloroethoxy 
and trifluoroethoxy carbamate, the oxidation ability gets stronger and more electrophilic reagents lead to 
higher reactivity (entries 34 vs 12). Regarding ligand effect, a significantly smaller 
Fe(OTf)2phenanthroline-oxazoline hybrid ligand (L2) complex is less reactive than the tri-dentate 
bisoxazoline tetramethyl PyBOX ligand L1, while an Fe(OTf)2terpyridine (L3) complex is totally inactive 
(entries 5–6). The four methyl groups in ligand L1 are necessary and crucial to this transformation. Without 
methyl groups, the iron–ligand catalyst will do abstraction reactions, which will subsequently destroy the 
6 
catalyst itself (entry 6). In terms of the counter ion effect, we observed that Fe(NTf2)2 is equally reactive 
compared to Fe(OTf)2, while FeCl2 is inactive (entries 1011).  
Table 1.1 Catalyst discovery for the iron-catalyzed intermolecular olefin amino-oxygenation 
 
 Substrate scope 
With the optimized condition in hand, we next explored a variety of olefins to explore the scope 
and limitations of this method (Table 1.2). 
7 
We first studied α-methyl styrene, which is a 1,1-disubstituted olefin with our optimal condition. 
Oxazolidinone was isolated in excellent yield after hydrolysis (entry 2, 75% yield). Next, we evaluated 
those olefins that are problematic substrates for the existing amino-oxygenation methods (entries 38).  
Table 1.2 Substrate scope of the iron-catalyzed olefin amino-oxygenation 
 
8 
Allyl silane is a substrate that is incompatible with other iron-catalyzed amino hydroxylation 
methods, but it can be efficiently amino-oxygenated with 1.2d (entry 3, 78% yield). We further studied 
amino-oxygenation of cyclopentadiene with a labile CH bond. With less oxidative oxidant 1.2b and at 
low temperature, we observed the double bond in cyclopentadiene was selectively difunctionalized and 
converted to an oxazolidinone with a decent yield and excellent dr (entry 4, 61% yield).  
 
9 
We further observed that cyclohexadiene could be converted to an oxazolidinone with oxygen at 
the allylic position (entry 5, 62%). Although enol ethers have been challenging substrates for existing 
amino-oxygenation methods, they are excellent candidates for this iron-catalyzed method which delivers 
protected amino alcohols with good yields as single syn-isomers (entries 67, yield up to 77% and dr up 
to>20:1). The regio-selectivity in enol ether amino-oxygenation reaction can be explained by the fact the 
oxygen’s lone pair better stabilize the radical or carbocation intermediates at 2-position through resonance 
to the p-orbitals, which will favor the amino group first attack 3-position. One of the examples highlights 
the distinct strength of this method is glycal amino-hydroxylation. A protected glycal can participate in the 
reaction with 1.2b and afford a 2-amino-α-sugar with decent yield and excellent regioselectivity as well as 
diastereoselectivity (entry 8, 63% yield, dr>20:1 at both C1 and C2 positions).  
In addition, Fe(NTf2)2 and L1 complex can catalyze efficient indene amino-hydroxylation with 
exclusive single regioselectivity and diastereoselectivity. This reaction affords a protected cis-2-amino 
indanol, which is a valuable building block that is difficult to obtain directly with existing amino-
oxygenation methods (entry 9, 71% yield, dr>20:1). For comparison, osmium-catalyzed racemic indene 
aminohydroxylation will provide mixtures of 1- and 2-amino indanols.30,31 We also explored conjugated 
ene-ynes and dienes (entries 1015). An ene-yne is an excellent substrate for this amino-oxygenation 
reaction (entry 10, 62% overall yield). Conjugated aliphatic diene and aromatic phenyl diene can also be 
efficiently transformed into protected 1,2-amino alcohols or oxazolidinones with excellent yields and 
regioselectivity (entries 1113). It is worth noting that to achieve amino-oxygenation with phenyl diene, 
mixed salts of Fe(OTf)2 and FeCl2 were applied as the catalyst (entry 11). Fe(OTf)2 alone led to rapid 
polymerization and decomposition of the diene substrate; while FeCl2 was inactive in this transformation 
as described previously. This method is also compatible with a silyl dienol with an active alpha protons 
(entry 14, 63% yield). Furthermore, an electron deficient dienoate will afford desired amino-oxygenation 
product under this condition with acceptable yield (entry 15). Presumably, the relatively low yield due to 
the electron-deficient nature of this particular substrate. 
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To our delight, this method is also applicable to many isolated olefins. A 1,1-disubstituted olefin 
can be converted to oxazolidinone product with Fe(ClO4)2L1 complex (entry 16, 51% yield). When other 
iron salts were applied, rapid addition-elimination occurs, which leads to the undesired allylic amination 
products. Mono-substituted olefins are challenging substrates because of lack of stabilizing neighboring 
group. With excess amount of catalyst loading and prolonged reaction time, we observed that the 
Fe(OTf)2L1 complex catalyzes the reaction of 1-octene with 1.2c to afford the oxazolidinone with a 
synthetically useful yield (entry 17, 48% yield). 
It is worth pointing out that in the amino-oxygenation of those diene substrates (entries 4, 5, 12 and 
13), a significantly smaller ligand L2 rather than L1 was applied to favor the N-atom radical addition step. 
 Asymmetric induction 
One of the goals of this research is to achieve improved or complementary selectivity compared to 
other existing amino-hydroxylation methods. A good example is indene 1.6 asymmetric amino 
hydroxylation. Before our research, literature does not have an example of direct enantioselective indene 
amino-hydroxylation. The osmium-based approaches always provide a pair of racemic 1-, and 2-amino 
indanol as regio-isomers.30,31 To address this limitation, we explored a range of chiral ligands. We 
discovered that an ironchiral ligand L7 complex is uniquely in asymmetric induction for indene amino-
oxygenation, which delivers a chiral 2-amino indanol derivative 1.7 with enhanced enantioselectivity 
(Scheme 1.3, eq 1, 81% ee, dr>20:1). Interestingly, I isolated a significant amount of unexpected amino-
ethoxylation product when the commercially available chloroform solvent was not pre-treated with water 
before re-distillation.‡  Presumably, the small amount ethanol residue in solvent participated the reaction as 
competing nucleophile and generated the undesired amino-ethoxylation product. This observation makes it 
possible to introduce other external O-based nucleophiles to form more diverse amino-oxygenation 
products. Simple reduction and deprotection will transform 1.7 to a chiral 2-indanol building 1.8 without 
                                                 
‡ Commercially available anhydrous chloroform contains 0.5-1.0% ethanol as stabilizer. 
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decreasing its ee and dr. Notably, compound 1.8 is a valuable chiral building block in many chiral indenyl-
derived ligands synthesis. 
In addition to indene asymmetric amino-hydroxylation, we also observed iron salt-L7 complex 
catalyzed asymmetric enol ether amino-oxygenation, which was not reported in the literature. Enantio-
enriched 3-amino-tetrahydrofuran-alcohol derivative 1.9 was obtained with moderate enantioselectivity 
(Scheme 1.3, eq 2, 57% ee, dr>20:1). 
 
Scheme 1.3 Iron-catalyzed asymmetric olefin amino-oxygenation 
 Control experiments that provide mechanistic insights 
To better understand this reaction, we have carried out several control experiments to probe the 
possible mechanisms (Scheme 1.4–Scheme 1.8). First of all, when N-H groups in oxidant 1.2c were 
replaced by acetyl (Ac) or methyl (Me) group  (1.11 and 1.12), neither of them are still reactive under 
standard reaction conditions (Scheme 1.4). These results suggest that the N–H group in 1.2c is crucial for 
its activation.  
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Scheme 1.4 Amino-oxygenation with N-Ac and N-Me protected acyloxyl carbamates 
A cyclopropyl-substituted olefin 1.13 is widely used as a radical clock probe in many catalytic 
reactions to prove the existence of radical species. If the reaction goes through a radical process, once the 
radical generated, the cyclopropane ring will open due to strain and radical will migrate to the benzylic 
position. In this case, a ring opened product are expected to form. Under the reaction condition, we observed 
both ring-opened product 1.14 as well as the direct 1,2-amino-hydroxylation product 1.15 (Scheme 1.5). 
Isolation of ring opening product 1.14 strongly suggests that the reaction proceeds through a stepwise 
radical amination pathway. 
 
Scheme 1.5 Iron-catalyzed amino-oxygenation of trans-2-phenyl-1-vinylcyclopropane 
When reaction condition was applied to 2,3-dimethylbutene 1.16, which is usually used as a 
carbocation probe, we isolated four products  (Scheme 1.6). In addition to the standard cyclic 1,2 amino-
oxygenation product 1.17, we also isolated a 1,3-amino-oxygenation product 1.18, an aziridine species 1.19, 
and N-Troc protected allylic amine product 1.20.  In fact, the products 1.18 and 1.20 came from 1,2-hydride 
shift process after carbocation species was generated at 2-position after the radical amination step. The 
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presence of 1,2-hydride shift products (1.18 and 1.20) indicate that a carbocation intermediate may be 
involved in the olefin amino-oxygenation process.  
 
Scheme 1.6 Iron-catalyzed amino-oxygenation of 2,3-dimethyl-1-butene 
Importantly, the aziridine 1.19 cannot be converted to any of three other products under the 
reaction conditions, which indicate that amino-oxygenation products generated from carbocation reactive 
intermediate rather than an aziridine ring opening pathway. (Scheme 1.7) 
 
Scheme 1.7 Aziridine is not an intermediate in the amino-oxygenation reaction 
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Iron-catalyzed intermolecular amino-oxygenation of cis/trans β-methyl styrenes provided some 
interesting mechanistic insights (Scheme 1.8). The Fe(OTf)2L2 complex has to be used to achieve efficient 
amino-oxygenation of both cis/trans β-methyl styrenes. While the Fe(OTf)2L1 complex will promote 
undesirable CH abstraction and decompose the catalyst. There are three observations I want to highlight. 
First of all, the trans-isomer (1.21a) is more reactive than its cis counterpart (1.21b).32 Secondly, better 
diastereoselectivity was observed in the trans-β-methyl styrene (1.21a) reaction compared to the cis 
isomer’s reaction (1.21b). In addition to that, this method offers a significantly improved regioselectivity 
compared with the osmium-based method.1 These above-mentioned observations corroborate our initial 
hypothesis that the amino-oxygenation occurs in a stepwise fashion and the CN bond formation is more 
likely the rate-determining step.  
 
Scheme 1.8 Iron-catalyzed amino-oxygenation of cis/trans β-methyl styrenes 
We also observed an interesting product distribution pattern in the styrenyl olefins amino-
oxygenation reactions (Scheme 1.9). Electron-rich styrene, such as 4-methoxy styrene, provide an 
exclusively direct amino-hydroxylation product; while in non-substituted styrene reaction, the cyclized 
oxazoline became the major product. Presumably, the electron-donating group (such as X=OMe) will 
further stabilize the benzylic radical species and allow more time for carboxylate group transfer; while, in 
the amino-oxygenation reaction of nonsubstituted styrene, the intramolecular cyclization is kinetically 
favored and affords alkoxyl oxazoline as the major product. 
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Scheme 1.9 Electronic effect on iron-catalyzed amino-oxygenation of styrenes 
With the experimental evidence obtained, we proposed a mechanistic working hypothesis for this 
iron-catalyzed intermolecular olefin amino-oxygenation reaction (Scheme 1.10A). First of all, the NO 
bond in oxidant 1.2c is reductively cleaved by the ironligand complex and an iron-nitrenoid A was 
generated.  After a stepwise, radical addition process, A subsequently added to olefin 1.28 with the 
formation of a radical species B1, which equilibrates with its conformer B2. B1 can be oxidized to a 
carbocation B3 by the iron center,33,34 presumably through outer-sphere electron transfer. B3 will go through 
an intramolecular cyclization and is captured by the neighboring carbamate group to form oxazoline product 
1.29.§ Similarly, B2 could also be oxidized by the iron (III) center through one-electron oxidation to 
generate a carbocation B4, which will bond with carboxylate group to generate the direct amino-
hydroxylation product 1.30. It is also possible that B2 couples with the carboxylate group through inner-
sphere carboxylate group transfer to deliver 1.30. ** 
                                                 
§ For evidence for involvement of a possible carbocation intermediate, see Scheme 1.6. 
** This hypothesis is supported by the cis-configuration of indene amino-oxygenation product. 
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Mechanism of the iron-catalyzed intermolecular amino-oxygenation of those conjugated diene 
substrates using tert-butoxy carbamate as oxidant (1.2b) is a bit different in the last step, which affords 
oxazolidinone through an intramolecular cyclization and elimination of isobutene (Scheme 1.10B). 
 
Scheme 1.10 Mechanistic working hypothesis for the iron-catalyzed olefin amino-oxygenation 
17 
1.3 Experimental section†† 
 Materials and general information 
Materials:  Commercial reagents were purchased from Sigma Aldrich, Fluka, EM Science, and 
Lancaster and used as received. All solvents were used after being freshly distilled unless otherwise noted. 
Instrumentation: Proton nuclear magnetic resonance (1H NMR) spectra, carbon nuclear magnetic 
resonance (13C NMR) spectra and fluorine nuclear magnetic resonance (19F NMR) were recorded on Bruker 
UltraShield-400 (400 MHz).  Chemical shifts for protons are reported in parts per million downfield from 
tetramethylsilane and are referenced to the NMR solvent residual peak (CHCl3: δ 7.26). Chemical shifts for 
carbons are reported in parts per million downfield from tetramethylsilane and are referenced to the carbon 
resonances of the NMR solvent (CDCl3: δ 77.0). Chemical shifts for fluorine are reported in parts per 
million downfield and are referenced to the fluorine resonances of CFCl3. Data are represented as follows: 
chemical shift, multiplicity (br = broad, s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet), 
coupling constants in Hertz (Hz), and integration. The mass spectroscopic data were obtained at the Georgia 
State University mass spectrometry facility using a Micromass Platform II single quadruple instrument. 
Infrared (IR) spectra were obtained using a Perkin Elmer Spectrum 100 FT-IR spectrometer. Data are 
represented as follows: frequency of absorption (cm-1) and absorption strength (s = strong, m = medium, w 
= weak).  
All reactions were performed in oven-dried or flame-dried round-bottom flasks and vials. Stainless 
steel syringes and cannula were used to transfer air- and moisture-sensitive liquids. Flash chromatography 
was performed using silica gel 60 (230-400 mesh) from Sigma–Aldrich. 
                                                 
†† (1) compounds characterization spectra are in Appendix A.1; (2) detailed procedures for the complete substrate 
table can be found in: Lu, D. F.; Zhu, C. -L.; Jia, Z. X.; Xu, H. J. Am. Chem. Soc. 2014, 136, 13186–13189. 
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 Procedures for amino-oxygenation reagents preparation 
A: preparation of N-hydroxyl ethyl carbamate 1.32a and N-hydroxyl trichloroethyl carbamate 1.32c. 
 
Hydroxylamine hydrochloride (13.9 g, 200 mmol) was added to aqueous solution of NaOH (1.5 
M, 160 mL, 240 mmol). The solution was cooled to 0 °C and ethyl or 2,2,2-trichloroethyl chloroformate 
(38 mmol) was added drop-wise. Upon the completion of addition, the mixture was warmed up to room 
temperature and stirred for additional 2 h. The reaction was then acidified with aqueous HCl (6 M) till pH 
is around 4.5. Then the mixture was extracted with Et2O (200 mL × 3) and the combined organic layers 
were washed with brine and dried over anhydrous Na2SO4. After removal of the solvent in vacuo, the N-
hydroxyl carbamate 1.32a and 1.32c were used directly for the next step without further purification. 
B: preparation of N-hydroxyl tert-butyl carbamate 1.32b.   
 
A suspension of NH2OH·HCl (9.6 g, 0.14 mol, 1.5 equiv) and K2CO3 (7.2 g, 0.07 mol, 1.5 equiv) 
in Et2O (60 mL) and H2O (2 mL) was stirred for about 1 h at room temperature with evolution of CO2 gas. 
A solution of Boc2O (20.0 g, 92 mmol) in Et2O (40 mL) was then added drop-wise at 0 °C and the 
suspension was stirred at room temperature for 12 h. The organic phase was decanted and the solid was 
washed with Et2O (30 mL × 2) and the organic layers were combined and concentrated. Recrystallization 
with a cyclohexane/toluene mixture afforded the desired product 1.32b. 
C: preparation of N-hydroxyl trifluoroethyl carbamate 1.32d.   
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To a flame-dried 100 mL round bottom flask equipped with a stir bar was added CDI (1.78 g, 11 
mmol) in anhydrous THF (30 mL). The flask was cooled to 0 °C and trifluoroethanol (0.72 mL, 10 mmol) 
was added drop-wise. The mixture was stirred for additional 1 h at room temperature and then NH2OH·HCl 
(1.04 g, 15 mmol) and imidazole (0.82g, 12 mmol) were added in one portion. The reaction was monitored 
by TLC, until the starting material disappeared (about 1 h). Then the mixture was filtered and concentrated 
in vacuo. The residue was dissolved in EtOAc (40 mL) and washed with aqueous HCl (1 M, 20 mL × 3). 
The organic layer was dried over anhydrous Na2SO4 and concentrated to afford the crude product S1d as 
colorless oil (1.35g, 85% yield), which was used directly for the next step. 
D: general procedure for the DCC coupling reaction.  
 
To a 250 mL flame-dried round bottom flask equipped with a stir bar, an N-hydroxyl carbamate 
1.32 (a-d, 20 mmol, 1.0 equiv), 2,4-dichlorobenzoic acid (4.01 g, 21 mmol) and anhydrous CH2Cl2 (80 mL) 
were added. The flask was cooled to -15 °C. DCC (4.53 g, 22 mmol, dissolved in 20 mL of anhydrous 
CH2Cl2) solution was then added drop-wise. The reaction mixture was stirred at the same temperature for 
additional 30 min until the N-hydroxyl carbamate was fully consumed (monitored by TLC). The white 
precipitate (N,N′-dicyclohexylurea) was removed by filtration and the filtrate was concentrated in vacuo 
and dissolved again in Et2O (30 mL). The solution was cooled to -20 oC for 2 h and filtered again to remove 
additional precipitate. The organic layer was then concentrated in vacuo and the residue was recrystallized 
from hexanes and EtOAc to afford corresponding acyloxyl carbamate 1.2 (1.2a-d, yields 7376%).  
The amino-oxygenation reagent 1.2a was recrystallized from hexanes/EtOAc as white solid (73% 
yield, m.p. 7173 °C). 
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Ethyl (2,4-dichlorobenzoyl)oxycarbamate (1.2a): IR νmax (neat)/cm-1: 3230 (m), 2982 (w), 1780 (s), 1709 
(s), 1580 (m), 1496 (m), 1472 (m); 1H NMR (400 MHz, CDCl3) δ 8.35 (s, 1H), 7.94 (d, J = 8.4 Hz, 1H), 
7.54 (s, 1H), 7.37 (d, J = 8.5 Hz, 1H), 4.31 (q, J = 7.1 Hz, 2H), 1.34 (t, J = 7.1 Hz, 3H); 13C NMR (100 
MHz, CDCl3) δ 163.9, 156.4, 139.9, 135.7, 132.8, 131.3, 127.3, 125.0, 63.1, 14.2; HRMS (ESI, m/z): calcd 
for C10H8Cl2NO4-, [M - H+], 275.9836, found 275.9836.  
The amino-oxygenation reagent 1.2b was recrystallized from hexanes/EtOAc as white solid (73% 
yield, m.p. 4849 °C). 
 
tert-butyl (2,4-dichlorobenzoyl)oxycarbamate (1.2b): IR νmax (neat)/cm-1: 3281 (w), 2977 (w), 1772 (m), 
1732 (s), 1583 (m), 1469 (m); 1H NMR (400 MHz, CDCl3) δ 8.20 (s, 1H), 7.95 (d, J = 8.4 Hz, 1H), 7.53 (s, 
1H), 7.36 (d, J = 8.4 Hz, 1H), 1.53 (s, 9H); 13C NMR (100 MHz, CDCl3) δ 164.1, 155.4, 139.7, 135.6, 
132.8, 131.2, 127.3, 125.1, 83.7, 28.0; HRMS (ESI, m/z): calcd for C12H12Cl2NO4-, [M - H+], 304.0149, 
found 304.0148.  
The amino-oxygenation reagent 1.2c was recrystallized from hexanes/EtOAc as white solid (76% 
yield, m.p. 8587°C). 
 
2,2,2-Trichloroethyl (2,4-dichlorobenzoyl)oxycarbamate (1.2c): IR νmax (neat)/cm-1: 3271 (m), 2957 (w), 
1747 (s), 1583 (s), 1556 (w), 1469 (m); 1H NMR (400 MHz, CDCl3) δ 8.68 (br, 1H), 7.97 (d, J = 8.5 Hz, 
1H), 7.55 (s, 1H), 7.38 (d, J = 8.5 Hz, 1H), 4.86 (s, 2H); 13C NMR (100 MHz, CDCl3) δ 163.4, 154.5, 140.3, 
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136.0, 132.9, 131.4, 127.4, 124.3, 94.3, 75.3; HRMS (ESI, m/z): calcd for C10H6Cl5NNaO4+, [M + Na+], 
401.8632, found 401.8615. 
The amino-oxygenation reagent 1.2d was recrystallized from hexanes/EtOAc as white solid (74% 
yield, m.p. 8081°C). 
 
2,2,2-Trifluoroethyl (2,4-dichlorobenzoyl)oxycarbamate (1.2d): IR νmax (neat)/cm-1: 3230 (m), 2972 (w), 
1783 (m), 1735 (s), 1583 (m), 1497 (m); 1H NMR (400 MHz, CDCl3) δ 8.52 (s, 1H), 7.94 (d, J = 8.5 Hz, 
1H), 7.56 (d, J = 1.6 Hz, 1H), 7.39 (d, J = 8.5, 1.9 Hz, 1H), 4.61 (q, J = 8.2 Hz, 2H); 13C NMR (100 MHz, 
CDCl3) δ 163.4, 154.4, 140.3, 136.0, 132.8, 131.5, 127.4, 124.2, 122.4 (q, J = 277.5 Hz), 62.1 (q, J = 37.4 
Hz); 19F NMR (376 MHz, CDCl3) δ -74.10 (t, J = 8.2 Hz); HRMS (ESI, m/z): calcd for C10H5Cl2F3NO4-, 
[M - H+],  329.9553, found 329.9552.  
 Procedures nitrogen-based tri-dentate ligands synthesis 
A: the ligand L1 was synthesized according to a modified literature procedure.35 
 
To a 100 mL flame-dried flask charged with a stir bar and a reflux condenser was added 2,6-
pyridinedicarboxylic acid (3.34 g, 20 mmol). After the flask was evacuated and backfilled with N2 twice, 
SOCl2 (30 ml) and DMF (0.2 mL) were added. The reaction was heated under a reflux condition for 3 h. 
Then the mixture was cooled to room temperature and concentrated in vacuo to afford the 2,6-
pyridinedicarbonyl dichloride as a white solid which can be used directly in the next step. Under N2 
atmosphere, to a solution of 2-amino-2-methyl-1-propanol (6.23g, 70 mmol) and Et3N (10.1g, 100 mmol) 
in CH2Cl2 (70 mL), were added 2,6-pyridinedicarbonyl dichloride in CH2Cl2 (30 mL) drop-wise at 0 °C. 
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After the reaction mixture was stirred at room temperature for 16 h, the mixture was poured into an ice-
water mixture (60 mL), which was then extracted with CH2Cl2 (60 mL × 3). The combined organic layers 
were washed with water (20 mL) and brine (20 mL), dried over anhydrous Na2SO4 and concentrated in 
vacuo. The residue was purified through a silica gel flash column (hexanes/acetone: from 10:1 to 1:1) to 
afford the intermediate 1.33 as a white solid (3.53 g, 57% yield for 2 steps) as a known compound.35 
The intermediate 1.33 (3.09 g, 10 mmol) was dissolved in toluene (40 mL) in a 100 mL flame-dried 
flask charged with a stir bar and a reflux condenser. SOCl2 (7.14 g, 60 mmol) was added via a syringe and 
the mixture was heated under a reflux condition. The reaction was monitored with TLC. When the starting 
material disappeared, the reaction was cooled to 0 °C and quenched with saturated NaHCO3 solution (30 
mL). The organic layer was separated from the aqueous one which was then extracted with EtOAc (30 mL 
× 3). The combined organic layers were dried over anhydrous Na2SO4 and concentrated in vacuo. The 
residue was filtered through a short silica gel pad with EtOAc as an eluent and concentrated again. The 
obtained oil was dissolved in anhydrous THF (50 mL) under N2 atmosphere and cooled to 0 °C. NaH (2.0 
g, 50 mmol, 60% in mineral oil) was added to the solution portion-wise and the whole mixture was then 
warmed up to room temperature and monitored by TLC until the starting material was fully consumed. The 
reaction mixture was filtered through a Celite pad, concentrated and purified through a silica gel flash 
column (hexanes/acetone: from 20:1 to 2:1) to provide the ligand L1 as a white solid (2.02 g, 74% yield for 
2 steps).  
 
2,6-Bis(4,4-dimethyl-4,5-dihydrooxazol-2-yl)pyridine (L1): ligand L1 was further purified by 
recrystallization from a mixture of hexanes/EtOAc (9:1) as a colorless crystalline solid. m.p. 139141 °C. 
IR νmax (neat)/cm-1: 3423 (w), 2967 (m), 2927 (w), 2896 (w), 1641 (s), 1573 (s), 1459 (s), 1365 (s), 1302 
(s); 1H NMR (400 MHz, CDCl3) δ 8.22 (d, J = 7.9 Hz, 2H), 7.87 (t, J = 7.9 Hz, 1H), 4.24 (s, 4H), 1.42 (s, 
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12H); 13C NMR (100 MHz, CDCl3) δ 160.9, 147.0, 137.1, 125.7, 79.8, 68.0, 28.4; HRMS (ESI, m/z): calcd 
for C15H20N3O2+, [M + H+],  274.1550, found 274.1554. 
B: the ligand L2 was synthesized from 2-cyanophenanthroline according to a published procedure.36  
 
2-Cyanophenanthroline (4.10g, 20 mmol) was dissolved in anhydrous methanol (60 mL) in a flame-
dried flask equipped with a stir bar. NaOMe (108 mg, 2 mmol) was added to the reaction. The reaction 
mixture was stirred at room temperature and monitored with TLC until the starting material was fully 
consumed. The reaction was then quenched with acetic acid (0.22 mL) and the mixture was filtered and 
concentrated in vacuo. The residue was dissolved in toluene (100 mL) together with 2-amino-2-methyl-1-
propanol (1.87 g, 21 mmol) and p-TsOH∙H2O (380 mg, 2 mmol). The reaction mixture was then heated 
under a reflux condition with a DeanStark apparatus until the intermediate was consumed. After the 
reaction was cooled to room temperature, the solvent was removed in vacuo and the residue was purified 
through a silica gel flash column (hexanes/acetone: from 2:1 to 1:2) to afford L2 as a white solid (3.6g, 
65% yield).   
 
4,4-Dimethyl-2-(1,10-phenanthrolin-2-yl)-4,5-dihydrooxazole (L2): ligand L2 was further purified by 
recrystallization from a hexanes/EtOAc mixture as a white solid. m.p. 106108 °C). IR νmax (neat)/cm-1: 
3385 (m), 3223 (m), 2966 (w), 1646 (s), 1493 (m), 1400 (s); 1H NMR (400 MHz, CDCl3) δ 9.25 (dd, J = 
4.3, 1.3 Hz, 1H), 8.43 (d, J = 8.3 Hz, 1H), 8.34 (d, J = 8.3 Hz, 1H), 8.29 (d, J = 6.9 Hz, 1H), 7.86 (q, J = 
8.8 Hz, 2H), 7.68 (dd, J = 8.1, 4.4 Hz, 1H), 4.34 (s, 2H), 1.49 (s, 6H); 13C NMR (100 MHz, CDCl3) δ 161.7, 
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150.4, 146.4, 145.9, 145.5, 136.6, 136.2, 129.4, 128.9, 128.0, 126.1, 123.4, 122.7, 79.8, 68.1, 28.5; HRMS 
(ESI, m/z): calcd for C17H16N3O+, [M + H+],  278.1288, found 278.1289.  
 General procedure for the iron-catalyzed intermolecular olefin amino-oxygenation reaction 
 
Step 1: iron-catalyzed olefin amino-oxygenation:  
To a flame-dried sealable 2-dram vial (vial A) equipped with a stir bar were added an iron salt (0.04 
mmol) and a ligand (0.04 mmol). After the vial was evacuated and backfilled with N2 for three times, 
anhydrous CH2Cl2 (1.0 mL) and MeCN (0.2 mL) were added via a syringe and the mixture was stirred at 
room temperature for 20 min. To another flame-dried 3-dram vial (vial B) equipped with a stir bar were 
added freshly activated 4Å molecular sieves (50 mg) and the corresponding acyloxyl carbamate 1.2 (0.44 
mmol). The vial was evacuated and backfilled with N2 for three times and then anhydrous CH2Cl2 (2.8 mL) 
was added. Both vials were degassed with brief evacuation and backfilling with N2 twice. Subsequently, 
freshly distilled styrene 1.1 (46 µL, 0.4 mmol) was added to vial B and the catalyst solution in vial A was 
added through a syringe pump over 15 min to vial B at -15 C. The reaction was kept at this temperature 
for additional 45 min and quenched with saturated NaHCO3 solution (2 mL). The organic layer was 
separated from the aqueous one, which was extracted with CH2Cl2 (2 mL × 2) and EtOAc (2 mL× 2). The 
combined organic layers were dried over anhydrous Na2SO4 and concentrated in vacuo. The residue was 
further purified through a silica gel flash column (hexanes/EtOAc as the eluent) to afford the amino-
oxygenation products 1.3 and 1.4. 
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Compound 1.3c was obtained from the reaction of styrene 1.1 with 1.2c and isolated through a 
silica gel flash column (hexanes (buffered with 1% TEA)/acetone: from 50:1 to 10:1) as colorless oil (83.7 
mg, 71% yield).  
 
5-Phenyl-2-(2,2,2-trichloroethoxy)-4,5-dihydrooxazole (1.3c): IR νmax (neat)/cm-1: 2952 (w), 2881 (w), 
1671 (s), 1396 (s), 1330 (s), 1249 (s); 1H NMR (400 MHz, CDCl3) δ 7.49 – 7.33 (m, 5H), 5.74 (t, J = 8.2 
Hz, 1H), 4.93 (dd, J = 16.4, 11.6 Hz, 2H), 4.27 (dd, J = 12.8, 9.6 Hz, 1H), 3.82 (dd, J = 12.9, 7.7 Hz, 1H); 
13C NMR (100 MHz, CDCl3) δ 161.6, 139.5, 128.9, 128.7, 125.7, 94.2, 83.2, 79.6, 59.7; HRMS (ESI, m/z): 
calcd for C11H11Cl3NO2+ [M + H+], 293.9850, found 293.9849.  
Compound 1.4c was obtained from the reaction of styrene 1-1 with 1-2c and isolated through a 
silica gel flash column (hexanes (buffered with 1% TEA)/acetone: from 50:1 to 10:1) as colorless oil (23.3 
mg, 12% yield).  
 
 
1-Phenyl-2-(((2,2,2-trichloroethoxy)carbonyl)amino)ethyl 2,4-dichlorobenzoate (1.4c): IR νmax 
(neat)/cm-1: 3347 (w), 2927 (m), 2851 (w), 1727 (s), 1585 (m), 1522 (m); 1H NMR (400 MHz, CDCl3) δ 
7.87 (d, J = 8.4 Hz, 1H), 7.52 (s, 1H), 7.46 – 7.30 (m, 6H), 6.13 (dd, J = 7.7, 4.3 Hz, 1H), 5.29 (brs, 1H), 
4.80 – 4.66 (m, 2H), 3.87 – 3.64 (m, 2H); 13C NMR (100 MHz, CDCl3) δ 164.0, 154.6, 138.8, 136.8, 134.9, 
132.9, 131.1, 128.9, 128.8, 127.9, 127.2, 126.6, 95.4, 76.1, 74.6, 46.1; HRMS (ESI, m/z): calcd for 
C18H13Cl5NO4- [M - H+], 481.9293, found 481.9289.  
Step 2: hydrolysis:  
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The mixture of amino-oxygenation products 1.3 and 1.4 were dissolved in THF/H2O (3:1) mixed 
solvent (3 mL) and cooled to 4 °C. After the addition of p-TsOH∙H2O (38 mg, 0.2 mmol), the reaction was 
stirred at the same temperature and monitored by TCL until 1.3 was consumed. The reaction mixture was 
then concentrated in vacuo, treated with saturated NaHCO3 solution (2 mL) and extracted with EtOAc (2 
mL× 3). The organic phase was concentrated in vacuo and dissolved again in THF/MeOH/H2O (2:2:1) 
mixture (3 mL). After addition of LiOH (12 mg, 0.5 mmol), the mixture was stirred at room temperature 
for 4 h and then quenched by aqueous HCl (1.0 M, 0.6 mL). After concentrated in vacuo, the aqueous phase 
was extracted with EtOAc (2 mL× 3). The combined organic layers were concentrated and purified by 
column. 1.5 was isolated through a silica gel flash column (hexanes/acetone: from 10:1 to 2:1) as a white 
solid, which is a known compound.37 
 Procedures for iron-catalyzed amino-oxygenation of selected olefin substrates 
A: procedure for iron-catalyzed amino-oxygenation of cyclopentadiene. 
Cyclopentadiene was freshly obtained via retro-DielsAlder reaction by heating commercially 
available cyclopentadiene dimer above 150 °C. 
 
To a flame-dried sealable 2-dram vial (vial A) equipped with a stir bar were added Fe(OTf)2 (28.3 
mg, 0.08 mmol) and L2 (22.2 mg, 0.08 mmol). After the vial was evacuated and backfilled with N2 for 
three times, anhydrous CH2Cl2 (0.7 mL) and MeCN (0.5 mL) were added via a syringe and the mixture was 
stirred at room temperature for 20 min. To another flame dried 3-dram vial (vial B) equipped with a stir bar 
were added activated 4Å molecular sieves (200 mg) and 1.2b (122.4 mg, 0.40 mmol). The vial was 
evacuated and backfilled with N2 for three times and then anhydrous CH2Cl2 (4.8 mL) was added via a 
syringe. Both solutions were degassed with brief evacuation and backfilling with N2 twice. Then, freshly 
distilled 1,3-cyclopentadiene (67.2 μL, 0.8 mmol) was added to vial B and the catalyst solution (vial A) 
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was added by a syringe pump over 30 min to vial B at 0 °C. The reaction was kept stirring at the same 
temperature for 12 h until it was completed monitored by TLC. The reaction was quenched with saturated 
NaHCO3 aqueous solution (2 mL) and stirred vigorously for additional 10 min. The organic layer was 
separated and the aqueous phase was extracted with CH2Cl2 (2 mL × 2) and EtOAc (2 mL× 2). The 
combined organic layers were dried over anhydrous Na2SO4 and concentrated in vacuo. Product 1.34 was 
isolated through a silica gel flash column (hexanes/EtOAc: from 4:1 to 1:1) as a white solid (30.5 mg, 61% 
yield) which is a known compound.38  
B: procedure for iron-catalyzed amino-oxygenation of 2,3-dihydrofuran. 
2,3-Dihydrofuran is commercially available and it was distilled before usage.  
 
To a flame-dried sealable 2-dram vial (vial A) equipped with a stir bar were added Fe(OTf)2 (14.2 
mg, 0.04 mmol) and L1 (10.9 mg, 0.04 mmol). After the vial was evacuated and backfilled with N2 for 
three times, anhydrous CH2Cl2 (1.0 mL) and MeCN (0.2 mL) were added via a syringe and the mixture was 
stirred at room temperature for 20 min. To another flame dried 3-dram vial (vial B) equipped with a stir bar 
were added activated 4Å molecular sieves (200 mg) and 1.2d (132.8 mg, 0.40 mmol). The vial was 
evacuated and backfilled with N2 for three times and then anhydrous CH2Cl2 (4.8 mL) was added via a 
syringe. Both solutions were degassed with brief evacuation and backfilling with N2 twice. Then, 2,3-
dihydrofuran (36.3 μL, 0.48 mmol) was added to vial B and the catalyst solution (vial A) was added by a 
syringe pump over 30 min to vial B at -40 °C. The reaction was kept stirring at -40 °C for another 1.5 h.  
The reaction was quenched with saturated NaHCO3 aqueous solution (2 mL) and stirred vigorously for 
additional 10 min. The organic layer was separated and the aqueous phase was extracted with CH2Cl2 (2 
mL × 2) and EtOAc (2 mL × 2). The combined organic layers were dried over anhydrous Na2SO4 and 
concentrated in vacuo. Product 1.35 was isolated through a silica gel flash column (hexanes/EtOAc: from 
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20:1 to 4:1) as white solid (115.8 mg, 72% yield, m.p. 110−111 °C). Compound 1.35 was recrystallized 
from EtOAc/hexanes and its stereochemistry was confirmed by X-ray crystallographic analysis (Figure 
1.1). 
 
Figure 1.2 X-ray crystal structure of the 2,3-dihydrofuran amino-oxygenation product 
3-(((2,2,2-Trifluoroethoxy)carbonyl)amino)tetrahydrofuran-2-yl2,4-dichlorobenzoate (1.35): IR νmax 
(neat)/cm-1: 3347 (w), 2972 (w), 2906 (w), 1724 (s), 1585 (m), 1530 (m); 1H NMR (400 MHz, CDCl3) δ 
7.85 (d, J = 8.4 Hz, 1H), 7.51 (s, 1H), 7.40 – 7.31 (m, 1H), 6.44 (d, J = 4.3 Hz, 1H), 5.36 (d, J = 8.9 Hz, 
1H), 4.59 – 4.35 (m, 3H), 4.24 (td, J = 9.3, 2.5 Hz, 1H), 4.07 (dd, J = 16.8, 8.7 Hz, 1H), 2.52 – 2.40 (m, 
1H), 2.08 – 1.92 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 164.2, 153.8, 139.0, 134.2, 133.2, 131.1, 128.1, 
127.4, 122.9 (q, J = 277.5 Hz), 96.4, 67.5, 61.2 (q, J = 36.6 Hz), 53.5, 28.6; 19F NMR (376 MHz, CDCl3) δ 
-74.25 (t, J = 8.4 Hz); HRMS (ESI, m/z): calcd for C14H12Cl2F3NNaO5+, [M + Na+], 423.9937, found 
423.9941. 
C: procedure for iron-catalyzed amino-oxygenation of D-glucal. 
The D-glucal was protected based on a known two-step procedure.39 
 
To a flame-dried sealable 2-dram vial (vial A) equipped with a stir bar were added Fe(NTf2)2 (36.9 
mg, 0.06 mmol) and L1 (16.4 mg, 0.06 mmol). After the vial was evacuated and backfilled with N2 for 
three times, anhydrous CH2Cl2 (0.8 mL) and MeCN (0.2 mL) were added via a syringe and the mixture was 
stirred at room temperature for 20 min. To another flame dried 2-dram vial (vial B) equipped with a stir bar 
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were added activated 4Å molecular sieves (100 mg), protected D-glucal (137.0 mg, 0.4 mmol) and 1.2b 
(183.6 mg, 0.60 mmol). The vial was evacuated and backfilled with N2 for three times and then anhydrous 
CH2Cl2 (1.0 mL) was added via a syringe. Both solutions were degassed with brief evacuation and 
backfilling with N2 twice. Then the catalyst solution (vial A) was added by a syringe pump over 30 min to 
vial B at -30 °C. The reaction was kept stirring at the same temperature for another 2.5 h. The reaction was 
quenched with saturated NaHCO3 aqueous solution (2 mL) and stirred vigorously for additional 10 min. 
The organic layer was separated and the aqueous phase was extracted with CH2Cl2 (2 mL × 2) and EtOAc 
(2 mL× 2). The combined organic layers were dried over anhydrous Na2SO4 and concentrated in vacuo. 
Product 1.36 was isolated through a silica gel flash column (hexanes/ether: from 10:1 to 4:1) as colorless 
oil (163.5 mg, 63% yield, [α]D20 = +88.4 (c 1.0, CH2Cl2)). 
 
(4aR,6R,7R,8R,8aR)-7-((tert-Butoxycarbonyl)amino)-2,2-dimethyl-8 
((triisopropylsilyl)oxy)hexahydropyrano[3,2-d][1,3]dioxin-6-yl 2,4-dichlorobenzoate (1.36): IR νmax 
(neat)/cm-1: 2942 (m), 2866 (m), 1724 (s), 1585, 1499, 1368, 1269, 1130 (s), 982 (s); 1H NMR (400 MHz, 
C6D6) δ 7.41 (d, J = 8.4 Hz, 1H), 6.94 (d, J = 1.7 Hz, 1H), 6.77 (brd, J = 2.5 Hz, 1H), 6.55 (d, J = 8.4 Hz, 
1H), 4.87 (d, J = 8.7 Hz, 1H), 4.38 (t, J = 8.2 Hz, 1H), 4.18 (t, J = 9.4 Hz, 1H), 3.88 (td, J = 10.1, 5.3 Hz, 
1H), 3.70 (dd, J = 10.6, 5.1 Hz, 1H), 3.47 (t, J = 10.6 Hz, 1H), 3.39 (t, J = 9.3 Hz, 1H), 1.42 (s, 9H), 1.36 
(s, 3H), 1.21 (d, J = 9.1 Hz, 21H), 1.19 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 163.6, 155.0, 139.4, 134.5, 
133.8, 131.3, 127.5, 99.7, 94.3, 80.0, 74.6, 71.3, 66.5, 62.0, 55.2, 28.9, 28.3, 18.8, 18.3, 18.2, 12.8; HRMS 
(ESI, m/z): calcd for C30H46Cl2NO8Si-,  [M - H+], 646.2375, found 646.2352.  
D: procedure for iron-catalyzed amino-oxygenation of 1-octene. 
1-Octene is commercially available and it was distilled before usage.  
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To a flame-dried sealable 2-dram vial (vial A) equipped with a stir bar were added Fe(OTf)2 (42.5 
mg, 0.12 mmol) and L1 (32.8 mg, 0.12 mmol). After the vial was evacuated and backfilled with N2 for 
three times, anhydrous CH2Cl2 (1.6 mL) and MeCN (0.4 mL) were added via a syringe and the mixture was 
stirred at room temperature for 20 min. To another flame dried vial (vial B) equipped with a stir bar were 
added activated 4Å molecular sieves (200 mg) and 1.2c (152.4 mg, 0.40 mmol). The vial was evacuated 
and backfilled with N2 for three times and then anhydrous CH2Cl2 (10 mL) was added via a syringe. Both 
solutions were degassed with brief evacuation and backfilling with N2 twice. Then 1-octene (313 μL, 2.0 
mmol) was added to vial B and the catalyst solution (vial A) was added by a syringe pump over 30 min to 
vial B at 0 °C. The reaction was kept stirring at the same temperature for 24 h. The reaction was quenched 
with saturated NaHCO3 aqueous solution (2 mL) and stirred vigorously for additional 10 min. The organic 
layer was separated and the aqueous phase was extracted with CH2Cl2 (2 mL × 2) and EtOAc (2 mL× 2). 
The combined organic layers were dried over anhydrous Na2SO4 and concentrated in vacuo.  
The residue from last step was dissolved in THF/H2O (3:1) mixed solvent (3 mL) and cooled to 0 
°C. After the addition of p-TsOH∙H2O (38 mg, 0.2 mmol), the reaction was stirred at the same temperature 
and monitored by TCL until 3 was consumed. The reaction mixture was then concentrated in vacuo, treated 
with saturated NaHCO3 solution (2 mL) and extracted with EtOAc (2 mL× 3). The organic phase was 
concentrated in vacuo and dissolved again in THF/MeOH/H2O (2:2:1) mixture (3 mL). After addition of 
LiOH (12 mg, 0.5 mmol), the mixture was stirred at room temperature for 4 h and then quenched by aqueous 
HCl (1.0 M, 0.6 mL). After concentrated in vacuo, the aqueous phase was extracted with EtOAc (2 mL× 
3). The combined organic layers were concentrated and product 1.37 was isolated through a silica gel flash 
column (hexanes/acetone: from 10:1 to 2:1) as white foam. (33.5 mg, 49% yield). 
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5-Hexyloxazolidin-2-one (1.37): IR νmax (neat)/cm-1: 2927 (m), 2856 (w), 1745 (s), 1489 (w), 1264 (w), 
1239 (m), 1077 (m); 1H NMR (400 MHz, CDCl3) δ 6.04 (brs, 1H), 4.73 – 4.56 (m, 1H), 3.68 (dd, J = 11.2, 
5.4 Hz, 1H), 3.25 (t, J = 7.8 Hz, 1H), 1.86 – 1.75 (m, 1H), 1.72 – 1.59 (m, 1H), 1.53 – 1.43 (m, 1H), 1.42 
– 1.24 (m, 7H), 0.90 (t, J = 6.9 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 160.3, 77.2, 46.0, 34.9, 31.6, 28.9, 
24.6, 22.5, 14.0; HRMS (ESI, m/z): calcd for C9H18NO2+ [M + H+], 172.1332, found 172.1324. 
E: procedure for iron-catalyzed amino-oxygenation of indene. 
Indene 1.6 is commercially available and it was distilled before usage. 
 
To a flame-dried sealable 2-dram vial (vial A) equipped with a stir bar were added Fe(NTf2)2 (36.9 
mg, 0.06 mmol) and L1 (16.4 mg, 0.06 mmol). After the vial was evacuated and backfilled with N2 for 
three times, anhydrous CH2Cl2 (0.8 mL) and MeCN (0.2 mL) were added via a syringe and the mixture was 
stirred at room temperature for 20 min. To another flame dried 2-dram vial (vial B) equipped with a stir bar 
were added activated 4Å molecular sieves (100 mg) and 1.2c (182.9 mg, 0.48 mmol). The vial was 
evacuated and backfilled with N2 for three times and then anhydrous CH2Cl2 (1.0 mL) was added via a 
syringe. Both solutions were degassed with brief evacuation and backfilling with N2 twice. Then indene 1.6 
(46.6 μL, 0.40 mmol) was added to vial B and the catalyst solution (vial A) was added by a syringe pump 
over 30 min to vial B at -15 °C. The reaction was kept stirring at the same temperature for another 30 min.  
The reaction was quenched with saturated NaHCO3 aqueous solution (2 mL) and stirred vigorously for 
additional 10 min. The organic layer was separated and the aqueous phase was extracted with CH2Cl2 (2 
mL × 2) and EtOAc (2 mL× 2). The combined organic layers were dried over anhydrous Na2SO4 and 
concentrated in vacuo. 
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Product 1.7 was isolated through a silica gel flash column (hexanes/Acetone: from = 50:1 to 10:1) 
as a white solid (125.4 mg, 63% yield, m.p. 130−131 °C). 
 
2-(((2,2,2-Trichloroethoxy)carbonyl)amino)-2,3-dihydro-1H-inden-1-yl 2,4-dichlorobenzoate (1.7): 
IR νmax (neat)/cm-1: 3352 (w), 2952 (w), 1717 (w), 1853 (m), 1515 (m); 1H NMR (400 MHz, CDCl3) δ 7.78 
(d, J = 8.5 Hz, 1H), 7.64 (d, J = 7.4 Hz, 1H), 7.48 (s, 1H), 7.41 – 7.35 (m, 1H), 7.31 (d, J = 9.8 Hz, 3H), 
6.35 (d, J = 5.5 Hz, 1H), 5.66 (d, J = 8.6 Hz, 1H), 4.93 – 4.66 (m, 3H), 3.38 (dd, J = 15.4, 7.4 Hz, 1H), 3.08 
(dd, J = 15.5, 8.2 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 164.5, 154.2, 141.5, 138.7, 138.3, 134.3, 133.0, 
131.0, 130.1, 128.4, 127.5, 127.2, 127.1, 125.0, 95.4, 77.9, 74.7, 53.8, 36.9; HRMS (ESI, m/z): calcd for 
C19H14Cl6NO4- [M + Cl-], 529.9059, found 529.9054. 
 Procedure for iron-catalyzed asymmetric amino-oxygenation of indene  
 
Step (1): to a flame-dried sealable 2-dram vial (vial A) equipped with a stir bar were added 
Fe(NTf2)2 (36.9 mg, 0.06 mmol) and a chiral ligand L7 (0.06 mmol). After the vial was evacuated and 
backfilled with N2 for three times, anhydrous CHCl3 (0.8 mL) and MeCN (0.2 mL) were added via a syringe 
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and the mixture was stirred at room temperature for 20 min. To another flame dried 2-dram vial (vial B) 
equipped with a stir bar were added activated 4Å molecular sieves (100 mg) and 1.2c (152.4 mg, 0.40 
mmol). The vial was evacuated and backfilled with N2 for three times and then anhydrous CHCl3 (3.0 mL) 
was added via a syringe. Both solutions were degassed with brief evacuation and backfilling with N2 twice. 
Then indene (55.9 μL, 0.48 mmol) was added to vial B and the catalyst solution (vial A) was added by a 
syringe pump over 30 min to vial B at -30 °C. The reaction was kept stirring at the same temperature for 
another 30 min.  The reaction was quenched with saturated NaHCO3 aqueous solution (2 mL) and stirred 
vigorously for additional 10 min. The organic layer was separated and the aqueous phase was extracted 
with CH2Cl2 (2 mL × 2) and EtOAc (2 mL× 2). The combined organic layers were dried over anhydrous 
Na2SO4 and concentrated in vacuo. The product 1.7 was isolated through a silica gel flash column 
(hexanes/acetone: from 50:1 to 6:1) as a white solid (141.3 mg, 71% yield, dr >20:1, 81% ee, [α]D20 = -60.1 
(c 1.0, CHCl3)). The ee was measured by Chiral HPLC analysis (Chiral S.S. Whelk, 1.0 mL/min, 254 nm, 
5% EtOH in hexanes, tr (minor) = 20.66 min, tr (major) = 24.88 min).  
Step (2): compound 1.7 (99.5 mg, 0.20 mmol) was dissolved in anhydrous THF (3 mL) in a 10 mL 
flask equipped with a stir bar. The flask was cooled to -20 oC and then LiAlH4 powder (15.2 mg, 0.4 mmol) 
was added in three portions. The reaction mixture was stirred at the same temperature and monitored by 
TLC. After about 20 to 30 min, the reaction was quenched with saturated NH4Cl aqueous solution (1 mL) 
and aqueous HCl (1M, 2 mL) successively. The whole mixture was filtered through a short Celite pad and 
concentrated in vacuo. The resting aqueous phase was extracted with EtOAc (2 mL × 3) and dried over 
anhydrous Na2SO4. After removal of the solvent, the residue was purified through a silica gel flash column 
(hexanes/EtOAc: from 6:1 to 2:1) to afford the N-Troc-2-aminoindanol 1.8 as a white solid (53.2 mg, 85% 
yield, dr >20:1, m.p. 130−131 °C, 81% ee, [α]D20 = +23.2 (c 1.0, CHCl3)). The ee was determined by Chiral 
HPLC analysis (Chiral S.S. Whelk, 1.0 mL/min, 265 nm, 15% EtOH in hexanes, tr (major) = 12.24 min, tr 
(minor) = 16.74 min).‡‡ 
                                                 
‡‡ HPLC trace is in Appendix A.2 
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2,2,2-Trichloroethyl (1-hydroxy-2,3-dihydro-1H-inden-2-yl)carbamate (1.8): IR νmax (neat)/cm-1: 3412 
(m), 2952 (w), 1711 (s), 1507 (s), 1401 (m), 1242 (m), 1110 (m), 1012 (m); 1H NMR (400 MHz, CDCl3) δ 
7.42 (d, J = 7.1 Hz, 1H), 7.37 – 7.19 (m, 3H), 5.79 (d, J = 7.1 Hz, 1H), 5.06 (s, 1H), 4.74 (q, J = 12.0 Hz, 
2H), 4.48 – 4.36 (m, 1H), 3.28 (dd, J = 15.7, 7.3 Hz, 1H), 2.94 (dd, J = 15.8, 7.2 Hz, 1H), 2.17 (s, 1H); 13C 
NMR (100 MHz, CDCl3) δ 154.7, 141.8, 140.8, 129.5, 127.5, 125.3, 125.1, 95.5, 74.6, 74.6, 55.1, 36.7; 
HRMS (ESI, m/z): calcd for C12H11Cl3NO3- [M – H+], 321.9810, found 321.9807.  
Step (3): to a solution of 1.8 (0.15 mmol) and activated Zn powder (245 mg, 3.75 mmol) in THF 
(2.0 mL) at room temperature was added aqueous KH2PO4 (1 M, 0.4 mL). After being stirred for 1 h at 
room temperature, the mixture was filtrated through a Celite pad, concentrated and purified through a silica 
gel flash column (CHCl3/MeOH: from 20:1 to 10:1), 1.38 was obtained as a white solid (17.2 mg, 77% 
yield), which is determined to be syn by comparing its 1H NMR data with ones from a known compound.40,41 
 Procedure for amino-oxygenation of styrene with N-Ac and N-Me protected acyloxyl carbamates 
A: procedures for preparation of N-Ac and N-Me protected acyloxyl carbamates. 
 
A1: procedure for preparation of N-Ac protected acyloxyl carbamate (1.11). 
Acyloxyl carbamate 1.2c (191 mg, 0.5 mmol) was dissolved in CH2Cl2 (3 mL) with DMAP (1.2 
mg, 0.01 mmol) and the mixture was cooled to 0 oC. To the above solution, acetyl chloride (43 uL, 0.6 
mmol, dissolved in 1mL CH2Cl2) and TEA (83 µL, 0.6 mmol, dissolved in 1mL CH2Cl2) were added drop-
wise at the same time. The reaction was kept stirring and monitored by TLC. After 2c was consumed, the 
white precipitate was removed by filtration and the filtrate was concentrated in vacuo. The residue was 
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subsequently purified through a silica gel flash column (hexanes/EtOAc: from 30:1 to 5:1) to afford 1.11 
as colorless oil (133 mg, 63% yield).  
2,2,2-Trichloroethyl acetyl((2,4-dichlorobenzoyl)oxy)carbamate (1.11): IR νmax (neat)/cm-1: 3192, 
3056, 2973, 1790 (s), 1765 (s), 1740 (s), 1583, 1375, 1295 (s), 1226 (s), 1125 (s), 1074, 1006, 956; 1H 
NMR (400 MHz, CDCl3) δ 8.03 (d, J = 8.4 Hz, 1H), 7.56 (s, 1H), 7.39 (d, J = 8.4 Hz, 1H), 4.88 (s, 2H), 
2.68 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 165.7, 161.0, 149.8, 140.3, 136.2, 133.1, 131.4, 127.3, 123.9, 
93.6, 76.1, 24.8; HRMS (ESI, m/z): calcd for C12H9Cl5NO5+ [M + H+], 421.8918, found 421.8899. 
A2: procedure for preparation of N-Me protected acyloxyl carbamate (1.12). 
Acyloxyl carbamate 1.2c (191 mg, 0.5 mmol) was dissolved in THF (3 mL) with iodomethane (51 
µL, 1 mmol) and the mixture was cooled to 0 oC. After addition of TEA (70 uL, 0.5 mmol), the reaction 
was then warmed up to room temperature gradually and kept stirring for another 5 h. The reaction mixture 
was quenched by 0.5 mL EtOH and concentrated in vacuo and the residue was purified through a silica gel 
flash column (hexanes/EtOAc: from 30:1 to 7:1) to afford 1.12 as colorless oil (144 mg, 73% yield). 
2,2,2-Trichloroethyl (2,4-dichlorobenzoyl)oxy(methyl)carbamate (1.12): IR νmax (neat)/cm-1: 2982 (w), 
1782 (m), 1732 (s), 1583 (m), 1373 (m), 1231 (s), 1160, 1074, 1041, 982; 1H NMR (400 MHz, CDCl3) δ 
7.90 (d, J = 8.4 Hz, 1H), 7.54 (s, 1H), 7.37 (dd, J = 8.4, 1.7 Hz, 1H), 4.81 (s, 2H), 3.50 (s, 3H); 13C NMR 
(100 MHz, CDCl3) δ 162.3, 153.7, 139.8, 135.6, 132.7, 131.2, 127.3, 125.1, 94.6, 75.6, 38.0; HRMS (ESI, 
m/z): calcd for C11H9Cl5NO4+ [M + H+], 393.8969, found 393.8951. 
B: procedure for amino-oxygenation of styrene with acyloxyl carbamates 1.11 and 1.12. 
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To a flame-dried sealable 2-dram vial (vial A) equipped with a stir bar were added Fe(OTf)2 (7.1 
mg, 0.02 mmol) and L1 (5.5 mg, 0.02 mmol). After the vial was evacuated and backfilled with N2 for three 
times, anhydrous CH2Cl2 (0.5 mL) and MeCN (0.1 mL) were added via a syringe and the mixture was 
stirred at room temperature for 30 min. To another flame dried 2-dram vial (vial B) equipped with a stir bar 
were added activated 4Å molecular sieves (50 mg) and potential amino-oxygenation reagents (0.22 mmol). 
The vial was evacuated and backfilled with N2 for three times and then anhydrous CH2Cl2 (1.4 mL) was 
added via a syringe. Both vials were degassed with brief evacuation and backfilling with N2 twice. Then, 
freshly distilled styrene (23 uL, 0.2 mmol) was added to vial B and the catalyst solution in vial A was added 
with a syringe pump over 30 min to vial B at -15 °C. The reaction was kept stirring at the same temperature 
for another 30 min. Both 1.11 and 1.12 were fully recovered (>95% recovery) under this condition.  
 Procedure for iron-catalyzed amino-oxygenation of trans-2-phenyl-1-vinylcyclopropane 
trans-2-Phenyl-1-vinylcyclopropane 1.13 was synthesized according to a literature procedure.42 
 
To a flame-dried sealable 2-dram vial (vial A) equipped with a stir bar were added Fe(OTf)2 (7.1 
mg, 0.02 mmol) and L1 (5.5 mg, 0.02 mmol). After the vial was evacuated and backfilled with N2 for three 
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times, anhydrous CH2Cl2 (0.5 mL) and MeCN (0.1 mL) were added via a syringe and the mixture was 
stirred at room temperature for 20 min. To another flame dried 2-dram vial (vial B) equipped with a stir bar 
were added activated 4Å molecular sieves (100 mg) and 1.2d (66.4 mg, 0.20 mmol). The vial was evacuated 
and backfilled with N2 for three times and then anhydrous CH2Cl2 (2.4 mL) was added via a syringe. Both 
solutions were degassed with brief evacuation and backfilling with N2 twice. Then, trans-2-phenyl-1-
vinylcyclopropane 1.13 (34.6 mg, 0.24 mmol) was added to vial B and the catalyst solution (vial A) was 
added by a syringe pump over 30 min to vial B at -40 °C. The reaction was kept stirring at -40 °C for 
another 30 min. The reaction was quenched with saturated NaHCO3 aqueous solution (2 mL) and stirred 
vigorously for additional 10 min. The organic layer was separated and the aqueous phase was extracted 
with CH2Cl2 (2 mL × 2) and EtOAc (2 mL× 2). The combined organic layers were dried over anhydrous 
Na2SO4 and concentrated in vacuo. Ring opening product 1.14 and direct amino-oxygenation product 1.15 
were isolated through a flash column (hexanes/EtOAc, from 50:1 to 6:1) in 42% and 23% yield, 
respectively. 
(E)-1-Phenyl-5-(((2,2,2-trifluoroethoxy)carbonyl)amino)pent-3-en-1-yl 2,4-dichlorobenzoate (1.14): 
IR νmax (neat)/cm-1: 3352 (w), 2916 (w), 2846, 1722 (s), 1585, 1517, 1376, 1279 (s), 1241(s), 1163(s), 1100 
(m), 1047 (m), 969 (m); 1H NMR (400 MHz, CDCl3) δ 7.83 (d, J = 8.4 Hz, 1H), 7.50 (s, 1H), 7.47 – 7.30 
(m, 6H), 6.04 (t, J = 6.7 Hz, 1H), 5.71 – 5.47 (m, 2H), 4.84 (s, 1H), 4.45 (q, J = 8.5 Hz, 2H), 3.76 (t, J = 
5.5 Hz, 2H), 2.87 – 2.74 (m, 1H), 2.74 – 2.63 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 164.0, 139.2, 138.5, 
134.9, 132.6, 131.1, 129.3, 128.6, 128.3, 128.0, 127.1, 126.6, 123.1 (q, J = 277.5 Hz), 60.9 (q, J = 36.6 Hz), 
42.9, 39.3; 19F NMR (376 MHz, CDCl3) δ -74.34 (t, J = 8.5 Hz); HRMS (ESI, m/z): C21H17Cl2F3NO4- [M - 
H+], 474.0492, found 474.0487. 
2-Phenylcyclopropyl-2-(((2,2,2-trifluoroethoxy)carbonyl)amino)ethyl 2,4-dichlorobenzoate (1.15): IR 
νmax (neat)/cm-1: 2921 (m) , 1727 (s), 1585, 1522, 1375, 1282 (s), 1241, 1168 (s), 1100, 1050; 1H NMR (400 
MHz, CDCl3) δ 7.84 (d, J = 8.3 Hz, 1H), 7.53 (s, 1H), 7.36 (d, J = 8.4 Hz, 1H), 7.33 – 7.28 (m, 2H), 7.21 
(t, J = 7.3 Hz, 1H), 7.09 (d, J = 7.6 Hz, 2H), 5.21 (t, J = 5.5 Hz, 1H), 4.86 (td, J = 8.3, 4.2 Hz, 1H),  4.53 – 
4.41 (m, 1H), 4.40 – 4.29 (m, 1H), 3.81 – 3.69 (m, 1H), 3.66 – 3.54 (m, 1H), 2.08 – 1.98 (m, 1H), 1.47 – 
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1.38 (m, 1H), 1.14 – 1.07 (m, 1H); 13C NMR (100 MHz, CDCl3) δ 164.7, 154.4, 141.0, 138.6, 134.7, 132.6, 
131.1, 128.5, 128.3, 127.2, 126.2, 125.9, 123.0 (q, J = 277.4 Hz), 60.9 (q, J = 36.6 Hz), 44.7, 29.7, 24.2, 
21.4, 14.1; 19F NMR (376 MHz, CDCl3) δ -74.33 (t, J = 8.5 Hz); HRMS (ESI, m/z): C21H17Cl2F3NO4- [M - 
H+], 474.0492, found 474.0496. 
 Procedure for the iron-catalyzed amino-oxygenation of 2,3-dimethyl-1-butene  
2,3-Dimethyl-1-butene is commercially available and redistilled before usage. 
 
To a flame-dried sealable 2-dram vial (vial A) equipped with a stir bar were added Fe(ClO4)2 (20.4 
mg, 0.08 mmol), L1 (21.8 mg, 0.08 mmol) and activated 4Å molecular sieves (40 mg). After the vial was 
evacuated and backfilled with N2 for three times, anhydrous CH2Cl2 (1.5 mL) and MeCN (0.3 mL) were 
added via a syringe and the mixture was stirred at room temperature for 20 min. To another flame dried 3-
dram vial (vial B) equipped with a stir bar were added activated 4Å molecular sieves (200 mg) and 1.2c 
(152.4 mg, 0.40 mmol). The vial was evacuated and backfilled with N2 for three times and then anhydrous 
CH2Cl2 (4.2 mL) was added via a syringe. Both solutions were degassed with brief evacuation and 
backfilling with N2 twice. Then 2,3-dimethyl-1-butene 1.16 (99 μL, 0.8 mmol) was added to vial B and the 
catalyst solution (vial A) was added by a syringe pump over 30 min to vial B at -15 °C. The reaction was 
kept stirring at the same temperature for 1.5 h until it was completed monitored by TLC. The reaction was 
quenched with saturated NaHCO3 aqueous solution (2 mL) and stirred vigorously for additional 10 min. 
The organic layer was separated and the aqueous phase was extracted with CH2Cl2 (2 mL × 2) and EtOAc 
(2 mL× 2). The combined organic layers were dried over anhydrous Na2SO4 and concentrated in vacuo. 
Four products were isolated through a flash column (hexanes (with 1% TEA)/EtOAc from 50:1 to 10:1).  
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Compound 1.17 was isolated as colorless oil (28.6 mg, 26% yield). 
 
5-iso-Propyl-5-methyl-2-(2,2,2-trichloroethoxy)-4,5-dihydrooxazole (1.17): IR νmax (neat)/cm-1: 2967 
(w), 2876 (w), 1689 (s), 1449 (w), 1396 (m), 1333 (m); 1H NMR (400 MHz, CDCl3) δ 4.90 – 4.77 (m, 2H), 
3.68 (d, J = 12.7 Hz, 1H), 3.42 (d, J = 12.7 Hz, 1H), 2.05 – 1.88 (m, 1H), 1.40 (s, 3H), 0.98 (t, J = 5.5 Hz, 
3H), 0.95 (d, J = 6.8 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 160.5, 94.3, 92.2, 79.1, 60.4, 36.2, 22.6, 16.9, 
16.8; HRMS (ESI, m/z): calcd for C9H15Cl3NO2+ [M + H+], 274.0163, found 274.0154. 
Compound 1.18 was isolated as colorless oil (13.2 mg, 12% yield). 
 
5,6,6-Trimethyl-2-(2,2,2-trichloroethoxy)-5,6-dihydro-4H-1,3-oxazine (1.18): IR νmax (neat)/cm-1: 2977 
(w), 1686 (s), 1456 (w), 1370 (m), 1279 (s), 1199 (m); 1H NMR (400 MHz, CDCl3) δ 4.83 – 4.65 (m, 2H), 
3.38 (dd, J = 15.7, 5.3 Hz, 1H), 3.06 (dd, J = 15.7, 10.2 Hz, 1H), 1.90 – 1.77 (m, 1H), 1.42 (s, 3H), 1.25 (s, 
3H), 0.95 (d, J = 6.9 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 151.7, 95.2, 82.1, 76.5, 47.8, 35.6, 27.1, 20.5, 
13.4; HRMS (ESI, m/z): calcd for C9H15Cl3NO2+ [M + H+], 274.0163, found 274.0154. 
Compound 1.19 was isolated as colorless oil (16.5 mg, 15% yield). 
 
2,2,2-Trichloroethyl 2-isopropyl-2-methylaziridine-1-carboxylate (1.19): IR νmax (neat)/cm-1: 2922 (w), 
1727 (s), 1378 (m), 1305 (m), 1226 (s), 1135 (m); 1H NMR (400 MHz, CDCl3) δ 4.78 (q, J = 11.9 Hz, 2H), 
2.23 (d, J = 3.7 Hz, 2H), 1.56 – 1.45 (m, 1H), 1.07 (d, J = 6.8 Hz, 3H), 1.00 (d, J = 6.9 Hz, 3H); 13C NMR 
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(100 MHz, CDCl3) δ 160.3, 95.1, 75.5, 48.9, 38.1, 34.7, 18.5, 18.2, 15.8; HRMS (ESI, m/z): calcd for 
C9H15Cl3NO2+ [M + H+], 274.0163, found 274.0155. 
Compound 1.20 isolated as colorless oil (12.1 mg, 11% yield). 
 
2,2,2-Trichloroethyl (2,3-dimethylbut-2-en-1-yl)carbamate (1.20): IR νmax (neat)/cm-1: 3332 (w), 2916 
(w), 1714 (s), 1520 (m), 1489 (w), 1234 (s), 1135 (s); 1H NMR (400 MHz, CDCl3) δ 4.86 (brs, 1H), 4.78 
(s, 2H), 3.87 (d, J = 5.4 Hz, 2H), 1.76 (s, 3H), 1.71 (s, 3H), 1.70 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 
154.7, 129.8, 123.7, 95.7, 74.5, 44.0, 20.8, 20.2, 16.9; HRMS (ESI, m/z): calcd for C9H15Cl3NO2+ [M + 
H+], 274.0163, found 274.0154. 
 Procedure for amino-oxygenation of cis/trans β-methyl styrenes 
Both trans (1.21a) and cis β-methylstyrene (1.21b) are commercially available and they were distilled 
before usage. 
  
To a flame-dried sealable 2-dram vial (vial A) equipped with a stir bar were added Fe(OTf)2 (28.3 
mg, 0.08 mmol) and L2 (22.2 mg, 0.08 mmol). After the vial was evacuated and backfilled with N2 for three 
times, anhydrous CH2Cl2 (0.7 mL) and MeCN (0.5 mL) were added via a syringe and the mixture was 
stirred at room temperature for 20 min. To another flame dried 2-dram vial (vial B) equipped with a stir bar 
were added activated 4Å molecular sieves (100 mg) and 1.2d (132.8 mg, 0.40 mmol). The vial was 
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evacuated and backfilled with N2 for three times and then anhydrous CH2Cl2 (0.8 mL) was added via a 
syringe. Both solutions were degassed with brief evacuation and backfilling with N2 twice. Then, 1.21a or 
1.21b (94.6 mg, 0.8 mmol) was added to vial B and the catalyst solution (vial A) was added by a syringe 
pump over 30 min to vial B at 0 °C. The reaction was kept stirring at the same temperature until it was 
completed (another 1.5 h for trans and 2.5 h for cis). The reaction was quenched with saturated NaHCO3 
aqueous solution (2 mL) and stirred vigorously for additional 10 min. The organic layer was separated and 
the aqueous phase was extracted with CH2Cl2 (2 mL × 2) and EtOAc (2 mL× 2). The combined organic 
layers were dried over anhydrous Na2SO4, concentrated in vacuo and purified through a silica gel flash 
column (hexanes (with 1% TEA)/acetone: from 50:1 to 10:1) 
Compound 1.22-anti was isolated from the reaction of 1.21a as colorless oil (61.2 mg, 59% yield). 
anti-4-Methyl-5-phenyl-2-(2,2,2-trifluoroethoxy)-4,5-dihydrooxazole (1.22-anti): IR νmax (neat)/cm-1: 
2967 (w), 1761 (s), 1421 (m), 1345 (m), 1264 (s), 1166 (s); 1H NMR (400 MHz, CDCl3) δ 7.48 – 7.30 (m, 
5H), 5.16 (d, J = 7.5 Hz, 1H), 4.67 (q, J = 8.0 Hz, 2H), 4.04 (p, J = 6.7 Hz, 1H), 1.41 (d, J = 6.5 Hz, 3H); 
13C NMR (100 MHz, CDCl3) δ 160.5, 138.8, 128.9, 126.7, 125.6, 122.5 (q, J = 277.6 Hz), 90.5, 67.7, 66.2 
(q, J = 37.1 Hz), 21.6; 19F NMR (377 MHz, CDCl3) δ -74.26 (t, J = 8.2 Hz); HRMS (ESI, m/z): calcd for 
C12H13F3NO2+ [M + H+], 260.0893, found 260.0882.  
Compound 1.22-syn was isolated from the reaction of 1.21b as colorless oil (15.1 mg, 14% yield).  
syn-4-Methyl-5-phenyl-2-(2,2,2-trifluoroethoxy)-4,5-dihydrooxazole (1.22-syn): IR νmax (neat)/cm-1: 
2968 (w), 1761 (s), 1421 (m), 1343 (m), 1264 (s), 1167 (s); 1H NMR (400 MHz, CDCl3) δ 7.45 – 7.31 (m, 
3H), 7.31 – 7.19 (m, 2H), 5.84 (d, J = 9.1 Hz, 1H), 4.76 – 4.59 (m, 2H), 4.45 (dq, J = 13.9, 6.9 Hz, 1H), 
0.79 (d, J = 6.9 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 161.2, 135.7, 128.4, 128.2, 125.8, 122.5 (d, J = 
277.3 Hz), 86.3, 66.2 (q, J = 37.1 Hz), 62.7, 18.2; 19F NMR (377 MHz, CDCl3) δ -74.25 (t, J = 8.2 Hz; 
HRMS (ESI, m/z): calcd for C12H13F3NO2+ [M + Na+], 260.0893, found 260.0887.  
The relative stereochemistry of 1.22-anti and 1.22-syn was determined through NOE analysis for 
both diastereomers.  
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Compound 1.23-anti was isolated from the reaction of 1.21a as colorless oil (major diastereomer, 
32.0 mg, 16% yield). 
anti-1-Phenyl-2-(((2,2,2-trifluoroethoxy)carbonyl)amino)propyl 2,4-dichlorobenzoate (1.23-anti): IR 
νmax (neat)/cm-1: 3352 (w), 2977 (w), 1719 (s), 1585 (m), 1520 (m), 1279 (m), 1163 (s); 1H NMR (400 MHz, 
CDCl3) δ 7.93 (d, J = 8.4 Hz, 1H), 7.52 (d, J = 1.6 Hz, 1H), 7.44 – 7.29 (m, 6H), 6.13 (d, J = 3.3 Hz, 1H), 
5.12 (d, J = 9.0 Hz, 1H), 4.57 – 4.39 (m, 2H), 4.39 – 4.24 (m, 1H), 1.21 (d, J = 6.9 Hz, 3H); 13C NMR (100 
MHz, CDCl3) δ 163.9, 153.8, 138.8, 136.0, 134.9, 133.1, 131.2, 128.6, 128.5, 127.8, 127.2, 126.6, 79.0, 
50.9, 15.7; 19F NMR (377 MHz, CDCl3) δ -74.25 (t, J = 8.5 Hz); HRMS (ESI, m/z): calcd for 
C19H16Cl2F3NNaO4+ [M + H+], 472.0301, found 472.0281. 
 Procedure for iron-catalyzed amino-oxygenation of 4-Me and 4-OMe styrenes 
 
A: procedure for the iron-catalyzed amino-oxygenation of 4-methyl styrene.  
4-Methyl styrene was commercially available and it was distilled before usage.  
To a flame-dried sealable 2-dram vial (vial A) equipped with a stir bar were added Fe(OTf)2 (14.2 
mg, 0.04 mmol) and L1 (10.9 mg, 0.04 mmol). After the vial was evacuated and backfilled with N2 for 
three times, anhydrous CH2Cl2 (1.0 mL) and MeCN (0.2 mL) were added via a syringe and the mixture was 
stirred at room temperature for 20 min. To another flame dried 3-dram vial (vial B) equipped with a stir bar 
were added activated 4Å molecular sieves (100 mg) and 1.2c (167.6 mg, 0.44 mmol). The vial was 
evacuated and backfilled with N2 for three times and then anhydrous CH2Cl2 (2.8 mL) was added via a 
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syringe. Both solutions were degassed with brief evacuation and backfilling with N2 twice. Then, 4-methyl 
styrene (52.7 μL, 0.40 mmol) was added to vial B and the catalyst solution (vial A) was added by a syringe 
pump over 30 min to vial B at -15 °C. The reaction was kept stirring at the same temperature for another 
30 min.  The reaction was quenched with saturated NaHCO3 aqueous solution (2 mL) and stirred vigorously 
for additional 10 min. The organic layer was separated and the aqueous phase was extracted with CH2Cl2 
(2 mL × 2) and EtOAc (2 mL× 2). The combined organic layers were dried over anhydrous Na2SO4 and 
concentrated in vacuo. 
Product 1.24 was isolated through a silica gel flash column (hexanes (with 1% TEA)/acetone from 
50:1 to 10:1) as colorless oil (46.9 mg, 38% yield). 
5-(p-Tolyl)-2-(2,2,2-trichloroethoxy)-4,5-dihydrooxazole (1.24): IR νmax (neat)/cm-1: 2951 (w), 2921 (m), 
1667 (s), 1396 (s), 1328 (s); 1H NMR (400 MHz, CDCl3) δ 7.35 – 7.16 (m, 4H), 5.71 (t, J = 8.6 Hz, 1H), 
5.01 – 4.83 (m, 2H), 4.24 (dd, J = 12.4, 10.0 Hz, 1H), 3.81 (dd, J = 12.9, 7.8 Hz, 1H), 2.38 (s, 3H); 13C 
NMR (100 MHz, CDCl3) δ 161.7, 138.7, 136.4, 129.5, 125.8, 94.2, 83.3, 79.5, 59.6, 21.2; HRMS (ESI, 
m/z): calcd for C12H13Cl3NO2+ [M + H+], 308.0006, found 307.9999.  
Product 1.25 was isolated through a silica gel flash column (hexanes (with 1% TEA)/acetone from 
50:1 to 10:1) as colorless oil (75.9 mg, 38% yield). 
1-(p-Tolyl)-2-(((2,2,2-trifluoroethoxy)carbonyl)amino)ethyl 2,4-dichlorobenzoate (1.25): IR νmax 
(neat)/cm-1:3352 (w), 2947 (w), 2921 (w), 1719 (s), 1953 (m), 1515 (m); 1H NMR (400 MHz, CDCl3) δ 
7.85 (d, J = 8.4 Hz, 1H), 7.51 (d, J = 1.8 Hz, 1H), 7.39 – 7.30 (m, 3H), 7.22 (d, J = 7.9 Hz, 2H), 6.09 (dd, 
J = 7.4, 4.7 Hz, 1H), 5.31 (t, J = 4.7 Hz, 1H), 4.78 – 4.69 (m, 2H), 3.86 – 3.66 (m, 2H), 2.37 (s, 3H);  13C 
NMR (100 MHz, CDCl3) δ 164.0, 154.6, 138.7, 138.7, 134.9, 133.8, 132.9, 131.1, 129.6, 128.0, 127.2, 
126.6, 95.5, 76.0, 74.6, 46.0, 21.2; HRMS (ESI, m/z): calcd for C19H16Cl5NNaO4+ [M + Na+], 519.9414, 
found 519.9405. 
B: procedure for the iron-catalyzed amino-oxygenation of 4-methoxyl styrene.  
4-Methoxyl styrene is commercially available and it was distilled before usage.  
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To a flame-dried sealable 2-dram vial (vial A) equipped with a stir bar were added Fe(OTf)2 (3.5 
mg, 0.01 mmol), FeCl2 (1.3 mg, 0.01 mmol) and L1 (5.5 mg, 0.02 mmol). After the vial was evacuated and 
backfilled with N2 for three times, anhydrous CH2Cl2 (1.0 mL) and MeCN (0.2 mL) were added via a 
syringe and the mixture was stirred at room temperature for 20 min and then 4-methoxyl styrene (53.9 μL, 
0.40 mmol) was added to it.  To another flame dried 2-dram vial (vial B) equipped with a stir bar were 
added activated 4Å molecular sieves (100 mg) and 1.2c (167.6 mg, 0.44 mmol). The vial was evacuated 
and backfilled with N2 for three times and then anhydrous CH2Cl2 (2.8 mL) was added via a syringe. Both 
solutions were degassed with brief evacuation and backfilling with N2 twice. Then the solution in vial A 
was added by a syringe pump over 30 min to vial B at -15 °C. The reaction was kept stirring at the same 
temperature for another 30 min. The reaction was quenched with saturated NaHCO3 aqueous solution (2 
mL) and stirred vigorously for additional 10 min. The organic layer was separated and the aqueous phase 
was extracted with CH2Cl2 (2 mL × 2) and EtOAc (2 mL× 2). The combined organic layers were dried over 
anhydrous Na2SO4, concentrated in vacuo.  
Product 1.27 was isolated through silica gel flash column (hexanes: EtOAc = 30:1 to 5:1) as 
colorless oil (165.0 mg, 80% yield). 
1-(4-Methoxyphenyl)-2-(((2,2,2-trifluoroethoxy)carbonyl)amino)ethyl 2,4-dichlorobenzoate (1.27): 
IR νmax (neat)/cm-1:3362 (w), 2952 (w), 1724 (s), 1583 (m), 1512 (s); 1H NMR (400 MHz, CDCl3) δ 7.84 
(d, J = 8.4 Hz, 1H), 7.49 (d, J = 0.8 Hz, 1H), 7.38 (d, J = 8.3 Hz, 2H), 7.32 (d, J = 8.4 Hz, 1H), 6.93 (d, J 
= 8.4 Hz, 2H), 6.08 (t, J = 6.1 Hz, 1H), 5.35 (t, J = 5.6 Hz, 1H), 4.78 – 4.68 (m, 2H), 3.82 (s, 3H), 3.75 (t, 
J = 6.1 Hz, 2H); 13C NMR (101 MHz, CDCl3) δ 164.0, 159.9, 154.6, 138.7, 134.9, 132.9, 131.1, 128.8, 
128.2, 127.2, 114.2, 95.5, 75.8, 74.6, 55.3, 45.9; HRMS (ESI, m/z): calcd for C19H16Cl5NNaO5+ [M + Na+], 
535.9363, 
  
45 
1.4 Conclusion 
We developed an iron-catalyzed intermolecular olefin amino-oxygenation method, which does not 
occur under our previously reported intramolecular conditions. With the exploration of a range of iron salts, 
ligands as well as oxidants (the amination reagents), we achieved a fine balance between the catalyst 
stability and reactivity. We also observed that non-coordinating counter ions and bulky nitrogen-based 
tridentate ligands are indispensable for the reaction and the protecting groups of hydroxylamine is crucial 
to its reactivity. This method is compatible with a broad range of synthetically valuable olefins including 
those that are incompatible with the existing amino-hydroxylation methods, such as cyclopentadienes, enol 
ethers, glycals, indene, and allyl silanes. It can effectively afford amino alcohol derivatives with regio- and 
stereochemical selectivity complementary to existing methods. The potential practical application of this 
new catalytic method was demonstrated by the gram-scale reactions of indene and glycal, which afford the 
valuable vicinal amino alcohol derivatives with very good yield and excellent stereoselectivity. Our 
preliminary mechanistic studies suggest that an iron-nitrenoid is a possible reactive intermediate, and this 
transformation goes through a stepwise, radical amination pathway. 
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2 IRON(II)-CATALYZED INTERMOLECULAR AMINOFLUORINATION OF OLEFINS§§ 
Abstract 
In this chapter, an iron-catalyzed intermolecular olefin aminofluorination method using 
nucleophilic fluoride ion will be discussed.***  Alike the intermolecular olefin amino-oxygenation method 
in Chapter 1, this method tolerates a broad range of unfunctionalized olefins, including styrenyl olefins and 
non-styrenyl olefins. With comparison to other existing olefin aminofluorination methods, this new 
approach has its advantage in broader substrate scope, complementary regio-selectivity and less expensive 
catalyst. With this method, vicinal fluoro carbamates with fluorine at the internal position can be achieved 
from simplest olefin precursors in a straightforward way. Our preliminary mechanistic studies suggest that 
it goes through a stepwise radical amination pathway with both an iron-nitrenoid and carbocation species 
as reactive intermediates.  
2.1 Introduction 
Introducing fluorine atoms to drug molecules will change their biological activities dramatically. 
Intermolecular olefin aminofluorination reactions are particularly useful because it can directly convert 
simple olefin starting materials to vicinal fluoro primary amines that are important structural motifs in many 
pharmaceuticals and biological probes (Figure 2.1).43 In particular, intermolecular olefin difunctionalization 
via fluorine atom transfer represents a convenient approach to synthesize these high-value building blocks 
with fluorine-containing stereogenic centers.44-51 Among a variety of olefin fluorination reactions, the 
intermolecular aminofluorination of unfunctionalized olefins is of great importance since it can readily 
deliver vicinal fluoro primary amines that are valuable building blocks in medicinal chemistry.52  
                                                 
§§ This chemistry was carried out with collaboration with the following co-workers: Lu, D.F. and Sears, J. D. 
*** Contents in this chapter were published in: Lu, D.-F.; Zhu, C.-L.; Sears, J. D.; Xu, H. J. Am. Chem. Soc. 2016, 138, 
11360–11367. 
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Figure 2.1 Fluoro amines and fluoro amino acids as biological probes 
Due to their significant advantages, olefin aminofluorination reactions attracted great attention and 
a few methods were reported in the literature. However most of them use electrophilic fluorine source and 
were exclusively compatible with styrenyl olefins.53-58  Among these strategies, Liu reported a palladium-
catalyzed styrene aminofluorination using electrophilic NFSI, which affords terminal sulfonamido 
fluorides;54 the same group later documented a related styrene aminofluorination using AgF that provides 
sulfonamido fluorides with fluorine at the internal position.56 Zhang reported a copper-catalyzed styrene 
aminofluorination with NFSI, which affords the same internal sulfonamide fluorides as Liu’s method with 
AF (Scheme 2.1).  
 
Scheme 2.1 Existing intermolecular olefin aminofluorination methods with electrophilic fluorine species 
In spite of these exiting strategies with electrophilic fluorine source, a catalytic amino-fluorination 
method for unfunctionalized olefins with nucleophilic fluorine donors is highly desirable (Scheme 2.2).  
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Scheme 2.2 Proposed iron-catalyzed intermolecular olefin aminofluorination using fluoride ion 
This new aminofluorination approach are expected to have two obvious advantages compared to 
other existing methods: first, it affords vicinal fluoro primary amines directly from simplest 
unfunctionalized olefin precursors; additionally, this method is potentially applicable in 18F PET imaging, 
considering the only readily available radioactive fluorine source is K18F with weakly nucleophilic fluoride.  
Built upon our success in both intra and intermolecular olefin amino-oxygenation reactions, we 
wanted to extend this iron-catalyzed olefin difunctionalization methodology to aminofluorination reaction. 
However, the development of an iron-catalyzed intermolecular olefin aminofluorination reaction 
with nucleophilic fluoride donor is challenging. First of all, due to the strong Fe–F bond, it is unlikely that 
fluoride can be transferred from the highly stable Fe–F bond. 59††† Secondly, those nucleophilic fluorine 
sources that are compatible with iron catalysis are usually weak nucleophiles.60 Regardless those 
difficulties, our group have discovered an efficient iron-catalyzed intramolecular aminofluorination of 
olefins with functionalized hydroxylamines (Scheme 2.3). In this reaction, Et3N·3HF was used as 
nucleophilic fluorine source and XtalFluor-E was applied to trap the carboxylate group (3,5-
bis(trifluoromethyl)-benzoyl) generated after N–O bond cleavage to suppress the competing 
aminohydroxylation side-reactions.26 Although XtalFluor-E was reported to be fluorine sources in some 
other deoxy-fluorination reactions, itself alone cannot deliver fluorine to olefins in this iron-catalyzed 
aminofluorination reaction. 
                                                 
††† BDE for Fe–F is 107 kcal/mol, while BDEs for Fe–Cl and Fe–Br are 80 and 58 kcal/mol, respectively. 
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Scheme 2.3 Iron-catalyzed intramolecular olefin aminofluorination 
In this chapter, a more challenging intermolecular olefin aminofluorination based on redox iron 
catalysis and N–O bond cleavage with nucleophilic fluoride ion is described (Scheme 2.4).  
 
Scheme 2.4 Iron-catalyzed intermolecular olefin aminofluorination using fluoride ion 
2.2 Results and discussions 
 Unsuccessful attempts for intermolecular olefin aminofluorination 
Inspired by our previous discovery in iron-catalyzed intramolecular aminofluorination and 
intermolecular amino-oxygenation, we simply combined both reaction conditions to do the intermolecular 
aminofluorination. When the oxidant, catalyst and ligand that are used in the intermolecular amino-
oxygenation and the fluorine source in the intramolecular aminofluorination were applied to styrene, no 
reaction was observed and both olefin and oxidants were recovered. This nonproductive outcome indicates 
that the catalysts are unable to promote the desired intermolecular olefin aminofluorination under the 
reaction condition described above (Scheme 2.5).  
 
Scheme 2.5 Early unsuccessful attempts for intermolecular olefin aminofluorination  
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 Fluoride-induced catalyst deactivation 
To find out the possible reason of catalyst deactivation under the initial reaction conditions, a few 
control experiments were carried out (Scheme 2.6). When we mixed Fe(BF4)2 catalyst and L1 ligand in the 
presence of nucleophilic fluorine source Et3N·3HF, two compounds were isolated from this system 
(Scheme 2.6, eq 1). One is insoluble FeF2 species and it is unlikely that FeF2 can transfer fluoride by 
breaking the strong Fe–F bond. The other iron complex was recrystallized from EtOAc/hexanes mixed 
solvents and was analyzed by X-ray crystallography. Its crystal structure was determined to be 
Fe(L1)2(BF4)2, in which the iron center hexa-coordinated with two ligands. Further experiments showed 
that this Fe(L1)2(BF4)2 complex was unable to catalyze known styrene aminohydroxylation reaction. This 
result suggests that the iron catalyst was deactivated by the nucleophilic Et3N·3HF. 
 
Scheme 2.6 Fluoride-induced catalyst deactivation 
 Discovery of the intermolecular olefin aminofluorination reaction 
Styrene was selected as a model substrate and the same catalyst as well as oxidant in the 
intermolecular amino-oxygenation were used to explore the intermolecular olefin aminofluorination 
reaction (Table 2.1). Since we observed significant XtalFluor-E effect in intramolecular olefin 
aminofluorination reaction, it was added to this intermolecular reaction system as the same amount as the 
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fluorine source (Et3N·3HF). The desired aminofluorination product, vicinal amino fluoride 2.3, was isolated 
for the first time although in a low yield (16%), together with the competing amino-oxygenation oxazoline 
product 2.4 (entry 1). In addition, it is not a surprise that the iron catalyst is necessary to facilitate this 
transformation (entry 2). 
With one more equivalent of XtalFluor-E, we observed a higher yield of desired fluorination 
product 2.3, but at the same time, an undesired side product imidazoline 2.5 was also detected (entry 3). 
The overall mass balance under the condition of entry 3 is approximately 70% with the excessive oxidant 
consumed. We suspected that the oxidant 1.2c was too reactive and decomposed rapidly under reaction 
condition.  
When 1.2c was replaced with less oxidative 2.2a, the reaction afforded the desired 
aminofluorination product in a comparable yield, but with a better mass balance (entry 4). Further 
increasing the XtalFluor-E loading resulted in a decreased yield of desired fluorination product (entry 5). 
Notably, no desired product was observed in the absence of Et3N·3HF (entry 6).  
This reaction affords both 2.3 and 2.4 efficiently when trichloroethoxy carbamate 2.2a was replaced 
by the more electrophilic trifluoroethoxy carbamate 2.2b (entry 7). To disfavor the formation of undesired 
oxazoline 2.4, the trifluoroethyl group was replace with hexafluoroisopropyl group and we observed a 
significantly improved yield of desired aminofluorination product (entry 8). Higher loading of XtalFluor-E 
and Et3N·3HF is beneficial to the yield of desired fluorination product (entry 9, 81% yield). 
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Table 2.1 Reaction discovery for the iron-catalyzed intermolecular olefin amino-fluorination 
 
Presumably, the side product 2.5 was generated from MeCN (co-solvent) participated Ritter-type 
reaction, which is believed to go through a carbocation intermediate (Scheme 2.8).   
 
Scheme 2.7 Mechanism of the CH3CN involved Ritter-type reaction 
To suppress the MeCN incorporated side-reaction, a preformed orange-red crystalline iron-ligand 
solid complex (cat. 1) was prepared (see experimental section for preparation). To our surprise, cat. 1 can 
catalyze styrene aminofluorination effectively in the absence of the MeCN. Aminofluorination product 2.3 
was isolated in excellent yield with minimal amount of side products 2.4 and 2.5 (Table 2.1, entry 10, 88%). 
X-ray analysis reveals that the crystal structure of cat. 1 is Fe(L1)(MeCN)(H2O)2(BF4)2,  in which the iron 
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center coordinated with one ligand, two H2O molecules and one MeCN molecule (Figure 2.2). Presumably, 
in the reaction process, H2O and MeCN disassociate from the iron center and leave it open for the iron-
nitrene generation. For comparison, in the aforementioned catalytically inactive iron complex 
Fe(L1)2(BF4)2 (Scheme 2.6), the iron center is fully occupied by two ligands, in which case the iron-nitrene 
generation is prohibited. 
 
Figure 2.2  X-ray crystal structure of Fe(L1)(MeCN)(H2O)2(BF4)2 (cat. 1) 
 Screening of other nucleophilic fluorination reagents 
To test the applicability of this novel iron-catalyzed aminofluorination method, we explored variant 
other nucleophilic fluorination reagents as fluoride donors under the optimized conditions (Table 2.2). First, 
replacements of Et3N·3HF with Et3N·HF, Et3N·2HF, TBAF·(t–BuOH)4, KF, or AgF all lead to 
decomposition of the oxidant 2.2c (entry 1). Presumably, the reaction medium may be slightly basic due to 
solvation of above fluorine source with trace amount of moisture in the reaction system and we suspect that 
the acyloxyl carbamate decomposes under weakly basic conditions. 
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Table 2.2 Screen other nucleophilic fluorination reagents 
 
 Next, XtalFluor-M also affords the desired product although in a lower yield (entry 2, 65% yield). 
Furthermore, using benzoyl fluoride instead of Et3N·3HF/XtalFluor-E leads to benzoylation of 2.2c rather 
than aminofluorination product (entry 3). Furthermore, using DFI,61 PhenoFluor,62 or DAST,63 reagents that 
can presumably sequester benzoates, leads to unproductive decomposition of 2.2c (entries 4−5). 
Surprisingly, the DAST/XtalFluor-E (1.5:1) combination can provide the desired amino fluoride 2.3c with 
good yield (entry 6).  
These results showed that XtalFluor-E and Et3N·3HF combination is uniquely effective in this 
transformation. And their relative ratio (1.6:1) will be discussed in the next section. 
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 The XtalFluor-E effects: a twofold purpose 
According to the accumulated observations, the reagent XtalFluor-E was used for two purposes in 
this intermolecular olefin aminofluorination reaction. 
First, XtalFluor-E will react Et3N·3HF to generate a catalyst-friendly XtalFluor-E/Et3N·3HF 
dynamic complexes, which could attenuate the concentration of hydrofluoric acid and therefore 
significantly slow down the fluoride-induced catalyst deactivation (Scheme 2.9). 
 
Scheme 2.8 Proposed XtalFluor-E/Et3N·3HF complex formation 
In addition, XtalFluor-E also served as carboxylate group sequester that suppresses competing 
aminohydroxylation. A possible mechanism that XtalFluor-E takes carboxylate group is described in 
Scheme 2.10 and the carboxylate ends up as an N,N-diethyl amide byproduct. 
 
Scheme 2.9 Proposed mechanism of carboxylate group trapped by XtalFluor-E 
 Substrate scope 
With the optimized reaction condition, we next explored a broad range of olefins with this new 
aminofluorination approach (Table 2.3). First, this iron-catalyzed intermolecular aminofluorination works 
very well for the styrenyl olefins, including both electron-rich styrenes and electron deficient styrenes 
(entries 1a−1d). Additionally, conjugated ene-yne and 1,1-disubstituted α-methyl styrene are both 
compatible with this method (entries 2−3). 
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An allyl silane with active α-protons was converted to an internal amino fluoride with excellent 
yield and regioselectivity (entry 4, 82% yield). The TBDP (tert-Butyldiphenyl) protecting group is 
necessary to prevent the α-protons from elimination. The silyl dienol substrate has one of its double bonds 
selectively difunctionalized. Notably, the silyl protecting group survived in the presence of fluoride ion, 
indicating our fluorination method is considerably mild (entry 5). The ethyl dienoate substrate, an electro-
deficient conjugate diene, was also tolerated by this method to produce amino allylic fluorides in reasonable 
yield (entry 6). Isoprene is also an excellent substrate, which provided a pair of vicinal amino allylic 
fluorides with an excellent yield and good regioselectivity (entry 7). Furthermore, a linear aliphatic diene 
would generate both 1,2- and 1,4-amino fluorides with excellent combined yield, which are separable from 
each other (entry 8).  
Not surprisingly, 1,1-disubstituted olefin was an excellent candidate for this reaction (entry 9). 
Moreover, even with the least reactive, unfunctionalized, monosubstituted olefin, our method still gave a 
synthetically useful yield, even though with increased catalyst loading and amount of fluorination reagents 
(entry 10). 
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Table 2.3 Substrate scope of the iron-catalyzed olefin aminofluorination reaction 
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We subsequently explored indene aminofluorination with the Fe(NTf2)2−L1 complex: an anti-2-
amino fluoride was isolated as the major product with excellent regioselectivity and significant 
diastereoselectivity (Scheme 2.11). The gram-scale aminofluorination of both indene and isoprene 
demonstrated its great potential practicality of this methodology.  
 
Scheme 2.10 Iron-catalyzed gram-scale aminofluorination of indene and isoprene 
Fluorinated amphetamines are of great interest to biological studies of the central nervous system; 
therefore, we evaluated the aminofluorination of trans-β-methyl styrene (Scheme 2.12).64 Interestingly, 
although the Fe(BF4)2−L1 complex cat.1 promotes undesirable C−H abstraction, a less sterically hindered 
Fe(NTf2)2−L2 complex catalyzes efficient aminofluorination to afford 2.10 (72% yield, dr: 2.0:1). 
 
Scheme 2.12 Ligand-controlled iron-catalyzed aminofluorination of trans-β-methyl styrene 
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Vicinal fluoro carbamates that are obtained after aminofluorination reaction, can be easily 
derivatized to N-Boc protected vicinal fluoro primary amines in excellent yields through simple base-
catalyzed hydrolysis and protection procedures (Scheme 2.13). 
 
Scheme 2.11 Derivatization of olefin aminofluorination products to vicinal fluoro amines 
 Asymmetric indene aminofluorination 
Direct enantioselective aminofluorination of unfunctionalized olefins has been a challenging 
problem in organic synthesis.65-68 With indene as a model substrate, we explored a range of chiral ligand 
and oxidants to achieve the asymmetric induction (Table 2.4).  
With Fe(NTf2)2chiral indanol PyBOX ligand L7 complex as catalyst and 2.2c as the oxidant, we 
observed significant enantioselectivity induction in indene aminofluorination that affords anti-2-amino 
fluoride 2.6c (entry 1, 60% ee). Further investigation showed that less sterically hindered acyloxyl 
carbamates, 2.2a and 2.2b, lead to increased ee, but both reactions evidently suffer from lower reactivity 
(entries 2–3, 78–83% ee). In order to achieve better reactivity, the benzoyl activating group in 2.2b was 
switched to 3,5-bis(trifluoromethyl)-benzoyl group (2.2d), while a dramatically decreased ee was observed 
(entry 4, 55% ee). By replacing the oxidant 2.2c with 2.2e, we observed a significantly improved 
enantioselectivity in indene aminofluorination in synthetically useful yield (entry 5, 59% yield, 84% ee). 
Other chiral ligands, including tridentate L8 and L9, were less effective. The results of oxidant screening 
(entries 1−5) indicated that the acyloxyl moiety are crucial for stereochemistry induction in this iron-
catalyzed indene aminofluorination and the benzoate group generated during N−O bond cleavage may be 
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involved in the ee-determining step. Additionally, since the same ee was observed for both diastereomers 
of 2.6, it is likely that the C−N bond formation step is ee-determining. 
Table 2.4 Catalyst discovery for iron-catalyzed enantioselective indene aminofluorination 
 
The absolute stereochemistry of 2.6a, b, c, d, e was determined by X-ray crystallographic analysis 
of enantio-enriched aminofluorination product 2.6c (Figure 2.2). The major product has fluorine atom and 
amino group trans to each other with the fluoride at the internal position. 
 
Figure 2.1 X-ray crystal structure of enantio-pure indene aminofluorination product 
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 Aminofluorination of myrcene and (-)-β-pinene 
We also evaluated two complex natural product substrates, myrcene and (-)-β-pinene. The 
aminofluorination of both substrates provides interesting mechanistic insight. Myrcene is a highly reactive 
system that contains both a 1,1,2-trisubstituted olefin and a conjugated diene. The aminofluorination of 
myrcene readily affords both a direct 1,2-aminofluoriantion product 2.12b and a cyclized 1,6-
aminofluorination product 2.12a (Scheme 2.14, eq 1). Presumably, once the carbo radical was generated 
and it was quickly oxidized the carbocation species. A following cascade cyclization will provide thee 
stable tertiary cation intermediate 2.12, which will subsequently afford the cyclized 1,6-aminofluorination 
product 2.12a after fluoride transfer. 
 
Scheme 2.12 Iron-catalyzed aminofluorination of myrcene and (-)-β-pinene 
Interestingly, in the aminofluorination of (-)-β-pinene, we didn't observe any 1,2-addition product, 
but rather the cyclized 1,6-aminofluorination product 2.12a and an elimination product (Scheme 2.14, eq 
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2). Unlike the myrcene’s pathway, in (-)-β-pinene aminofluorination, once the carbo radical was generated, 
the ring will open and radical migrated to the tertiary carbon, which will be oxidized to the same carbo 
cation species 2.12. The cyclized 1,6-aminofluorination product 2.12a will be formed after fluoride transfer. 
At the same time, elimination of one proton from the methyl groups will afford 2.12c. Notably, the enantio 
pure starting material (ee=92%) was converted to the enantio pure aminofluorination product (ee=91%) 
with the stereochemistry remained after aminofluorination–rearrangement cascade. The structure of 
cyclized 1,6-aminofluorination product 2.12a was confirmed by X-ray analysis (Figure 2.3).  
The observation of aminofluorination product 2.12a in myrcene reaction and elimination product 
2.12c in (-)-β-pinene reaction strongly indicate that carbocation species got involved in both pathways. 
 
Figure 2.2 X-ray crystal structure of myrcene 1,6-aminofluorination product 
 Control experiments for mechanistic studies 
We next carried out several control experiments to collect more evidence for its mechanism.  
A cyclopropyl-substituted olefin 1.13 was chosen as a radical clock probe, and the 
aminofluorination of 1.13 afforded only the ring-opening aminofluorination product 2.13 together with a 
small amount of competing amino-oxygenation product 2.14 (Scheme 2.15). This result suggests that the 
reaction proceeds through a stepwise radical amination pathway. Moreover, unlike the amino-oxygenation 
of the same radical clock probe (Scheme 1.5), no direct 1,2-addition products were detected under the 
aminofluorination condition. This discrepancy suggests that the cyclopropyl ring opening step is fast, while 
the fluoride or carboxylate transfer is rate-determining. 
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Scheme 2.13  Iron-catalyzed aminofluorination of trans-2-phenyl-1-vinylcyclopropane 
When the reaction condition was applied to a carbo cation probe 1.16, we observed both 1,2- amino 
fluoride 2.15 and 1,3-aminofluoride 2.16. Presumably, the product 2.16 is obtained through 1,2-hydride 
shift from a carbocation intermediate, which is a strong evidence that carbocation species are also involved 
in the reaction pathway (Scheme 2.16). 
 
Scheme 2.14 Iron-catalyzed aminofluorination of 2,3-dimethyl-1-butene 
To prove the role of XtalFluor-E as benzoate trapping agent, its analog XtalFluor-M was used to 
replace XtalFluor-E in standard styrene aminofluorination. ‡‡‡ Benzoylated morpholine 2.17 was isolated 
                                                 
‡‡‡  XtalFluor-M was used rather than XtalFluor-E because the benzoylated morpholine 2.17 has been fully 
characterized in the literature and is easier to isolate. 
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as a byproduct (Scheme 2.17, eq 1). In a control reaction between benzoic acid and XtalFluor-M, the same 
benzoylated morpholine product was isolated (Scheme 2.17, eq 2). These results suggest that XtalFluor-E 
or XtalFluor-M can sequester benzoic acids to suppress the competing aminohydroxylation process. 
 
Scheme 2.15 XtalFluor-M as benzoate sequester in the intermolecular aminofluorination  
 Plausible working hypothesis for the iron-catalyzed intermolecular olefin aminofluorination 
The iron-catalyzed olefin aminofluorination proceeds in a similar way as the amino-oxygenation 
reaction that is described in Chapter 1 (Scheme 2.18). 
First, the iron catalyst reductively cleaves the N−O bond in oxidant 2.2 and generates a reactive 
iron-nitrenoid species A. Next, A readily initiates radical addition to olefin 2.1 with formation of carbo-
radical species B. Subsequently, the high-valent iron intermediate may oxidize the radical to a carbocation 
C1 and its conformer C2, presumably through outer sphere single electron transfer pathway (SET). In the 
absence of nucleophilic fluoride, C1 may be efficiently captured by the neighboring carbamate group to 
afford amino-oxygenation product 2.4. While in the presence of a suitable nucleophilic fluoride and 
benzoate sequestering reagent (e.g., Et3N·3HF/XtalFluorE), C2 can be converted to amino fluoride 2.3 after 
fluorine transfer. Notably, the oxazoline 2.4 can be converted to amino fluoride 2.3 under reaction 
conditions, presumably through ring opening process and with carbocation C1 as an intermediate. 
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Scheme 2.18 Mechanistic working hypothesis for the iron-catalyzed intermolecular olefin 
aminofluorination 
2.3 Experimental section§§§ 
 Materials and general information 
Materials:  Commercial reagents were purchased from Sigma Aldrich, Fluka, EM Science, and 
Lancaster and used as received. All solvents were used after being freshly distilled unless otherwise noted. 
Instrumentation: Proton nuclear magnetic resonance (1H NMR) spectra, carbon nuclear magnetic 
resonance (13C NMR) spectra and fluorine nuclear magnetic resonance (19F NMR) were recorded on Bruker 
UltraShield-400 (400 MHz).  Chemical shifts for protons are reported in parts per million downfield from 
tetramethylsilane and are referenced to the NMR solvent residual peak (CHCl3: δ 7.26). Chemical shifts for 
carbons are reported in parts per million downfield from tetramethylsilane and are referenced to the carbon 
resonances of the NMR solvent (CDCl3: δ 77.0). Chemical shifts for fluorine are reported in parts per 
million downfield and are referenced to the fluorine resonances of CFCl3. Data are represented as follows: 
chemical shift, multiplicity (br = broad, s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet), 
coupling constants in Hertz (Hz), and integration. When 19F NMR is used for quantitative purpose (dr 
determination), 30 degrees pulse and a longer delay time (d1 = 5 s) were employed and the receiver gain 
                                                 
§§§ (1) the characterization spectra can be found in Appendix A.2; (2) detailed procedures for complete substrate 
stable can be found in: Lu, D.-F.; Zhu, C.-L.; Sears, J. D.; Xu, H. J. Am. Chem. Soc. 2016, 138, 11360–11367. 
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was manually set as 32. The mass spectroscopic data were obtained at the Georgia State University mass 
spectrometry facility using a Micromass Platform II single quadruple instrument. Infrared (IR) spectra were 
obtained using a Perkin Elmer Spectrum 100 FT-IR spectrometer. Data are represented as follows: 
frequency of absorption (cm-1) and absorption strength (s = strong, m = medium, w = weak).  
All reactions were performed in oven-dried or flame-dried round-bottom flasks and vials.  Stainless 
steel syringes and cannula were used to transfer air- and moisture-sensitive liquids. Flash chromatography 
was performed using silica gel 60 (230-400 mesh) from Sigma–Aldrich. 
 Procedure of new amination reagents preparation 
A: procedure for the synthesis of acyloxyl carbamate 2.2a and 2.2b.   
 
To a 100 mL oven-dried round bottom flask equipped with a stir bar were added S2.2a (or S2.2b) 
(21 mmol) and anhydrous Et2O (30 mL).  After the flask was cooled to -15 °C, benzoyl chloride (2.32 mL, 
20 mmol in 10 mL Et2O) and Et3N (2.92 mL, 21 mmol in 10 mL Et2O) were added dropwise simultaneously.  
The reaction was monitored by TLC until S1 (or S2) was fully consumed.  The reaction mixture was then 
washed with H2O (50 mL) and the aqueous phase was extracted by Et2O (20 mL × 2).  The combined 
organic layers were dried over anhydrous Na2SO4, concentrated in vacuo and purified through a silica gel 
flash column (hexanes/EtOAc from 30:1 to 4:1) as a white solid and further purified through 
recrystallization from the hexanes/EtOAc mixture. 
Compound 2.2a was prepared according to the above procedure and isolated as a white solid (5.11 
g, 78% yield, m.p. 94–96 °C).  
2,2,2-Trichloroethyl (benzoyloxy)carbamate (2.2a): IR νmax (neat)/cm-1: 3199 (m), 2964 (w), 2933 (w), 
1776 (s), 1734 (s), 1469 (m), 1221 (m), 1087 (s), 994 (m), 819 (m); 1H NMR (400 MHz, CDCl3) δ 8.68 
(brs, 1H), 8.19–8.04 (m, 2H), 7.70–7.60 (m, 1H), 7.54–7.45 (m, 2H), 4.87 (s, 2H); 13C NMR (100 MHz, 
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CDCl3) δ 165.5, 154.6, 134.5, 130.1, 128.8, 126.3, 94.4, 75.2; HRMS (ESI, m/z): calcd for 
C10H8Cl3NNaO4+, [M + Na+], 333.9411, found 333.9418. 
Compound 2.2b was prepared according to the above procedure and isolated as white solid (4.48 
g, 81% yield, m.p. 68–70°C).  
2,2,2-Trifluoroethyl (benzoyloxy)carbamate (2.2b): IR νmax (neat)/cm-1: 3249 (m), 2994 (w), 2967 (w), 
1773 (s), 1731 (s), 1492 (m), 1230 (m), 1172 (s), 1129 (m), 704 (m);  1H NMR (400 MHz, CDCl3) δ 8.63 
(s, 1H), 8.15–8.02 (m, 2H), 7.71–7.59 (m, 1H), 7.53–7.45 (m, 2H), 4.59 (q, J = 8.2 Hz, 1H); 19F NMR (376 
MHz, CDCl3) δ -74.15 (t, J = 8.2 Hz, 3F); 13C NMR (100 MHz, CDCl3) δ 165.4, 154.5, 134.5, 130.0, 128.8, 
126.2, 122.5 (q, J = 277.4 Hz), 61.9 (q, J = 37.4 Hz);  HRMS (ESI, m/z): calcd for C10H8F3NNaO4+, [M + 
Na+], 286.0298, found 286.0301.  
B: procedures for the synthesis of acyloxyl carbamate 2.2c. 
Method A: 
 
To an oven-dried 200 mL round bottom flask equipped with a stir bar was added hexafluoro-2-
propanol (1.8 mL, 17.1 mmol) in anhydrous THF (30 mL). The mixture was cooled to -30 °C and then 
phosgene solution (12.8 mL, 18.0 mmol, 15 wt % in toluene) was added dropwise (note: phosgene solution 
should be handedly carefully in a fume hood).  NEt(iPr)2 (3.27 mL, 18.8 mmol in 10 ml THF) was added to 
the reaction mixture in 40 min via a syringe-pump. Then the reaction mixture was warmed up to -15 °C and 
stirred for another 10 min to generate the putative carbonochloridate intermediate. O-
benzoylhydroxylamine S2.2c (prepared according to literature procedures,69,70 2.81 g, 20.5 mmol in 20 mL 
THF) was then added dropwise to the reaction mixture, which was warm up to 0 °C in 1 h.  After S2.2c 
was fully consumed monitored by TLC, the reaction was quenched with H2O (30 mL). After removal of 
THF in vacuo, the aqueous phase was extracted with Et2O (30 mL × 3). The combine organic layers were 
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dried over Na2SO4 and were concentrated in vacuo. The residue was purified through a silica gel flash 
column (hexanes/EtOAc: from 50:1 to 9:1) to afford 2.2c as a white solid (4.13 g, 73% yield, m.p. 48–
49°C). 
Method B: 
 
To an oven-dried 250 mL round bottom flask equipped with a stir bar were added CDI (7.14 g, 44 
mmol) and THF (100 mL) under N2. After the flask was cooled to 0 °C, hexafluoro-2-propanol (4.2 mL, 
40 mmol) was added dropwise via a syringe and the solution was then warmed up to room temperature.  
The reaction was monitored by 19F NMR until hexafluoro-2-propanol was fully consumed. The mixture 
was then cooled to -30 °C and S2.2c (5.5 g, 40 mmol in 30 mL THF) was added dropwise.  The reaction 
mixture was warmed up to 0 °C in 1 h. After the intermediate was consumed (monitored by TLC), the 
reaction mixture was concentrated in vacuo and re-dissolved in EtOAc (100 mL), which was washed with 
0.5 M HCl (50 mL × 2) and concentrated again.  The residue was purified through a silica gel flash column 
(hexanes/EtOAc: from 50:1 to 9:1) to afford 2.2c as a white solid (7.42 g, 56% yield, m.p. 48–49°C). 
1,1,1,3,3,3-Hexafluoropropan-2-yl (benzoyloxy)carbamate (2.2c): IR νmax (neat)/cm-1: 3269 (m), 2990 
(w), 1778 (m), 1754 (s), 1486 (m), 1382 (s), 1360 (m), 1198 (s), 1131 (s), 1128 (s), 990 (s), 906 (s), 881 
(m), 689 (m); 1H NMR (400 MHz, CDCl3) δ 8.14–8.05 (m, 2H), 7.67 (dd, J = 10.7, 4.3 Hz, 1H), 7.51 (t, J 
= 7.8 Hz, 2H), 5.80–5.65 (m, 1H);  13C NMR (100 MHz, CDCl3) δ 165.1, 152.6, 134.7, 130.1, 128.9, 125.8, 
120.2 (q, J = 283.4 Hz), 69.17–67.59 (m); 19F NMR (376 MHz, CDCl3) δ -73.46 (d, J = 6.2 Hz);  HRMS 
(ESI, m/z): calcd for C11H8F6NO4+, [M + H+], 332.0352, found 332.0350. 
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 Studies of the fluoride-induced catalyst deactivation 
 
To a flame-dried 2-dram vial equipped with a stir bar were added Fe(BF4)2·6H2O (34 mg, 0.1 
mmol), ligand L1 (27.3 mg, 0.1 mmol) and freshly activated 4Å powdered molecular sieves. After the vial 
was evacuated and backfilled with N2 three times, anhydrous CH2Cl2 (4.0 mL) and MeCN (0.4 mL) were 
added via a syringe and the mixture was stirred at room temperature for 1 h. The solution was filtered 
through a cotton wool under N2 into another 2-dram vial equipped with a stir bar followed by addition of 
Et3N·3HF (163 µL, 1.0 mmol). The mixture was stirred at room temperature for 2 h and it was filtered 
through a cotton wool under N2 to remove white FeF2 precipitate. The filtrate was then concentrated and 
dried in vacuo to afford dark-red residue. The residue was suspended and sonicated in anhydrous Et2O. 
After Et2O was removed via a syringe, the solid was dried in vacuo to afford dark-red powder.   
For the purpose of X-ray crystallographic analysis, the solid (30 mg) was recrystallized from 
CH2Cl2/MeCN (0.5/0.1 mL) and Et2O (4 ml) through vapor diffusion. The structure of Fe(L1)2(BF4)2, has 
been deposited to The Cambridge Crystallographic Data Centre as CCDC 1404792 (Figure 2.3). 
 
Figure 2.3 X-ray crystal structure of catalytically inactive Fe(L1)2(BF4)2 complex 
Test of reactivity of catalyst Fe(L1)2(BF4)2 in styrene aminohydroxylation:  
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To a flame-dried sealable 2-dram vial (vial A) equipped with a stir bar were added catalyst 
Fe(L1)2(BF4)2 (17.1 mg, 0.02 mmol), and freshly activated 4 Å powdered molecular sieves (20 mg).  Vial 
A was degassed and backfilled with N2 three times and then anhydrous CH2Cl2 (0.5 mL) and MeCN (0.1 
mL) were added via a syringe and the mixture was stirred at room temperature for 20 min. To another 
flame-dried 3-dram vial (vial B) equipped with a stir bar were added freshly activated 4 Å powdered 
molecular sieves (50 mg) and the corresponding acyloxyl carbamate 1.2c (91 mg, 0.24 mmol). The vial was 
evacuated and backfilled with N2 for three times and then anhydrous CH2Cl2 (1.5 mL) was added. Both 
vials were degassed with N2 twice and vial B was then cooled to -15 °C. Freshly distilled styrene (23 µL, 
0.2 mmol) was added to vial B and the catalyst solution in vial A was added through a syringe pump over 
15 min to vial B at -15 C. The reaction was kept at this temperature for additional 2 h and quenched with 
saturated NaHCO3 solution (2 mL). Styrene and 1.2c were recovered and there is no desired olefin 
aminohydroxylation product formation. 
 Catalytically active Fe(L1)(MeCN)(H2O)2(BF4)2 complex preparation 
 
To a flame-dried 25 mL round bottom flask equipped with a stir bar were added Fe(BF4)2·6H2O 
(168.8 mg, 0.5 mmol), ligand L1 (136.5 mg, 0.5 mmol) and freshly activated 4 Å powdered molecular 
sieves. After the vial was evacuated and backfilled with N2 three times, anhydrous CH2Cl2 (6 mL) and 
MeCN (2 mL) were added via a syringe and the mixture was stirred at room temperature for 1 h. The 
solution was filtered through a cotton wool under N2 and the filtrate was concentrated and dried in vacuo 
to afford orange color residue, which was suspended and sonicated in anhydrous Et2O under N2. After Et2O 
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was removed via a syringe, the catalyst complex was further dried in vacuo, which can be directly used in 
catalytic reactions. For the purpose of X-ray crystallographic analysis, the aforementioned solid (30 mg) 
was recrystallized from CH2Cl2/MeCN (0.5/0.1 mL) and Et2O (4 ml) through vapor diffusion. The structure 
of cat.1 has been deposited to The Cambridge Crystallographic Data Centre as CCDC 1404791 (Figure 
2.1). 
 General procedure for the iron-catalyzed intermolecular olefin aminofluorination reaction 
Procedure A: with pre-mixed Fe(NTf2)2/ligand catalyst. 
 
To a flame-dried sealable 2-dram vial (vial A) equipped with a stir bar were added Fe(NTf2)2 (12.3 
mg, 0.02 mmol) and L1 (5.5 mg, 0.02 mmol). After vial A was evacuated and backfilled with N2 three 
times, anhydrous CH2Cl2 (0.5 mL) and MeCN (0.08 mL) were added and the mixture was stirred at room 
temperature for 20 min. To a second flame-dried sealable 2-dram vial (vial B) equipped with a stir bar were 
added XtalFluor-E (various equivalents for different experiments) and freshly activated powdered 4 Å 
molecular sieves (50 mg). After vial B was evacuated and backfilled with N2 three times, anhydrous CH2Cl2 
(2.0 mL) and Et3N·3HF (various equivalents for different experiments) were added. The mixture was stirred 
at room temperature for 10 min. To a third flame-dried sealable 3-dram vial (vial C) equipped with a stir 
bar were added acyloxyl carbamate 2.2 (0.22 mmol) and freshly activated powdered 4 Å molecular sieves 
(100 mg). It was evacuated and backfilled with N2 three times and then anhydrous CH2Cl2 (0.5 mL) was 
added. After vial C was cooled to -15 °C, freshly distilled styrene (23 µL, 0.2 mmol) was added, followed 
by the addition of fluorinating reagents in vial B via a syringe. The catalyst solution in vial A was then 
added to vial C via a syringe pump at -15 C over 15 min and the reaction was kept at this temperature for 
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additional 2 h and quenched with saturated NaHCO3 solution (3 mL). The organic layer was separated from 
the aqueous one, which was extracted with CH2Cl2 (2 mL × 3). The combined organic layers were dried 
over anhydrous Na2SO4 and concentrated in vacuo. The residue was purified through a silica gel flash 
column (hexanes/acetone: from 100:1 to 4:1) to afford the desired styrene aminofluorination product. 
Compound 2.3a was isolated from the experimental condition in entry 4 of Table 2.1 as a white 
solid (28.3 mg, 45% yield, m.p. 57–58 °C).   
 
2,2,2-Trichloroethyl-(2-fluoro-2-phenylethyl)carbamate (2.3a): IR νmax (neat)/cm-1: 3344 (m), 2946 (w), 
1703 (s), 1540 (s), 1453 (m), 1250 (s), 1161 (m), 1040 (m), 959 (m), 832 (m), 650 (m); 1H NMR (400 MHz, 
CDCl3) δ 7.48–7.29 (m, 5H), 5.58 (ddd, J = 48.2, 8.3, 3.1 Hz, 1H), 5.46 (brs, 1H), 4.79–4.69 (m, 2H), 3.77 
(dddd, J = 30.2, 14.8, 7.5, 3.2 Hz, 1H), 3.54 (dddd, J = 17.8, 14.7, 8.3, 4.9 Hz, 1H); 13C NMR (100 MHz, 
CDCl3) δ 154.7, 136.7 (d, J = 19.5 Hz), 129.0 (d, J = 1.7 Hz), 128.7, 125.5 (d, J = 7.1 Hz), 95.4, 92.8 (d, J 
= 173.4 Hz), 74.7, 46.9 (d, J = 24.1 Hz); 19F NMR (376 MHz, CDCl3) δ -183.75 (ddd, J = 48.0, 30.2, 17.7 
Hz, 1F), -184.88 (ddd, J = 48.0, 30.2, 17.7 Hz, rotamer); HRMS (ESI, m/z): calcd for C11H12Cl3FNO2+, [M 
+ H+], 313.9912, found 313.9919. 
Compound 2.3b was isolated from the experimental condition in entry 7 of Table 2.1 as a white 
solid (24.4 mg, 46% yield, m.p. 56–57 °C).  
 
2,2,2-Trifluoroethyl-(2-fluoro-2-phenylethyl)carbamate (2.3b): IR νmax (neat)/cm-1: 3335 (m), 2970 (w), 
1709 (s), 1551 (s), 1247 (m), 1155 (s), 968 (m), 795 (m), 697 (m); 1H NMR (400 MHz, CDCl3) δ 7.49–
7.32 (m, 5H), 5.58 (ddd, J = 48.3, 8.3, 3.1 Hz, 1H), 5.33 (brs, 1H), 4.50 (q, J = 8.5 Hz, 2H), 3.78 (dddd, J 
= 30.3, 14.8, 7.7, 3.2 Hz, 1H), 3.53 (dddd, J = 17.5, 14.7, 8.4, 4.7 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 
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154.5, 136.7 (d, J = 19.5 Hz), 129.0 (d, J = 1.7 Hz), 128.7, 125.5 (d, J = 7.1 Hz), 123.0 (q, J = 277.4 Hz), 
92.7 (d, J = 173.5 Hz), 61.1 (q, J = 36.7 Hz), 46.9 (d, J = 24.2 Hz); 19F NMR (376 MHz, CDCl3) δ -74.32 
(t, J = 8.5 Hz, 3F), -184.00 (ddd, J = 48.0, 30.4, 17.5 Hz, 1F), -184.83 (ddd, J = 48.0, 30.4, 17.5 Hz, 
rotamer); HRMS (ESI, m/z): calcd for C11H11F4NO2Na+, [M + Na+], 288.0618, found 288.0623. 
Procedure B: optimized with pre-formed solid Fe(L1)(MeCN)(H2O)2(BF4)2 complex (cat.1). 
 
To a flame-dried sealable 2-dram vial (vial A) equipped with a stir bar were added XtalFluor-E 
(115 mg, 0.5 mmol) and freshly activated 4 Å powdered molecular sieves (50 mg). After the vial was 
evacuated and backfilled with N2 three times, anhydrous CH2Cl2 (1.5 mL) and Et3N·3HF (49 µL, 0.3 mmol) 
were added successively via syringes. The mixture was stirred at room temperature for 20 min. To another 
flame-dried sealable 3-dram vial (vial B) equipped with a stir bar were added cat.1 
(Fe(L1)(MeCN)(H2O)2(BF4)2, 11.6 mg, 0.02 mmol), and freshly activated 4 Å powdered molecular  sieves 
(100 mg). Vial B was evacuated and backfilled with N2 three times and anhydrous CH2Cl2 (0.75 mL) was 
added. Both vials were degassed and backfilled with N2 twice and vial B was cooled to -30 °C. Freshly 
distilled styrene (23 µL, 0.2 mmol) was then added into vial B followed by addition of the fluorinating 
reagents in vial A via a syringe. Acyloxyl carbamate 2.2c (79.4 mg, 0.24 mmol) in 0.75 mL CH2Cl2 was 
added dropwise at last to vial B. The reaction was kept at -30 °C for 30 min and allowed to warm up 
gradually to -15°C. The reaction was kept at this temperature for additional 1 h and quenched with saturated 
NaHCO3 solution (3 mL). The organic layer was separated from the aqueous one, which was extracted with 
CH2Cl2 (2 mL × 3). The combined organic layers were dried over anhydrous Na2SO4 and concentrated in 
vacuo. The residue was purified through a silica gel flash column (hexanes/acetone: from 100:1 to 4:1) to 
afford 2.3c as a white solid (58.6 mg, 88% yield, m.p. 9597 °C). 
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1,1,1,3,3,3-Hexafluoropropan-2-yl (2-fluoro-2-phenylethyl)carbamate (2.3c): IR νmax (neat)/cm-1: 3327 
(m), 2967 (w), 1740 (s), 1555 (s), 1383 (m), 1253 (s), 1190 (s), 1162 (m), 1107 (s), 960 (m), 903 (m), 763 
(m), 699 (m);  1H NMR (400 MHz, C6D6) δ 7.08–6.99 (m, 3H), 6.98–6.92 (m, 2H), 5.77–5.66 (m, 1H), 5.01 
(ddd, J = 48.0, 8.0, 3.2 Hz, 1H), 4.41 (brs, 1H), 3.13 (dddd, J = 28.4, 14.7, 7.0, 3.3 Hz, 1H), 2.91 (dddd, J 
= 17.8, 14.5, 8.0, 5.5 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 152.7, 136.3 (d, J = 19.5 Hz), 129.1 (d, J = 
1.6 Hz), 128.8, 125.4 (d, J = 7.1 Hz), 120.6 (q, J = 282.5 Hz), 92.4 (d, J = 173.9 Hz), 68.9–66.6 (m), 47.1(d, 
J = 24.3 Hz); 19F NMR (376 MHz, C6D6) δ -73.72 (d, J = 6.2 Hz, 6F), -183.86 (ddd, J = 48.0, 29.0, 18.2 
Hz, 1F), -184.72 (ddd, J = 48.0, 29.0, 18.2 Hz, rotamer); HRMS (ESI, m/z): calcd for C12H10F7NO2Na+, [M 
+ Na+], 356.0492, found 356.0481.  
 Procedures for iron-catalyzed aminofluorination of selected olefin substrates 
A: procedure for iron-catalyzed aminofluorination of allyl(tert-butyl)diphenylsilane. 
Allyl(tert-butyl)diphenylsilane S2.18 was synthesized according to a literature procedure.71   
 
To a flame-dried sealable 2-dram vial (vial A) equipped with a stir bar were added XtalFluor-E 
(115 mg, 0.5 mmol) and freshly activated 4 Å powdered molecular sieves (50 mg). After the vial was 
evacuated and backfilled with N2 three times, anhydrous CH2Cl2 (1.5 mL) and Et3N·3HF (49 µL, 0.3 mmol) 
were added successively via syringes. The mixture was stirred at room temperature for 20 min. To another 
flame-dried sealable 3-dram vial (vial B) equipped with a stir bar were added the preformed catalyst 
Fe(L1)(BF4)2(MeCN)(H2O)2 (11.6 mg, 0.02 mmol) and freshly activated 4 Å powdered molecular sieves 
(100 mg). Vial B was evacuated and backfilled with N2 three times and then anhydrous CH2Cl2 (0.75 mL) 
was added.  Both vials were degassed and backfilled with N2 twice and vial B was cooled to -35 °C. Allyl 
silane S2.18 (56.1 mg, 0.2 mmol) was added into vial B followed by addition of fluorinating reagent 
solution in vial A via a syringe. Acyloxyl carbamate 2.2c (79.4 mg, 0.24 mmol) in 0.75 mL CH2Cl2 was 
75 
added dropwise at last to vial B. The reaction was kept at -35 °C for 4 h and quenched with saturated 
NaHCO3 solution (3 mL).  The organic layer was separated from the aqueous one, which was extracted 
with CH2Cl2 (2 mL × 3).  The combined organic layers were dried over anhydrous Na2SO4 and concentrated 
in vacuo.  The residue was purified through a silica gel flash column (hexanes/acetone: from 100:1 to 10:1) 
to afford the desired product 2.18 as white foam (88.7 mg, 87% yield). 
1,1,1,3,3,3-Hexafluoropropan-2-yl (3-(tert-butyldiphenylsilyl)-2-fluoropropyl)carbamate (2.18): IR 
νmax (neat)/cm-1: 3348 (m), 2934 (w), 2861 (w), 1754 (s), 1527 (s), 1387 (m), 1236 (s), 1198 (s), 1109 (m), 
701 (m);  1H NMR (400 MHz, CDCl3) δ 7.72–7.53 (m, 4H), 7.53–7.30 (m, 6H), 5.72–5.55 (m, 1H), 5.22 
(brs, 1H), 4.65 (dddd, J = 49.1, 14.3, 7.6, 2.6 Hz, 1H), 3.34 (dddd, J = 28.9, 14.5, 7.0, 2.6 Hz, 1H), 3.16 
(dddd, J = 19.4, 14.4, 7.5, 5.1 Hz, 1H), 1.78 (td, J = 15.3, 7.7 Hz, 1H), 1.48 (ddd, J = 21.4, 15.5, 7.1 Hz, 
1H), 1.07 (s, 9H);  13C NMR (100 MHz, CDCl3) δ 152.5, 135.95, 135.86, 133.5, 133.2, 129.62, 129.55, 
127.9, 127.8, 120.6 (q, J = 282.2 Hz), 91.1 (d, J = 170.9 Hz), 68.8–66.6 (m), 47.5 (d, J = 21.4 Hz), 27.6, 
18.0, 15.5 (d, J = 21.4 Hz);  19F NMR (376 MHz, CDCl3) δ -73.45–-73.82 (m, 6F), -169.3–-169.8 (m, 1F);  
HRMS (ESI, m/z): calcd for C23H26F7NO2SiNa+, [M + Na+], 532.1513, found 532.1493. 
B: procedure for iron-catalyzed aminofluorination of (E)-triisopropyl(penta-2,4-dien-1-yloxy)silane. 
(E)-triisopropyl(penta-2,4-dien-1-yloxy)silane S2.19 was prepared according to a literature procedure.72 
 
To a flame-dried sealable 2-dram vial (vial A) equipped with a stir bar were added XtalFluor-E 
(184 mg, 0.8 mmol) and freshly activated 4 Å powdered molecular sieves (50 mg). After the vial was 
evacuated and backfilled with N2 three times, anhydrous CH2Cl2 (2.5 mL) and Et3N·3HF (79 µL, 0.48 
mmol) were added successively via syringes. The mixture was stirred at room temperature for 20 min. To 
another flame-dried sealable 3-dram vial (vial B) equipped with a stir bar were added the preformed 
Fe(NTf2)2L1 complex (27.9 mg, 0.03 mmol) and freshly activated 4 Å powdered molecular sieves (100 
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mg). Vial B was evacuated and backfilled with N2 three times and then anhydrous CH2Cl2 (0.75 mL) was 
added.  Both vials were degassed and backfilled with N2 twice and vial B was cooled to -35 °C.  (E)-
Triisopropyl(penta-2,4-dien-1-yloxy)silane S2.19 (68 µL, 0.24 mmol) was then added into vial B followed 
by the addition of fluorinating reagent solution in vial A via a syringe. Acyloxyl carbamate 2.2c (66.2 mg, 
0.20 mmol) in 0.75 mL CH2Cl2 was added dropwise at last to vial B and the reaction was kept at -35 °C for 
3 h and quenched with saturated NaHCO3 solution (3 mL). The organic layer was separated from the 
aqueous one, which was extracted with CH2Cl2 (2 mL × 3). The combined organic layers were dried over 
anhydrous Na2SO4 and concentrated in vacuo. The residue was purified through a silica gel flash column 
(hexanes/acetone: from 100:1 to 10:1) to afford the desired product 2.19 as colorless oil (61.1 mg, 65% 
yield).   
1,1,1,3,3,3-Hexafluoropropan-2-yl (E)-(2-fluoro-5-((tri-iso-propylsilyl)oxy)pent-3-en-1-yl)carbamate 
(2.19): IR νmax (neat)/cm-1:2942 (m), 2866 (m), 1747 (s), 1527 (m), 1385 (m), 1290 (m), 1232 (s), 1193 (s), 
1108 (s);  1H NMR (400 MHz, CDCl3) δ 6.05–5.93 (m, 1H), 5.87–5.76 (m, 1H), 5.73–5.61 (m, 1H), 5.46 
(brs, 1H), 5.16–4.91 (m, 1H), 4.34–4.27 (m, 2H), 3.62 (dddd, J = 27.6, 14.6, 7.2, 3.2 Hz, 1H), 3.38 (dddd, 
J = 19.4, 14.6, 7.7, 5.0 Hz, 1H), 1.18–0.98 (m, 21H); 13C NMR (100 MHz, CDCl3) δ 152.7, 135.5 (d, J = 
10.5 Hz), 122.9 (d, J = 18.8 Hz), 120.6 (q, J = 282.7 Hz), 91.2 (d, J = 169.8 Hz), 68.8–66.7 (m), 62.5 (d, J 
= 0.9 Hz), 45.6 (d, J = 22.8 Hz), 17.9, 12.0;  19F NMR (376 MHz, CDCl3) δ -73.60–-73.85 (m, 6F), -181.45–
-181.96 (m, 1F); HRMS (ESI, m/z): calcd for C18H31F7NO3SiNa+, [M + Na+], 470.1956, found 470.1961. 
C: procedure for iron-catalyzed aminofluorination of 1-octene. 
1-Octene is commercially available and it was distilled before usage. 
 
To a flame-dried sealable 2-dram vial (vial A) equipped with a stir bar were added Fe(NTf2)2 (36.9 
mg, 0.06 mmol) and L1 (16.4 mg, 0.06 mmol). After vial A was evacuated and backfilled with N2 three 
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times, anhydrous CH2Cl2 (0.65 mL) and MeCN (0.15 mL) were added via a syringe and the mixture was 
stirred at room temperature for 20 min. To a second flame-dried sealable 2-dram vial (vial B) equipped 
with a stir bar were added XtalFluor-E (69 mg, 0.3 mmol) and freshly activated 4 Å powdered molecular 
sieves (50 mg). After vial B was evacuated and backfilled with N2 three times, anhydrous CH2Cl2 (1.0 mL) 
and Et3N·3HF (29 µL, 0.18 mmol) were added successively via syringes. The mixture was stirred at room 
temperature for 20 min. To another flame-dried sealable 3-dram vial (vial C) equipped with a stir bar were 
added acyloxyl carbamate 2.2c (66.2 mg, 0.20 mmol) and freshly activated 4 Å powdered molecular sieves 
(100 mg). Vial C was evacuated and backfilled with N2 three times and then anhydrous CH2Cl2 (0.3 mL) 
was added. All three vials were degassed and backfilled with N2 twice and vial C was cooled to -30 °C.  
Freshly distilled 1-octene (157 µL, 1.0 mmol) was then added into vial C followed by the addition of 
fluorinating reagent solution in vial B via a syringe. The catalyst solution in vial A was added with a syringe 
pump over 20 min to vial C at -30 C and the reaction was warmed up to 0 °C and kept stirring for additional 
5 minutes. Meanwhile, to another flame-dried sealable 2-dram vial (vial D) equipped with a stir bar was 
added XtalFluor-E (115 mg, 0.5 mmol).  Vial D was evacuated and backfilled with N2 three times, then 
anhydrous CH2Cl2 (1.0 mL) and Et3N·3HF (82 µL, 0.5 mmol) were added successively via syringes. After 
being stirred at room temperature for 10 min, the solution in vial D was added to vial C via a syringe at 0 
°C. The reaction in vial C was stirred at 0 °C for additional 2 h and quenched with saturated NaHCO3 
solution (3 mL). The organic layer was separated from the aqueous one, which was extracted with CH2Cl2 
(2 mL × 3). The combined organic layers were dried over anhydrous Na2SO4 and concentrated in vacuo.  
The residue was purified through a silica gel flash column (hexanes/acetone: from 100:1 to 10:1) to afford 
the desired product 2.8 as a white solid (42.3 mg, 62% yield, m.p. 55–56 °C). 
1,1,1,3,3,3-Hexafluoropropan-2-yl (2-fluorooctyl)carbamate (2.8): IR νmax (neat)/cm-1: 3669 (m), 3331 
(m), 2969 (m), 1741 (s), 1558 (m), 1385 (m), 1251 (s), 1197 (s), 1153 (m), 1107 (s), 1066 (m), 951 (m), 
903(m), 690 (m);  1H NMR (400 MHz, CDCl3) δ 5.75–5.62 (m, 1H), 5.41 (brs, 1H), 4.68–4.45 (m, 1H), 
3.57 (dddd, J = 29.5, 14.6, 7.1, 2.6 Hz, 1H), 3.32 (dddd, J = 19.7, 14.5, 7.6, 5.1 Hz, 1H), 1.81–1.22 (m, 
10H), 0.89 (t, J = 6.7 Hz, 3H);  13C NMR (100 MHz, CDCl3) δ 152.8, 120.6 (q, J = 283.2 Hz), 92.7 (d, J = 
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169.8 Hz), 69.1–66.6 (m), 45.5 (d, J = 20.6 Hz), 32.1 (d, J = 19.9 Hz), 31.6, 28.9, 24.7 (d, J = 4.7 Hz), 22.5, 
14.0;  19F NMR (376 MHz, CDCl3) δ -73.51–-73.82 (m, 6F), -186.23–-186.79 (m, 1F);  HRMS (ESI, m/z): 
calcd for C12H19F7NO2+, [M + H+], 342.1299, found 342.1285.  
D: procedure for iron-catalyzed aminofluorination of indene at gram scale.  
Indene is commercially available and it was distilled before usage.  
 
To a flame-dried 25 mL round bottom flask (flask A) equipped with a stir bar were added Fe(NTf2)2 
(461 mg, 0.75 mmol) and L1 (205 mg, 0.75 mmol). After flask A was evacuated and backfilled with N2 
three times, anhydrous CH2Cl2 (8.0 mL) and MeCN (1.6 mL) were added via a syringe and the mixture was 
stirred at room temperature for 20 min. To a second flame-dried 100 mL round bottom flask (flask B) 
equipped with a stir bar were added XtalFluor-E (5.73 g, 25 mmol) and freshly activated 4 Å powdered 
molecular sieves (1.5 g). After flask B was evacuated and backfilled with N2 three times, anhydrous CH2Cl2 
(60 mL) and Et3N·3HF (2.44 mL, 15 mmol) were added successively via syringes. The mixture was stirred 
at room temperature for 20 min. To another flame-dried sealable 250 mL round bottom flask (flask C) 
equipped with a stir bar were added 2.2c (1.655g, 5.0 mmol) and freshly activated 4 Å powdered molecular 
sieves (2.5 g). Flask C was evacuated and backfilled with N2 three times and then anhydrous CH2Cl2 (100 
mL) was added. All three flasks were degassed and backfilled with N2 twice and flask C was cooled to -78 
°C. Freshly distilled indene (0.9 mL, 7.5 mmol) was added into flask C. Pre-cooled fluorinating reagent 
solution in flask B (in -35 °C cold bath) was quickly transferred to flask C (in -78 °C cold bath) via a 
stainless steel cannula. Flask C was moved to -35 °C cold bath and the catalyst solution in flask A was 
added with a syringe pump over 20 min to flask C. The reaction was kept at -35 °C for additional 3 h and 
allowed to warm up gradually to -15 °C. After being stirred at -15 °C for 3 h, the reaction mixture was 
quenched with saturated NaHCO3 solution (50 mL) and stirred vigorously for 10 min. The organic layer 
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was separated from the aqueous one, which was extracted with CH2Cl2 (20 mL × 3). The combined organic 
layers were dried over anhydrous Na2SO4 and concentrated in vacuo. The residue was purified through a 
silica gel flash column (hexanes/EtOAc: from 100:1 to 9:1) to afford the desired products as white solid 
(1.18 g, 68% overall yield of two diastereomers, dr: 6.2:1). 
(±)1,1,1,3,3,3-Hexafluoropropan-2-yl (trans-1-fluoro-2,3-dihydro-1H-inden-2-yl)carbamate (2.6c-
trans): m.p. 98–100 °C; IR νmax (neat)/cm-1: 3334 (m), 2970 (m), 1733 (s), 1546 (m), 1380 (m), 1262 (m), 
1186 (s), 1165 (m), 1107 (s), 980 (m), 904 (m), 889 (m), 744 (m), 690 (m);  1H NMR (400 MHz, CDCl3) δ 
7.48 (d, J = 7.3 Hz, 1H), 7.39 (t, J = 7.3 Hz, 1H), 7.36–7.24 (m, 2H), 5.87 (dd, J = 55.8, 3.5 Hz, 1H), 5.76–
5.65 (m, 1H), 5.37 (brd, J = 5.6 Hz, 1H), 4.62–4.44 (m, 1H), 3.55 (dd, J = 16.3, 7.6 Hz, 1H), 2.93–2.82 (m, 
1H);  13C NMR (100 MHz, CDCl3) δ 152.1, 140.4 (d, J = 4.7 Hz), 137.4 (d, J = 18.4 Hz), 130.4 (d, J = 3.4 
Hz), 127.8 (d, J = 2.7 Hz), 125.7 (d, J = 1.5 Hz), 125.2 (d, J = 1.9 Hz), 120.5 (q, J = 282.3 Hz), 98.8 (d, J 
= 183.3 Hz), 68.9–66.6 (m), 58.6 (d, J = 26.2 Hz), 36.2 (d, J = 2.0 Hz);  19F NMR (376 MHz, CDCl3) δ -
73.58 (d, J = 5.6 Hz, 6F), -170.55 (dd, J = 55.9, 18.4 Hz, 1F);  HRMS (ESI, m/z): calcd for C13H10F7NO2Na+, 
[M + Na+], 368.0492, found 368.0482. 
(±)1,1,1,3,3,3-Hexafluoropropan-2-yl (cis-1-fluoro-2,3-dihydro-1H-inden-2-yl)carbamate (2.6c-cis): 
m.p. 91–92 °C; IR νmax (neat)/cm-1: 3335 (m), 2976 (m), 1732 (s), 1540 (m), 1380 (m), 1261 (m), 1182 (s), 
1168 (m), 1109 (s), 980 (m), 901 (m), 896 (m), 742 (m), 685 (m);  1H NMR (400 MHz, CDCl3) δ 7.53 (dd, 
J = 12.7, 6.0 Hz, 1H), 7.50–7.39 (m, 1H), 7.33 (t, J = 7.1 Hz, 2H), 5.74 (dd, J = 58.0, 4.8 Hz, 1H), 5.73 (m, 
2H), 4.54 (dddd, J = 16.6, 13.4, 8.5, 4.9 Hz, 1H), 3.37 (dt, J = 20.9, 10.5 Hz, 1H), 3.02 (ddd, J = 15.5, 8.5, 
3.8 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 152.4, 142.2 (d, J = 5.3 Hz), 136.9 (d, J = 15.4 Hz), 131.2 (d, 
J = 4.5 Hz), 129.7 (q, J = 171.2 Hz), 127.7 (d, J = 3.7 Hz), 126.5 (d, J = 2.6 Hz), 125.3 (d, J = 3.1 Hz), 93.9 
(d, J = 178.6 Hz), 69.15–66.27 (m), 54.3 (d, J = 19.2 Hz), 36.4;  19F NMR (376 MHz, CDCl3) δ -70.72–-
75.24 (m, 6F), -178.96 (dd, J = 57.7, 24.3 Hz, 1F);  HRMS (ESI, m/z): calcd for C13H10F7NO2Na+, [M + 
Na+] 368.0492, found 368.0478. 
E: procedure for iron-catalyzed aminofluorination of isoprene at gram scale.  
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Isoprene is commercially available and it was distilled before usage.  
To a flame-dried sealable 100 mL round bottom flask (flask A) equipped with a stir bar were added 
XtalFluor-E (5.04 g, 20 mmol) and freshly activated 4 Å powdered molecular sieves (1.5 g). After the vial 
was evacuated and backfilled with N2 three times, anhydrous CH2Cl2 (50 mL) and Et3N·3HF (2.15 mL, 12 
mmol) were added successively via syringes. The mixture was stirred at room temperature for 20 min. To 
another flame-dried sealable 200 mL flask (flask B) equipped with a stir bar were added the preformed 
catalyst cat.1, Fe(L1)(BF4)2(MeCN)(H2O)2 (300 mg, 0.5 mmol) and freshly activated 4 Å powdered 
molecular sieves (2.0 g). Flask B was evacuated and backfilled with N2 three times and then anhydrous 
CH2Cl2 (30 mL) was added. Both flasks were degassed and backfilled with N2 twice and flask B was cooled 
to -78 °C and freshly distilled isoprene (1 mL, 10 mmol) was added into flask B. Pre-cooled fluorinating 
reagent solution in flask A (in -35 °C cold bath) was quickly transferred to flask B (in -78 °C cold bath) via 
a stainless steel cannula, and then flask B was moved to -35 °C cold bath. Acyloxyl carbamate 2.2c (1.65 
g, 5.0 mmol) in 4.0 mL CH2Cl2 was added dropwise at last to flask B and the reaction was kept at -35 °C 
for 3 h and quenched with saturated NaHCO3 solution (30 mL). The organic layer was separated from the 
aqueous one, which was extracted with CH2Cl2 (20 mL × 3). The combined organic layers were dried over 
anhydrous Na2SO4 and concentrated in vacuo. The residue was purified through a silica gel flash column 
(hexanes/acetone: from 100:1 to 8:1) to afford the aminofluorination products as white solid (1.15 g, 78% 
yield).   
1,1,1,3,3,3-Hexafluoropropan-2-yl (2-fluoro-2-methylbut-3-en-1-yl)carbamate (2.11a): m.p.53–55 °C; 
IR νmax (neat)/cm-1: 3338 (m), 2971 (m), 1740 (s), 1553 (m), 1385 (m), 1241 (s), 1192 (s), 1152 (m), 1105 
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(s), 1073 (s), 933 (m), 903 (m), 687 (m); 1H NMR (400 MHz, CDCl3) δ 5.83 (ddd, J = 18.7, 17.4, 11.0 Hz, 
1H), 5.72–5.62 (m, 1H), 5.38 (d, J = 17.4 Hz, 1H), 5.33 (brs, 1H), 5.25 (d, J = 11.0 Hz, 1H), 3.46 (dd, J = 
21.2, 6.3 Hz, 2H), 1.44 (d, J = 21.6 Hz, 3H);  13C NMR (100 MHz, CDCl3) δ 153.0, 137.0 (d, J = 22.0 Hz), 
120.6 (q, J = 281.6 Hz), 116.0 (d, J = 11.0 Hz), 95.2 (d, J = 172.7 Hz), 68.9–66.6 (m), 49.0 (d, J = 22.8 
Hz), 22.8 (d, J = 23.7 Hz);  19F NMR (376 MHz, CDCl3) δ -73.67 (d, J = 6.2 Hz, 6F), -154.86–-156.17 (m, 
1F);  HRMS (ESI, m/z): calcd for C9H11F7NO2+, [M + H+], 298.0673, found 298.0671.  
 Procedures for aminofluorination products derivatization 
A: procedure for derivatization of indene aminofluorination product. 
 
In a 2-dram vial equipped with a stir bar, vicinal fluorocarbamate 7 (69.0 mg, 0.2 mmol) was 
dissolved in THF (2 mL) and cooled to 0 °C.  LiOH (14.4 mg, 0.6 mmol) in 0.4 mL water was added and 
the reaction was vigorously stirred for 1.5 h until the starting material was consumed (monitored by TLC).  
To the above reaction mixture, di-tert-butyl dicarbonate (87 mg, 0.4 mmol) in 1.0 ml THF was added at 0 
°C. The resulting mixture was warmed up to room temperature and kept stirring for additional 3 h.  The 
reaction was then neutralized with dilute aqueous HCl solution (1M). After evaporation of THF in vacuo, 
the residue was extracted with EtOAc (4 × 2 mL). The combined organic layer was dried over anhydrous 
Na2SO4, concentrated in vacuo and the residue was purified through a silica gel column to afford 2.7c as 
white foam (44.8 mg, 89% yield, dr >20:1). 
tert-Butyl-1-fluoro-2,3-dihydro-1H-inden-2-yl carbamate (2.7c): IR νmax (neat)/cm-1: 3334 (m), 2977 
(m), 2931 (w), 1681 (s), 1518 (s), 1366 (m), 1277 (m), 1163 (s), 752 (s); 1H NMR (400 MHz, CDCl3) δ 
7.46 (d, J = 7.4 Hz, 1H), 7.35 (t, J = 7.1 Hz, 1H), 7.32 – 7.22 (m, 2H), 5.81 (d, J = 56.1 Hz, 1H), 4.78 (s, 
1H), 4.43 (d, J = 14.0 Hz, 1H), 3.48 (dd, J = 16.3, 7.5 Hz, 1H), 2.77 (d, J = 16.1 Hz, 1H), 1.46 (s, 9H); 19F 
NMR (376 MHz, CDCl3) δ -170.15 (dd, J = 55.7, 17.7 Hz); 13C NMR (100 MHz, CDCl3) δ 155.3, 141.4, 
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138.1 (d, J = 18.3 Hz), 130.1 (d, J = 3.4 Hz), 127.4 (d, J = 2.7 Hz), 125.7 (d, J = 1.5 Hz), 125.2 (d, J = 2.0 
Hz), 99.5 (d, J = 178 Hz), 79.9, 57.9, 36.8, 28.4;  HRMS (ESI, m/z): calcd for C14H18FNO2Na+, [M + Na+], 
274.1214, found 274.1215. 
B: procedure for derivatization of 1-octene aminofluorination product. 
 
In a 2-dram vial equipped with a stir bar, vicinal fluorocarbamate 2.8 (68.3 mg, 0.2 mmol) was 
dissolved in THF (2 mL) and cooled to 0 °C. LiOH (14.4 mg, 0.6 mmol) in 0.4 mL water was added and 
the reaction was vigorously stirred for 1.5 h until the starting material was consumed (monitored by TLC).  
To the above reaction mixture, di-tert-butyl dicarbonate (87 mg, 0.4 mmol) in 1.0 ml THF was added at 0 
°C. The resulting mixture was warmed up to room temperature and kept stirring for additional 3 h. The 
reaction was then neutralized with dilute aqueous HCl solution (1M). After evaporation of THF in vacuo, 
the residue was extracted with EtOAc (4 × 2 mL). The combined organic layer was dried over anhydrous 
Na2SO4, concentrated in vacuo and the residue was purified through a silica gel column to afford 2.9 as 
colorless oil (48 mg, 97% yield).   
tert-Butyl-(2-fluorooctyl)carbamate (2.9): IR νmax (neat)/cm-1: 3337 (m), 2926 (s), 2855 (m), 1694 (s), 
1512 (m), 1365 (m), 1249 (m), 1165 (s); 1H NMR (400 MHz, CDCl3) δ 4.86 (brs, 1H), 4.65 – 4.41 (m, 1H), 
3.46 (ddd, J = 30.8, 13.7, 6.6 Hz, 1H), 3.25 – 3.05 (m, 1H), 1.74 – 1.52 (m, 2H), 1.52 –1.40 (m, 10H), 1.39 
– 1.22 (m, 7H), 0.88 (t, J = 6.8 Hz, 3H);  19F NMR (376 MHz, CDCl3) δ -184.14 – -187.49 (m);  13C NMR 
(100 MHz, CDCl3) δ 155.9, 93.6 (d, J = 167.0 Hz), 79.5, 44.6 (d, J = 20.2 Hz), 32.3 (d, J = 20.1 Hz), 31.6, 
29.0, 28.4, 24.8 (d, J = 4.8 Hz), 22.5, 14.0; HRMS (ESI, m/z): calcd for C13H26FNO2Na+, [M + Na+], 
270.1840, found 270.1833. 
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 Procedures for the iron-catalyzed asymmetric aminofluorination of indene 
 
To a flame-dried sealable 2-dram vial (vial A) equipped with a stir bar were added Fe(NTf2)2 (24.6 
mg, 0.04 mmol) and a chiral ligand L7 (15.7 mg, 0.04 mmol). After vial A was degassed and backfilled 
with N2 three times, anhydrous CH2Cl2 (0.5 mL) and MeCN (0.08 mL) were added via a syringe and the 
mixture was stirred at room temperature for 20 min. To a second flame-dried sealable 2-dram vial (vial B) 
equipped with a stir bar were added XtalFluor-E (183 mg, 0.8 mmol) and freshly activated 4 Å powdered 
molecular sieves (50 mg). After vial B was evacuated and backfilled with N2 three times, anhydrous CH2Cl2 
(4.0 mL) and Et3N·3HF (78 µL, 0.48 mmol) were added successively via syringes. The mixture was stirred 
at room temperature for 20 min. To another flame-dried sealable 3-dram vial (vial C) equipped with a stir 
bar were added acyloxyl carbamate 2.2e (0.20 mmol) and freshly activated 4Å powdered molecular sieves 
(100 mg).  Vial C was evacuated and backfilled with N2 three times and then anhydrous CH2Cl2 (2.0 mL) 
was added.  All three vials were cooled to -35 °C. Freshly distilled indene (35 µL, 0.3 mmol) was then 
added into vial C followed by the addition of fluorinating reagent solution in vial B via a syringe. The 
catalyst solution in vial A was added to vial C via a syringe pump over 20 min and the reaction was kept at 
the same temperature for 2 h. Meanwhile, to another flame-dried sealable 2-dram vial (vial D) equipped 
with a stir bar was added XtalFluor-E (46 mg, 0.2 mmol). Vial D was evacuated and backfilled with N2 
three times, then anhydrous CH2Cl2 (1.0 mL) and Et3N·3HF (33 µL, 0.2 mmol) were added successively 
via syringes. After stirring at room temperature for 10 min, the solution in vial D was added to vial C the 
reaction mixture was warmed up to 0 °C and stirred for additional 1 h. The reaction was then quenched 
with saturated NaHCO3 solution (3 mL). The organic layer was separated from the aqueous one, which was 
extracted with CH2Cl2 (2 mL × 3).  The combined organic layers were dried over anhydrous Na2SO4 and 
concentrated in vacuo.  
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Compound 2.6e-trans was isolated through a silica gel flash column (hexanes/EtOAc: from 30:1 
to 10:1) as white solid (24.3 mg, 44% yield, m.p. 60–62 °C, [α]D20 = +4.5° (c 2.0, CHCl3)).   
2,2,2-Trifluoroethyl ((1S,2S)-1-fluoro-2,3-dihydro-1H-inden-2-yl)carbamate (2.6e-trans): IR νmax 
(neat)/cm-1:3330 (m), 2970 (w), 1731 (s), 1545 (m), 1388 (m), 1260 (m), 1181 (s), 1100 (s), 970 (m), 914 
(m), 890 (m), 740 (m), 696 (m);  1H NMR (400 MHz, CDCl3) δ 7.47 (d, J = 7.5 Hz, 1H), 7.42–7.34 (m, 
1H), 7.34–7.27 (m, 2H), 5.85 (dd, J = 56.0, 4.1 Hz, 1H), 5.21 (brd, J = 7.3 Hz, 1H), 4.81–4.23 (m, 3H), 
3.51 (dd, J = 16.2, 7.7 Hz, 1H), 2.84 (dt, J = 16.5, 4.5 Hz, 1H);  13C NMR (100 MHz, CDCl3) δ 154.0 , 
140.6 (d, J = 4.7 Hz), 137.7 (d, J = 18.4 Hz), 130.3 (d, J = 3.4 Hz), 127.7 (d, J = 2.8 Hz), 125.6 (d, J = 1.6 
Hz), 125.2 (d, J = 1.8 Hz), 123.0 (q, J = 277.4 Hz), 99.0 (d, J = 182.9 Hz), 61.1 (q, J = 36.7 Hz), 58.3 (d, J 
= 25.8 Hz), 36.4;  19F NMR (376 MHz, CDCl3) δ -74.26 (t, J = 8.5 Hz, 3F), -170.98 (dd, J = 56.1, 18.6 Hz, 
1F);  HRMS (ESI, m/z): calcd for C12H11F4NO2Na+, [M + Na+], 300.0618, found 300.0625. 
The ee was determined by Chiral HPLC analysis (Chiralcel OD-H column, 5% isopropanol in 
hexanes, flow rate = 1.0 mL/min, UV detection at 210 nm). tr (minor) = 23.5 min, tr (major) = 16.7 min, 
84% ee.  
Compound 2.6e-cis was isolated through a silica gel flash column (hexanes/EtOAc: from 30:1 to 
10:1) as white solid (8.3 mg, 15% yield, m.p. 47–48 °C, [α]D20 = +7.6° (c 1.2, CHCl3)).   
2,2,2-Trifluoroethyl ((1R,2S)-1-fluoro-2,3-dihydro-1H-inden-2-yl)carbamate (2.6e-cis): IR νmax 
(neat)/cm-1: 3330 (m), 2970 (w), 1732 (s), 1530 (m), 1279 (m), 1182 (s), 1170 (m), 1100 (s), 980 (m), 900 
(m), 894 (m), 741 (m), 680 (m);  1H NMR (400 MHz, CDCl3) δ 7.55–7.47 (m, 1H), 7.46–7.37 (m, 1H), 
7.31 (t, J = 6.3 Hz, 2H), 5.71 (dd, J = 58.1, 4.7 Hz, 1H), 5.54 (brd, J = 7.7 Hz, 1H), 4.69–4.39 (m, 3H), 3.34 
(dd, J = 15.8, 7.4 Hz, 1H), 2.98 (ddd, J = 15.6, 8.5, 3.8 Hz, 1H);  13C NMR (100 MHz, CDCl3) δ 154.2, 
142.5 (d, J = 5.4 Hz), 137.1 (d, J = 15.4 Hz), 131.0 (d, J = 4.5 Hz), 127.6 (d, J = 3.7 Hz), 126.5 (d, J = 2.6 
Hz), 125.2 (d, J = 3.0 Hz), 123.0 (q, J = 277.6 Hz), 94.1 (d, J = 178.1 Hz), 61.1 (q, J = 36.5 Hz), 54.1 (d, J 
= 19.2 Hz), 36.5;  19F NMR (376 MHz, CDCl3) δ -74.24 (t, J = 8.2 Hz, 3F), -179.07 (dd, J = 58.1, 25.0 Hz, 
1F);  HRMS (ESI, m/z): calcd for C12H11F4NO2Na+, [M + Na+], 300.0618, found 300.0625.  
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The ee was determined by Chiral HPLC analysis (Chiralpak AD-H column, 15% EtOH in hexanes, 
flow rate = 1.0 mL/min, UV detection at 210 nm). tr (minor) = 12.2 min, tr (major) = 8.02 min, 84% ee. 
 Procedures for the iron-catalyzed aminofluorination of myrcene and (-)-β-pinene 
A: procedure for iron-catalyzed aminofluorination of myrcene. 
Myrcene is commercially available and it was distilled before usage.  
 
To a flame-dried sealable 2-dram vial (vial A) equipped with a stir bar were added XtalFluor-E 
(229 mg, 1.0 mmol) and freshly activated 4 Å powdered molecular sieves (50 mg).  After the vial was 
evacuated and backfilled with N2 three times, anhydrous CH2Cl2 (3.0 mL) and Et3N·3HF (98 µL, 0.6 mmol) 
were added successively via syringes. The mixture was stirred at room temperature for 20 min. To another 
flame-dried sealable 3-dram vial (vial B) equipped with a stir bar were added the preformed catalyst cat.1, 
Fe(L1)(BF4)2(MeCN)(H2O)2 (17.4 mg, 0.03 mmol) and freshly activated 4 Å powdered molecular  sieves 
(100 mg). Vial B was evacuated and backfilled with N2 three times and then anhydrous CH2Cl2 (0.5 mL) 
was added. Both vials were degassed and backfilled with N2 twice and vial B was cooled to -35 °C.  
Myrcene (134 µL, 0.8 mmol) was then added into vial B followed by addition of fluorinating reagent 
solution in vial A via a syringe. Acyloxyl carbamate 2.2c (66.2 mg, 0.20 mmol) in 0.5 mL CH2Cl2 was 
added dropwise at last to vial B and the reaction was kept at -35 °C for 2 h and gradually warmed up to -15 
°C. After the reaction was kept at -15 °C for another 2 h, it was then quenched with saturated NaHCO3 
solution (3 mL). The organic layer was separated from the aqueous one, which was extracted with CH2Cl2 
(2 mL × 3). The combined organic layers were dried over anhydrous Na2SO4 and concentrated in vacuo. 
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Compound 2.12a was isolated through a silica gel flash column (hexanes/Et2O: from 100:1 to 8:1) 
as a white solid (23.4 mg, 32% yield, m.p. 48–49 °C). Its structure was confirmed through X-ray 
crystallographic analysis (Figure 2.3), which has been deposited to The Cambridge Crystallographic Data 
Centre as CCDC 1429400.   
1,1,1,3,3,3-Hexafluoropropan-2-yl ((4-(2-fluoropropan-2-yl)cyclohex-1-en-1-yl)methyl) carbamate 
(2.12a): IR νmax (neat)/cm-1: 3340 (w), 2967 (w), 1740 (s), 1531 (m), 1385 (m), 1234 (w), 1194 (s), 1109 
(m), 904 (m), 689 (m);  1H NMR (400 MHz, CDCl3) δ 5.75–5.64 (m, 1H), 5.64–5.58 (m, 1H), 5.09 (brs, 
1H), 3.76 (d, J = 6.2 Hz, 2H), 2.19–2.09 (m, 1H), 2.08–2.01 (m, 2H), 1.98–1.67 (m, 3H), 1.35 (s, 3H), 1.38–
1.24 (m, 1H), 1.29 (s, 3H); 19F NMR (376 MHz, CDCl3)  δ -73.65 (d, J = 6.4 Hz, 6F), -140.01–-142.40 (m, 
1F); 13C NMR (100 MHz, CDCl3) δ 152.6, 133.4, 123.3, 120.6 (q, J = 282.4 Hz), 97.3 (d, J = 166.5 Hz), 
68.5–66.8 (m), 47.3 , 43.3 (d, J = 22.4 Hz), 26.8 , 26.3 (d, J = 7.3 Hz), 24.7 (d, J = 24.9 Hz), 23.9 (d, J = 
25.3 Hz), 23.3 (d, J = 5.1 Hz);  HRMS (ESI, m/z): calcd for C14H18F7NO2Na+, [M + Na+], 388.1118, found 
388.1108.  
Compound 2.12b was isolated through a silica gel flash column (hexanes/Et2O: from 100:1 to 8:1) 
as a white solid (13.9 mg, 19% yield, m.p. 64–65 °C). 
1,1,1,3,3,3-Hexafluoropropan-2-yl (2-fluoro-6-methyl-2-vinylhept-5-en-1-yl)carbamate (2.12b): IR 
νmax (neat)/cm-1: 3343 (m), 2978 (m), 2928 (m), 1731 (s), 1552 (m), 1383 (m), 1242 (s), 1196 (s), 1148 (m), 
1105 (s), 949 (m), 905 (m), 882 (m), 693 (m); 1H NMR (400 MHz, CDCl3) δ 5.84–5.59 (m, 2H), 5.38 (dd, 
J = 17.4, 1.2 Hz, 1H), 5.30 (dt, J = 11.1, 1.6 Hz, 1H), 5.06 (t, J = 7.3 Hz, 1H), 3.52–3.41 (m, 2H), 2.14–
1.97 (m, 2H), 1.82–1.57 (m, 2H), 1.68 (s, 3H), 1.59 (s, 3H); 19F NMR (376 MHz, CDCl3) δ -73.61–-73.73 
(m, 6F), -165.51–-166.65 (m, 1F); 13C NMR (100 MHz, CDCl3) δ 152.9, 135.5 (d, J = 21.6 Hz), 132.6, 
123.0 , 120.6 (q, J = 282.2 Hz), 116.7 (d, J = 11.4 Hz), 97.4 (d, J = 177.3 Hz), 68.8–66.5 (m), 48.1 (d, J = 
22.2 Hz), 36.3 (d, J = 21.7 Hz), 25.6 , 21.6 (d, J = 5.1 Hz), 17.6; HRMS (ESI, m/z): calcd for C14H19F7NO2+, 
[M + H+], 366.1299, found 366.1294.  
B: procedure for iron-catalyzed aminofluorination of (-)-β-pinene. 
(-)-β-Pinene was purchased from Sigma-Aldrich (with ee = 92%) and it was distilled before usage. 
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To a flame-dried sealable 2-dram vial (vial A) equipped with a stir bar were added Fe(NTf2)2 (18.5 
mg, 0.03 mmol) and L1 (8.2 mg, 0.03 mmol). After vial A was evacuated and backfilled with N2 three 
times, anhydrous CH2Cl2 (0.5 mL) and MeCN (0.08 mL) were added via a syringe and the mixture was 
stirred at room temperature for 20 min. To a second flame-dried sealable 2-dram vial (vial B) equipped 
with a stir bar were added XtalFluor-E (184 mg, 0.8 mmol) and freshly activated 4 Å powdered molecular 
sieves (30 mg). After vial B was evacuated and backfilled with N2 three times, anhydrous CH2Cl2 (2.0 mL) 
and Et3N·3HF (79 µL, 0.48 mmol) were added successively via syringes. The mixture was stirred at room 
temperature for 20 min. To another flame-dried sealable 3-dram vial (vial C) equipped with a stir bar were 
added acyloxyl carbamate 2.2c (66.2 mg, 0.20 mmol) and freshly activated 4 Å powdered molecular sieves 
(60 mg). Vial C was evacuated and backfilled with N2 three times and then anhydrous CH2Cl2 (1.5 mL) 
was added. All three vials were degassed and backfilled with N2 twice and vial C was cooled to -35 °C.  
Freshly distilled (-)-β-pinene (63 µL, 0.4 mmol) was then added into vial C followed by the addition of 
fluorinating reagent solution in vial B via a syringe.  The catalyst solution in vial A was added with a syringe 
pump over 20 min to vial C at -35 C and the reaction was kept at the same temperature for 2.5 h and 
allowed to warm up gradually to -15 °C. The reaction was kept at this temperature for additional 3.5 h and 
quenched with saturated NaHCO3 solution (3 mL). The organic layer was separated from the aqueous one, 
which was extracted with CH2Cl2 (2 mL × 3). The combined organic layers were dried over anhydrous 
Na2SO4 and concentrated in vacuo. The residue was purified through a silica gel flash column 
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(hexanes/EtOAc: from 100:1 to 9:1) to afford both the aminofluorination product (2.12a) and a side-product 
through elimination (2.12c). 
Compound 2.12a was isolated as a white solid (36 mg, 50% yield). The ee of 2.12a as determined 
by HPLC analysis after hydrolysis and N-benzoylation (procedure is below).  
C: procedure for product derivatization.  
 
In a 2-dram vial equipped with a stir bar, 2.12a (47 mg, 0.128 mmol) was dissolved in THF (2 mL) 
and cooled to 0 °C. LiOH (10 mg, 0.39 mmol) in 0.2 mL water was added and the reaction was vigorously 
stirred for 1.5 h until the starting material was consumed (monitored by TLC). To the above reaction 
mixture, benzoyl chloride (30 μL, 0.256 mmol) in 1.0 ml THF was added at 0 °C. The resulting mixture 
was warmed up to room temperature and kept stirring for additional 3 h. The reaction was then neutralized 
with dilute aqueous HCl solution (1M). After evaporation of THF in vacuo, the residue was extracted with 
EtOAc (4 × 2 mL). The combined organic layer was dried over anhydrous Na2SO4, concentrated in vacuo 
and the residue was purified through a silica gel column (hexanes/EtOAc: from 20:1 to 5:1) to afford 2.20 
as clear oil (30.0 mg, 85% yield). 
(R)-N-((4-(2-fluoropropan-2-yl) cyclohex-1-en-1-yl) methyl) benzamide (2.20): IR νmax (neat)/cm-1: 
3321 (br), 2924 (m), 2846 (w), 1640 (s), 1539 (s), 1490 (m), 1289 (m), 708 (m); 1H NMR (400 MHz, 
CDCl3) δ 7.78 (d, J = 7.8 Hz, 2H), 7.54 – 7.47 (m, 1H), 7.43 (t, J = 7.3 Hz, 2H), 6.16 (s, 1H), 5.71–5.57 
(m, 1H), 4.07 – 3.90 (m, 2H), 2.20 – 2.05 (m, 3H), 1.99 – 1.68 (m, 3H), 1.34 (s, 3H), 1.32 – 1.18 (m, 4H);  
19F NMR (376 MHz, CDCl3)  δ -140.87 (m, 1F);  13C NMR (100 MHz, CDCl3) δ 167.4, 134.6, 134.5, 131.4, 
128.6, 126.9, 122.5, 97.4 (d, J = 166.1 Hz), 45.4, 43.5 (d, J = 22.3 Hz), 27.2, 26.4 (d, J = 7.1 Hz), 24.7 (d, 
J = 24.9 Hz), 23.9 (d, J = 25.2 Hz), 23.5 (d, J = 5.2 Hz);  HRMS (ESI, m/z): calcd for C17H22FNONa+, [M 
+ Na+], 298.1578, found 298.1580.  
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The ee of 2.20 was determined by Chiral HPLC analysis (Chiralcel OD-H column, 10% 
isopropanol in hexanes, flow rate = 0.6 mL/min, UV detection at 254 nm). tr (major) = 32.5 min, tr (minor) 
= 34.4 min, 91% ee.  
Compound 2.12c was isolated through a silica gel column (hexanes/EtOAc: from 20:1 to 5:1) as 
colorless oil (25.6 mg, 37% yield). 
1,1,1,3,3,3-Hexafluoropropan-2-yl (R)-((4-(prop-1-en-2-yl) cyclohex-1-en-1-yl) methyl) carbamate 
(2.12c): IR νmax (neat)/cm-1: 3330 (m), 3079 (w), 2969 (w), 2919 (w), 2843 (w), 1735 (s), 1551 (m), 1384 
(m), 1249 (m), 1189 (s), 1105 (s), 902 (m), 689 (m); 1H NMR (400 MHz, CDCl3) δ 5.77–5.65 (m, 1H), 
5.63 (s, 1H), 5.07 (s, 1H), 4.72 (d, J = 10.8 Hz, 2H), 3.76 (d, J = 5.8 Hz, 2H), 2.27 – 1.79 (m, 7H), 1.73 (s, 
3H);  19F NMR (376 MHz, CDCl3)  δ -73.65 (d, J = 6.2 Hz);  13C NMR (100 MHz, CDCl3) δ 152.6, 149.4, 
133.1, 123.8, 120.6 (q, J = 282.2 Hz), 108.9, 68.7–66.8 (m), 47.4, 40.8, 30.4, 27.3, 26.7, 20.8; HRMS (ESI, 
m/z): calcd for C14H17F6NO2Na+, [M + Na+], 368.1056, found 368.1054.  
 Procedure for the iron-catalyzed aminofluorination of trans-2-phenyl-1-vinylcyclopropane 
trans-2-Phenyl-1-vinylcyclopropane 1.13 was synthesized according to a literature procedure.42 
 
To a flame-dried sealable 2-dram vial (vial A) equipped with a stir bar were added XtalFluor-E 
(184 mg, 0.8 mmol) and freshly activated 4 Å powdered molecular sieves (50 mg). After the vial was 
evacuated and backfilled with N2 three times, anhydrous CH2Cl2 (2.5 mL) and Et3N·3HF (79 µL, 0.48 
mmol) were added successively via syringes. The mixture was stirred at room temperature for 20 min. To 
another flame-dried sealable 3-dram vial (vial B) equipped with a stir bar were added cat.1 (17.4 mg, 0.03 
mmol) and freshly activated 4 Å powdered molecular sieves (100 mg).  Vial B was evacuated and backfilled 
with N2 three times and then anhydrous CH2Cl2 (0.75 mL) was added. Both vials were degassed and 
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backfilled with N2 twice and vial B was cooled to -40 °C. 1.13 (38 µL, 0.24 mmol) was then added into vial 
B followed by the addition of fluorinating reagent solution in vial A via a syringe. Acyloxyl carbamate 2.2b 
(53 mg, 0.20 mmol) in 0.75 mL CH2Cl2 was added dropwise at last to vial B and the reaction was kept at -
40 °C for 1 h and then quenched with saturated NaHCO3 solution (3 mL). The organic layer was separated 
from the aqueous one, which was extracted with CH2Cl2 (2 mL × 3). The combined organic layers were 
dried over anhydrous Na2SO4 and concentrated in vacuo.   
Compound 2.13 was isolated through a silica gel flash column (hexanes/acetone: from 100:1 to 
10:1) as colorless oil (26.3 mg, 43% yield).   
2,2,2-Trifluoroethyl (E)-(5-fluoro-5-phenylpent-2-en-1-yl)carbamate (2.13): IR νmax (neat)/cm-1: 3419 
(w), 3340 (w), 3032 (w), 2975 (w), 1719 (s), 1518 (m), 1284 (m), 1237 (m), 1163 (s), 967 (m), 760 (m), 
699 (m);  1H NMR (400 MHz, CDCl3) δ 7.42–7.28 (m, 5H), 5.71–5.54 (m, 2H), 5.45 (ddd, J = 47.5, 7.9, 
4.8 Hz, 1H), 4.88 (brs, 1H), 4.46 (q, J = 8.5 Hz, 2H), 3.79 (t, J = 5.8 Hz, 2H), 2.87–2.45 (m, 2H);  13C NMR 
(100 MHz, CDCl3) δ 154.2, 139.6 (d, J = 19.7 Hz), 129.2 , 128.5 , 128.4 (d, J = 2.1 Hz), 127.6 (d, J = 4.9 
Hz), 125.5 (d, J = 6.9 Hz), 123.1 (q, J = 277.4 Hz), 93.6 (d, J = 173.1 Hz), 60.9 (q, J = 36.3 Hz), 43.0, 40.0 
(d, J = 24.6 Hz);  19F NMR (376 MHz, CDCl3) δ -74.33 (t, J = 8.5 Hz, 3F), -175.01 (ddd, J = 46.8, 27.8, 
18.1 Hz, 1F);  HRMS (ESI, m/z): calcd for C14H15F4NO2Na+, [M + Na+], 328.0931, found 328.0930. 
Compound 2.14 was isolated through a silica gel flash column (hexanes/acetone: from 100:1 to 
10:1) as colorless oil (8.0 mg, 10% yield).   
(E)-1-Phenyl-5-(((2,2,2-trifluoroethoxy)carbonyl)amino)pent-3-en-1-yl benzoate (2.14): IR νmax 
(neat)/cm-1: 3353 (w), 2914 (w), 2846 (w), 1717 (s), 1585 (m), 1376 (m), 1279 (s), 1241(s), 1163(s), 1047 
(m), 969 (m);  1H NMR (400 MHz, CDCl3) δ 8.10–8.04 (m, 2H), 7.61–7.54 (m, 1H), 7.48–7.43 (m, 2H), 
7.42–7.29 (m, 5H), 6.03 (dd, J = 7.7, 5.6 Hz, 1H), 5.63 (dt, J = 14.9, 6.8 Hz, 1H), 5.53 (dt, J = 15.5, 5.8 Hz, 
1H), 4.74 (brs, 1H), 4.41 (q, J = 8.5 Hz, 2H), 3.72 (t, J = 5.8 Hz, 2H), 2.82–2.72 (m, 1H), 2.71–2.62 (m, 
1H);  13C NMR (100 MHz, CDCl3) δ 165.7, 154.1, 139.9, 133.1, 130.3, 129.6, 129.1, 128.5, 128.43, 128.40, 
128.1, 126.4, 123.1 (q, J = 277.5 Hz), 75.6, 60.9 (q, J = 36.6 Hz), 43.0, 39.5;  19F NMR (376 MHz, CDCl3) 
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δ -74.32 (t, J = 8.5 Hz);  HRMS (ESI, m/z): calcd for C21H21F3NO4Na+, [M + Na+], 408.1417, found 
408.1408.  
 Procedures for the iron-catalyzed aminofluorination of 2,3-dimethyl-1-butene 
2,3-Dimethyl-1-butene is commercially available and it was distilled before usage. 
 
To a flame-dried sealable 2-dram vial (vial A) equipped with a stir bar were added XtalFluor-E 
(138 mg, 0.6 mmol) and freshly activated 4 Å powdered molecular sieves (50 mg). After the vial was 
evacuated and backfilled with N2 three times, anhydrous CH2Cl2 (2.5 mL) and Et3N·3HF (59 µL, 0.36 
mmol) were added successively via syringes. The mixture was stirred at room temperature for 20 min. To 
another flame-dried sealable 3-dram vial (vial B) equipped with a stir bar were added catalyst cat.1, 
Fe(L1)(BF4)2(MeCN)(H2O)2 (17.4 mg, 0.03 mmol) and freshly activated 4 Å powdered molecular  sieves 
(100 mg). Vial B was evacuated and backfilled with N2 three times and then anhydrous CH2Cl2 (0.75 mL) 
was added. Both vials were degassed and backfilled with N2 twice and vial B was cooled to -35 °C. 2, 3-
Dimethyl-1-butene (50 µL, 0.4 mmol) was then added into vial B followed by the addition of fluorinating 
reagent solution in vial A via a syringe. Acyloxyl carbamate 2.2c (66.2 mg, 0.20 mmol) in 0.75 mL CH2Cl2 
was added dropwise at last to vial B and the reaction was kept at -35 °C for 1 h and then gradually warmed 
up to 0 °C. After the reaction was kept at 0 °C for 5 h, it was quenched with saturated NaHCO3 solution (3 
mL). The organic layer was separated from the aqueous one, which was extracted with CH2Cl2 (2 mL × 3).  
The combined organic layers were dried over anhydrous Na2SO4 and concentrated in vacuo.  
Compound 2.15 was purified through a silica gel flash column (hexanes/Et2O: from 100:1 to 10:1) 
as colorless oil (25.7 mg, 41% yield).  
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1,1,1,3,3,3-Hexafluoropropan-2-yl (2-fluoro-2,3-dimethylbutyl)carbamate (2.15): IR νmax (neat)/cm-1: 
3351 (m), 2973 (m), 1744 (s), 1532 (m), 1386 (m), 1231 (s), 1198 (s), 1140 (m), 1108 (s), 904 (m), 689 
(m);  1H NMR (400 MHz, CDCl3) δ 5.74–5.64 (m, 1H), 5.34 (brs, 1H), 3.58–3.36 (m, 2H), 2.04–1.91 (m, 
1H), 1.23 (d, J = 22.2 Hz, 3H), 1.00 (d, J = 6.9 Hz, 3H), 0.93 (d, J = 7.0 Hz, 3H);  13C NMR (100 MHz, 
CDCl3) δ 153.0, 120.6 (q, J = 280.8 Hz), 99.1 (d, J = 170.8 Hz), 69.9–65.1 (m), 47.6 (d, J = 21.2 Hz), 33.9 
(d, J = 21.5 Hz), 17.5 (d, J = 12.2 Hz), 17.3 (d, J = 4.4 Hz), 16.5 (d, J = 5.4 Hz);  19F NMR (376 MHz, 
CDCl3) δ -72.90–-74.54 (m, 6F), -152.70–-153.79 (m, 1F);  HRMS (ESI, m/z): calcd for C10H15F7NO2+, [M 
+ H+], 314.0986, found 314.0974.   
Compound 2.16 was purified through a silica gel flash column (hexanes/Et2O: from 100:1 to 10:1) 
as white foam (16.9 mg, 27% yield).   
1,1,1,3,3,3-Hexafluoropropan-2-yl (3-fluoro-2,3-dimethylbutyl)carbamate (2.16): IR νmax (neat)/cm-1: 
3364 (m), 2987 (m), 1745 (s), 1520 (m), 1385 (m), 1232 (s), 1198 (s), 1140 (m), 1108 (s), 904 (m), 689 
(m);  1H NMR (400 MHz, CDCl3) 5.73–5.62 (m, 1H), 5.38 (brs, 1H), 3.40 (ddd, J = 13.8, 6.4, 4.7 Hz, 1H), 
3.27 (dt, J = 13.8, 6.7 Hz, 1H), 2.04–1.88 (m, 1H), 1.40 (d, J = 22.6 Hz, 3H), 1.32 (d, J = 22.2 Hz, 3H), 
0.97 (d, J = 7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 152.7, 120.7 (q, J = 280.6 Hz), 98.6 (d, J = 165.3 
Hz), 69.2–65.8 (m), 43.7 (d, J = 3.8 Hz), 42.4 (d, J = 20.3 Hz), 26.3 (d, J = 24.8 Hz), 22.4 (d, J = 24.9 Hz), 
13.6 (d, J = 7.4 Hz);  19F NMR (376 MHz, CDCl3) δ -73.61–-74.08 (m, 6F), -138.35–-138.84 (m, 1F); 
HRMS (ESI, m/z): calcd for C10H15F7NO2+, [M + H+], 314.0986, found 314.0974. 
 Procedure for the iron-catalyzed aminofluorination of trans-β-methyl styrene 
A: procedure for iron-catalyzed aminofluorination of trans-β-methyl styrene. 
trans-β-Methylstyrene is commercially available and it was distilled before usage. 
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To a flame-dried sealable 2-dram vial (vial A) equipped with a stir bar were added Fe(NTf2)2 (18.5 
mg, 0.03 mmol) and L3 (8.3 mg, 0.03 mmol). After vial A was evacuated and backfilled with N2 three 
times, anhydrous CH2Cl2 (0.5 mL) and MeCN (0.05 mL) were added via a syringe and the mixture was 
stirred at room temperature for 20 min. To a second flame-dried sealable 2-dram vial (vial B) equipped 
with a stir bar were added XtalFluor-E (115 mg, 0.5 mmol) and freshly activated 4 Å powdered molecular 
sieves (50 mg). After vial B was evacuated and backfilled with N2 three times, anhydrous CH2Cl2 (3.0 mL) 
and Et3N·3HF (49 µL, 0.3 mmol) were added successively via syringes. The mixture was stirred at room 
temperature for 20 min. To another flame-dried sealable 3-dram vial (vial C) equipped with a stir bar were 
added acyloxyl carbamate 2.2c (66.2 mg, 0.2 mmol) and freshly activated 4 Å powdered molecular sieves 
(100 mg).  Vial C was evacuated and backfilled with N2 three times and then anhydrous CH2Cl2 (3.0 mL) 
was added.  All three vials were degassed and backfilled with N2 twice and vial C was cooled to -15 °C.  
Freshly distilled trans-β-methyl styrene (52 µL, 0.40 mmol) was then added into vial C followed by the 
addition of fluorinating reagent solution in vial B via a syringe. The catalyst solution in vial A was added 
with a syringe pump over 20 min to vial C at -15 C and the reaction was stirred at this temperature. After 
1.0 h, to another flame-dried sealable 2-dram vial (vial D) equipped with a stir bar was added XtalFluor-E 
(69 mg, 0.3 mmol). Vial D was evacuated and backfilled with N2 three times, then anhydrous CH2Cl2 (1.0 
mL) and Et3N·3HF (49 µL, 0.3 mmol) were added successively via syringes. After being stirred at room 
temperature for 10 min, the solution in vial D was added to vial C via a syringe in order to convert the 
corresponding oxazoline that was generated simultaneously to the desired amino fluoride.  The reaction in 
vial C was stirred at 0 °C for additional 3 h and quenched with saturated NaHCO3 solution (3 mL). The 
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organic layer was separated from the aqueous one, which was extracted with CH2Cl2 (2 mL × 3). The 
combined organic layers were dried over anhydrous Na2SO4 and concentrated in vacuo.  
The anti aminofluorination product 2.10a was isolated through a silica gel flash column 
(hexanes/acetone: from 100:1 to 10:1) as a white solid (33.3 mg, 48% yield, m.p. 71–73 °C). 
(±)1,1,1,3,3,3-Hexafluoropropan-2-yl ((anti)-1-fluoro-1-phenylpropan-2-yl)carbamate (2.10a): IR 
νmax (neat)/cm-1: 3326 (m), 2969 (m), 1734 (s), 1540 (m), 1454 (m), 1383 (m), 1250 (s), 1194 (s), 1105 (s), 
1093 (s), 977 (m), 885 (m), 700 (m);  1H NMR (400 MHz, C6D6) δ 7.12–6.95 (m, 5H), 5.83–5.68 (m, 1H), 
5.16 (dd, J = 47.7, 3.4 Hz, 1H), 4.48 (brd, J = 8.5 Hz, 1H), 3.90–3.71 (m, 1H), 0.58 (d, J = 6.9 Hz, 3H);  
13C NMR (100 MHz, CDCl3) δ 151.9, 136.3 (d, J = 20.2 Hz), 128.6 (d, J = 1.4 Hz), 128.5 (d, J = 1.0 Hz), 
125.0 (d, J = 8.7 Hz), 120.6 (q, J = 285.9 Hz), 94.7 (d, J = 178.7 Hz, 1H), 70.0–65.9 (m), 52.3 (d, J = 22.8 
Hz), 13.4 (d, J = 5.9 Hz);  19F NMR (376 MHz, C6D6) δ -72.78–-74.87 (m, 6F), -198.29 (dd, J = 47.7, 23.9 
Hz, 1F);  HRMS (ESI, m/z): calcd for C13H12F7NO2Na+, [M + Na+], 370.0648, found 370.0634.  
The syn aminofluorination product 2.10b was isolated through a silica gel flash column 
(hexanes/acetone: from 100:1 to 10:1) as a white solid (16.7 mg, 24% yield, m.p. 67–68 °C). 
(±)1,1,1,3,3,3-Hexafluoropropan-2-yl ((syn)-1-fluoro-1-phenylpropan-2-yl)carbamate (2.10b): IR νmax 
(neat)/cm-1: 3347 (m), 2966 (m), 1733 (s), 1540 (m), 1385 (m), 1237 (s), 1190 (s), 1130 (m), 1105 (s), 972 
(m), 904 (m), 689 (m);  1H NMR (400 MHz, C6D6) δ 7.10–6.92 (m, 5H), 5.70–5.56 (m, 1H), 4.83 (dd, J = 
46.2, 4.6 Hz, 1H), 4.35–4.23 (m, 1H), 3.95–3.76 (m, 1H), 0.62 (d, J = 6.9 Hz, 3H);  13C NMR (100 MHz, 
CDCl3) δ 151.9, 136.2 (d, J = 20.5 Hz), 128.8 (d, J = 1.5 Hz), 128.5, 125.6 (d, J = 7.5 Hz), 120.5 (q, J = 
286.1 Hz), 94.9 (d, J = 178.1 Hz), 68.4–66.8 (m), 51.9 (d, J = 19.5 Hz), 17.0 (d, J = 3.7 Hz);  19F NMR 
(376 MHz, CDCl3) δ -73.67 (m, 6F), -192.11 (dd, J = 45.9, 20.2 Hz, 1F);  HRMS (ESI, m/z): calcd for 
C13H12F7NO2Na+, [M + Na+], 370.0648, found 370.0634.  
B: procedure for iron-catalyzed amino-oxygenation of trans-β-methyl styrene and following ring-
opening with fluoride. 
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Iron-catalyzed amino-oxygenation (step 1): to a flame-dried sealable 2-dram vial (vial A) equipped 
with a stir bar were added Fe(NTf2)2 (18.5 mg, 0.03 mmol) and L2 (8.3 mg, 0.03 mmol). After vial A was 
evacuated and backfilled with N2 three times, anhydrous CH2Cl2 (0.5 mL) and MeCN (0.05 mL) were added 
via a syringe and the mixture was stirred at room temperature for 20 min. To a second flame-dried sealable 
3-dram vial (vial B) equipped with a stir bar were added acyloxyl carbamate 2.2c (66.2 mg, 0.2 mmol) and 
freshly activated 4 Å powdered molecular sieves (100 mg). Vial B was evacuated and backfilled with N2 
three times and then anhydrous CH2Cl2 (6.0 mL) was added. Both vials were degassed with N2 twice and 
vial B was cooled to -15 °C. Freshly distilled trans-β-methyl styrene (52 µL, 0.40 mmol) was then added 
into vial B. Then the catalyst solution in vial A was added with a syringe pump over 20 min to vial B at -
15 C and the reaction was kept at this temperature for 1.5 h. The reaction in vial B was moved to 0 °C and 
stirred for additional 12 h and quenched with saturated NaHCO3 solution (3 mL). The organic layer was 
separated from the aqueous one, which was extracted with CH2Cl2 (2 mL × 3). The combined organic layers 
were dried over anhydrous Na2SO4 and concentrated in vacuo. The residue was further purified through a 
silica gel flash column (hexanes/acetone: from 100:1 to 10:1) to afford the desired product 2.21 isolated as 
white foam (45.2 mg, 69% yield, dr >20:1).  
2-((1,1,1,3,3,3-Hexafluoropropan-2-yl)oxy)-4-methyl-5-phenyl-4,5-dihydrooxazole (2.21): IR νmax 
(neat)/cm-1: 2968 (m), 1681(s), 1384 (m), 1346 (m), 1271 (m), 1200 (s), 1107 (s), 1006 (m), 905 (m), 688 
(m);  1H NMR (400 MHz, CDCl3) δ 7.46–7.34 (m, 3H), 7.34–7.29 (m, 2H), 5.86 (hept, J = 6.1 Hz, 1H), 
5.23 (d, J = 7.3 Hz, 1H), 4.06 (p, J = 6.7 Hz, 1H), 1.40 (d, J = 6.6 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 
160.1, 138.3, 129.0, 125.5, 120.3 (q, J = 283.2 Hz), 91.6, 74.3–71.4 (m), 67.5, 21.4; 19F NMR (376 MHz, 
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CDCl3) δ -65.65–-84.56 (m);  HRMS (ESI, m/z): calcd for C13H12F6NO2+, [M + H+], 328.0767, found 
328.0772.  
Iron-catalyzed ring-opening with fluoride (step 2): To a flame-dried sealable 2-dram vial (vial A) 
equipped with a stir bar were added Fe(NTf2)2 (18.5 mg, 0.03 mmol) and L2 (8.3 mg, 0.03 mmol). After 
vial A was degassed and backfilled with N2 three times, anhydrous CH2Cl2 (0.5 mL) and MeCN (0.05 mL) 
were added via a syringe and the mixture was stirred at room temperature for 20 min. To a second flame-
dried sealable 2-dram vial (vial B) equipped with a stir bar were added XtalFluor-E (46 mg, 0.2 mmol). 
After vial B was evacuated and backfilled with N2 three times, anhydrous CH2Cl2 (1.0 mL) and Et3N·3HF 
(33 µL, 0.2 mmol) were added successively via syringes. The mixture was stirred at room temperature for 
10 min.  To another flame-dried sealable 3-dram vial (vial C) equipped with a stir bar were added 2.21 
(65.4 mg, 0.20 mmol), and freshly activated 4 Å powdered molecular sieves (50 mg). Vial C was evacuated 
and backfilled with N2 three times and then anhydrous CH2Cl2 (1.5 mL) was added.  All three vials were 
degassed with N2 twice. Vial C were cooled to 0 °C followed by addition of fluorinating reagent solution 
in vial B via a syringe. The catalyst solution in vial A was added to vial C via a syringe pump over 20 min 
and the reaction was kept at the same temperature for 3 h.**** The reaction was then quenched with saturated 
NaHCO3 solution (3 mL). The organic layer was separated from the aqueous one, which was extracted with 
CH2Cl2 (2 mL × 3). The combined organic layers were dried over anhydrous Na2SO4 and concentrated in 
vacuo. The residue was purified through a silica gel flash column (hexanes/acetone: from 100:1 to 10:1) to 
afford the desired product 2.10 as white solid (66 mg, 95%, dr: 2.4:1). 
 Procedures for the XtalFluor-M trapping experiment 
A: procedure for iron-catalyzed aminofluorination of styrene with XtalFluor-M/Et3N·3HF. 
                                                 
**** Note: there is no reaction at -15 °C and the starting material is recovered.  
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The reaction was carried out by following the general procedure, where XtalFluor-E was replaced 
by XtalFluor-M as a benzoate sequestering reagent. Morpholino(phenyl)methanone 2.17 was isolated, 
which is a known compound.73,74 
B: procedure for the benzoate group trapping experiment with XtalFluor-M. 
 
To an oven-dried sealable 2-dram vial equipped with a stir bar were added XtalFluor-M (121.5 mg, 
0.5 mmol) and anhydrous CH2Cl2 (2.0 mL). After the vial was evacuated and backfilled with N2 three times, 
benzoic acid (24.4 mg, 0.2 mmol) in anhydrous CH2Cl2 (1.0 mL) was added at -15 °C via syringe. The 
mixture was moved to 0 °C and stirred under this temperature for 6 h. Then, saturated NaHCO3 solution (2 
mL) was added to quench the reaction. The organic layer was separated from the aqueous one, which was 
extracted with CH2Cl2 (2 mL × 3). The combined organic layers were dried over anhydrous Na2SO4 and 
concentrated in vacuo. The residue was purified through a silica gel flash column (hexanes/acetone: from 
15:1 to 4:1) to afford 2.17 as colorless oil (22 mg, 57% yield). 
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2.4 Conclusion 
In this chapter, an iron-catalyzed intermolecular olefin aminofluorination method was described. 
This new approach tolerates a broad range of simple unfunctionalized olefin precursors and uses 
nucleophilic fluoride ion (commercially available Et3N·3HF/XtalFluor-E complex) as fluorine source. It 
also readily affords a variety of vicinal fluoro carbamates at gram-scale that can be converted to 
synthetically valuable vicinal fluoro primary amines through simple derivatization.  
We systematically described the reaction discovery, screening of various fluoride donors, substrate 
scope, enantioselectivity induction as well as the derivatization of vicinal fluoro carbamates products.  
A series of control experiments and preliminary mechanistic studies demonstrate that both an iron 
nitrenoid and a carbocation species (generated after radical amination step) may be possible reactive 
intermediates. The observations in asymmetric indene aminofluorination suggest that the C−N bond 
formation is ee-determining step. 
The limitations of this method include that: (1) it is less efficient with those electro deficient olefins 
with deactivating groups, such as alkyl cinnamates; (2) it barely affords desired aminofluorination products 
with indoles and glycals, which are both important olefinic substrates in pharmaceuticals and carbohydrate 
chemistry; (3) carbocation-mediated substrates polymerization is a severe side reaction in styrenyl dienes 
and other electro-rich olefins.  
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3 IRON(II)-CATALYZED OLEFIN TRIFLUOROMETHYL-AZIDATION FOR VICINAL 
TRIFLUOROMETHYLATED PRIMARY AMINE SYNTHESIS 
Abstract 
This chapter is about a recently developed iron-catalyzed olefin azido-trifluoromethylation method, 
which affords an efficient synthetic route to a wide variety of vicinal trifluoromethylated primary amines. 
A readily available Togni’s Reagent II and the commercially available TMSN3 were used as source of CF3 
and N3 functional groups. Compared to other trifluoromethyl azidation approaches, this method tolerates a 
broad range of simple and complex olefins, including styrenyl olefins, terminal and internal olefins, N-
heterocycles and monoterpenes. Many of them have been challenging substrates for existing methods. 
Additionally, our preliminary mechanistic studies and crystal structure of the catalytically active iron-
ligand-azide complex suggest that both the oxidant activation and rapid azido-group transfer steps may 
proceed through iron-ligand–azide species that are assembled in situ and activated thereafter. 
3.1 Introduction 
Vicinal trifluoromethylated primary amines are important structural motifs in a number of 
pharmaceuticals and biologically active molecules. Therefore, direct amino trifluoromethylation is of great 
interest in both organic synthesis and medicinal chemistry (Figure 3.1).75  
 
Figure 3.3.1 Vicinal trifluoromethylated primary amines with potential bioactivities 
Prior to our research, a few olefin amino trifluoromethylation methods have been developed: 
Sodeoka reported an intramolecular method to generate trifluoromethylated N-aryl aziridines and 
pyrrolidines using Togni’s Reagent II (3.1a), which was applied to convert N-aryl allylic amines to β-
trifluoromethyl amino alcohols via a rearrangement (Scheme 3.1, eq 1).76,77 Existing intermolecular amino 
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trifluoromethylation methods are exclusively limited to styrenyl olefins, which afford trifluoromethylated 
amides and anilines via the Ritter-type processes through β-trifluoromethyl carbenium ions.78 
An alternative efficient synthesis of these vicinal trifluoromethylated amines is simple reduction 
from its trifluoromethylated orangoazides precursor (Scheme 3.1, eq 2). Therefore, direct trifluoromethyl 
azidation with following reduction becomes one of the most straightforward ways to incorporate these 
valuable building blocks in organic molecules with double bonds. Liu developed a method that effectively 
transfers the CF3 group of Togni’s Reagent I (3.1b) to a range of terminal and cyclic olefins (Scheme 3.1, 
eq 3).79 Most recently, Hartwig also reported an iron-catalyzed azido-trifluoromethylation method for 
complex natural products with 3.1b.80 Although other methods through photo-redox catalysis for styrenyl 
olefins, enamides and enol ethers have been reported, only moderate yields are observed for isolated 
olefins.78 
 
Scheme 3.1 Copper and iron-catalyzed methods for vicinal trifluoromethyl amine synthesis 
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These existing olefin amino- and azido-trifluoromethylation methods are synthetically useful; 
however, there still have a few limitations associated with these transformations. First, there are a number 
of synthetically useful olefins are not compatible with the existing methods, especially those olefins contain 
labile allylic C–H or C–C bonds and therefore are prone to undergo β-H elimination or rearrangement, 
including allyl benzene, allyl acetate, and β-pinene. Next, β-trifluoromethylated amino-N-heterocycles are 
of great interest in medicinal chemistry; however, an efficient intermolecular azido-trifluoromethylation 
method for N-heterocycles has not been reported yet. 
In this chapter, an iron-catalyzed olefin azido-trifluoromethylation method for efficient synthesis 
of a wide variety of vicinal trifluoromethylated primary amines is described (Scheme 3.1, eq 4). This 
method tolerates a broad range of unfunctionalized olefins, N-heterocycles and monoterpene natural 
products. Preliminary mechanistic and crystallographic studies suggest that an unprecedented iron–azide 
species that are assembled in situ would activate the oxidant and transfer azido-group to olefins rapidly. 
3.2 Results and discussions 
 Reaction discovery 
We selected allyl benzene (3.2) as a model substrate for catalyst discovery because it is known to 
undergo facile olefin trifluoromethylation followed by elimination to afford an allylic trifluoromethylation 
product.81 Our group previously discovered Fe(NTf2)2tridentate ligand L1 complex can catalyzed efficient 
olefin diazidation reactions.82 When the same catalyst was used together with oxidant 3.1a and TMSN3, we 
observed an effective regio-selective olefin azido-trifluoromethylation affording the vicinal 
trifluoromethylated azide 3.3 with moderate yield (Table 3.1, entry 1). It was noted that oxidant 
decomposed in the presence of Fe(NTf2)2tridentate ligand L1 complex and lead to inefficient conversion 
of olefin starting material. We also observed that both 3.2 and 3.1a are fully recovered in the absence of the 
iron catalyst, which indicate the iron-catalyst is necessary in this transformation (entry 2). Next, because 
we observed quick decomposition of oxidant in entry 1, the Fe(NTf2)2 was replaced by a less oxidative iron 
catalyst Fe(OAc)2 and we are glad to find that Fe(OAc)2L1 complex evidently improved both the 
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conversion and yield (entry 3, 6 h, 81% yield). To our surprise, the Fe(OAc)2bidentate ligand L13 / L6 
complex catalyzed the reaction as efficient as  Fe(OAc)2tridentate ligand L1 complex but in shorter 
reaction time (entry 45, 3 h, 8386% yield). Interestingly, the FeCl2L6 complex also proves catalytically 
active; however, the corresponding β-trifluoromethyl chloride was identified as the side product (entry 6). 
We also evaluated the copper catalyst that was known to catalyze efficient olefin trifluoromethyl 
azidation.79 Unfortunately, this catalyst affords a range of different trifluoromethyl azide products. In 
addition to the desired 3.3 (44% yield), allylic trifluoromethylation product (14%) and 1,3 addition product 
(10%). Moreover, 3.3 can be readily converted to β-trifluoromethyl amminium salt 3.4 through a 
straightforward reduction–protonation sequence (87% yield). 
Table 3.1 Catalyst discovery for iron-catalyzed olefin trifluoromethyl-azidation 
 
 Substrate scope 
With discovery of this transformation, we explored a range of different types of olefins to determine 
the scope and limitation of this new methodology. 
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First, we evaluated a variety of styrenyl olefins, including electron-rich, electron-deficient or 
electron-neutral styrenes, as well as α or β–branch substituted styrenes (Table 3.2, entries 1–6). Not 
surprisingly, this chemistry is successfully applied to a broad range of substituted and unsubstituted 
styrenes. Moreover, cyclic styrenyl olefins, including indene and dihydronaphthalene, can also be 
diastereoselectively converted to vicinal trifluoromethylated amminium salts with excellent yield and dr 
(Table 3.2, entries 7–8, dr >20:1). 
Table 3.2 The iron-catalyzed vicinal trifluoromethyl primary amine synthesis from styrenyl olefins 
 
We next studied a variety of isolated terminal olefins (Table 3.3). Trifluoromethyl azidation of 
those terminal olefins with labile allylic C–H bonds, such as allyl benzene and allyl silane, was not reported 
in the literature. But they both prove to be an excellent candidate with this condition and no elimination 
products were detected (entries 9–10). In addition, allyl acetate and an allyl carbamate are compatible with 
this method, affording vicinal trifluoromethylated amino alcohol and diamine derivatives with excellent 
yield (entries 11–12). Both mono- and 1,1-disubstituted olefins are excellent substrates (entries 13–14). 
Moreover, an unprotected tertiary allylic alcohol can be directly applied to afford a trifluoromethylated 
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amino alcohol without comprise from a possible competing semi-pinacol rearrangement (entry 15). We are 
glad to see that an electron-rich enamide are also tolerated by the catalyst (entry 16). 
Table 3.3 The iron-catalyzed vicinal trifluoromethyl primary amine synthesis from terminal olefins 
  
Trifluoromethylated amino alcohols (3.5) and diamines (3.6) are valuable building blocks in 
medicinal chemistry; therefore, we explored this reaction of allyl acetate and allyl N-Troc-amine on a large 
scale. We are pleasant to observe that both reactions can be scaled up to gram scale with consistent yield 
and excellent regio-selectivity (Scheme 3.2). 
 
Scheme 3.2 Iron-catalyzed trifluoromethyl-azidation of allyl acetate and allyl N-Troc amine at gram-scale 
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We noted that acyclic or cyclic internal olefin is a type of substrates that have presented low 
reactivity toward existing methods. By using this procedure, a aliphatic trans-di-substituted olefins and a 
cyclic cyclooctene can be effectively converted to corresponding trifluoromethylated amines using this 
procedure (Table 3.4, entries 17–18). Interestingly, we also observed that iron catalyst effectively controls 
both the regio- and diastereoselectivity of the addition reaction with 1,3-cyclooctadiene (entry 19, dr >20:1, 
1,4-addition only) and a silyl dienol substrate (entry 20, 1,4-addition only). 
Table 3.4 The iron-catalyzed vicinal trifluoromethyl primary amine synthesis from internal olefins 
 
Trifluoromethylated amino-N-heterocycles are of great interest in medicinal chemistry; however, 
N-heterocycle amino- or azido-trifluoromethylation has been under-developed. Therefore, we explored this 
method with indole and pyrrole derivatives (Table 3.5). We discovered that the Fe(OAc)2L6 complex 
selectively transfers the CF3 group to the indole 2-position while installs the azido group at the 3-position 
with excellent dr (entry 21, dr >20:1). Subsequent reduction and N-Boc protection readily provided a 2-
trifluromethyl-3-amino-N-Boc-indolane. The 3-methyl substitution enhances its reactivity without 
diminishing diastereoselectivity (entry 22). The iron catalyst proves sufficiently functional group-tolerant 
such that both tryptamine carbamate and indole propionic acid are compatible with this method (entries 
2324). 3-Trifluoromethyl-4-amino-pyrrolidine motif has been incorporated in biologically probes; 
however, they used to be prepared through a multistep synthesis.83,84 We subsequently evaluated the 
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reactivity of N-Boc protected 3-pyrroline, which eventually afforded 3-trifluoromethyl-4-amino-N-Boc-
pyrrolidine with excellent dr yet in moderate yield (entry 25). Notably, the 3-pyrroline could be oxidized 
to pyrrole under reaction conditions and afford the corresponding trifluoromethyl azidation products as 
major side products. Moreover, N-Boc-pyrrole is an acceptable substrate and it can be converted to amino 
trifluoromethylated 2,3-dihydro-N-Boc-pyrrole as a single diastereomer (entry 26, dr >20:1). 
Table 3.5 Iron-catalyzed trifluoromethyl-azidation of N-heterocycles 
 
Complex terpenes provide diverse structural motifs with rich stereochemical information; however, 
complex primary-amine synthesis based upon these readily available natural products has been under-
explored. In order to develop a strategy for efficient synthesis of complex primary amines in short steps, 
we further evaluated this new method with a variety of terpenes (Table 3.6). We observed that both (+)-
camphene and (+)-3-carene can be selectively functionalized to the corresponding vicinal 
trifluoromethylated carbamates as a single diastereomer (entries 21–22). Interestingly, the iron catalyst can 
electronically differentiate two olefinic moieties within (+)-carvone and selectively transfer the azido-group 
to the less electron-deficient olefin (entry 23). We also discovered that the labile aldehyde group within in 
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(±)-citronellal is compatible with the iron catalyst without detrimental aldehyde oxidation (entry 24). 
Furthermore, the more electron-rich double bond in geranyl acetate preferentially gets functionalized in the 
presence of an allylic acetate moiety (entry 5).   
Table 3.6 Iron-catalyzed trifluoromethyl-azidation of monoterpenes 
 
To our great surprise, the iron catalyst can selectively 1,2-difunctionalize the exocyclic olefin of (-
)-β-pinene exclusively without ring-opening rearrangement product. A vicinal trifluoromethylated amine 
was obtained in excellent yield after reduction (entry 6, dr >20:1). 
 Controls experiments to probe working hypothesis 
 Different products observed in Cu and Fe-catalyzed trifluoromethyl azidation of (-)-β-pinene 
We noted that the known copper-catalyzed (-)-β-pinene trifluoromethyl azidation method affords 
the rearrangement product 3.7 only (Scheme 3.3, eq 1). Therefore, the absence of 3.7 in this iron-catalyzed 
method is mechanistically insightful (Scheme 3.3, eq 2). The product difference in copper and iron-
catalyzed azido-trifluoromethylation approaches suggests that iron catalyzed a faster azido-group transfer 
compared to copper, such that it does not allow time for ring-opening and intermediate rearrangement. 
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Scheme 3.3 Copper and iron-catalyzed trifluoromethyl-azidation of (-)-β-pinene 
 Proof of radical nature of iron-catalyzed olefin trifluoromethyl azidation reaction 
To differentiate between radical and carbocation nature of the reactive intermediate involved in the 
azido-group transfer process, we evaluated a hypersensitive mechanistic probe 3.10 that was developed by 
Newcomb (Scheme 3.4). 84,85 The probe design was based on the simple notion that, in ring openings of 
cyclopropylcarbinyl systems, a phenyl group will stabilize an incipient radical center more strongly than 
does an alkoxy group, or vice versa. According to this rationale. if a cyclopropyl carbinyl radical was 
generated through radical addition to 3.10, the cyclopropyl ring will open by breaking the bond a and form 
a benzylic radical species (3.10a), which will eventually afford product 3.11. It is also reported that a 
cyclopropyl carbinyl cation intermediate rapidly fragments through bond b and leads to an oxo-carbenium 
ion (3.10b). Interestingly, the benzylic azide (3.11) was observed exclusively in this iron-catalyzed 
trifluoromethyl-azidation of 3.10, presumably through the intermediacy of a benzylic radical species (77% 
yield, dr: 1:1). This result suggests that the iron-catalyzed azido-group transfer proceeds through a carbo-
radical rather than a carbocation species.  
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Scheme 3.4 A hypersensitive mechanistic probe for distinguishing between radical and carbocation 
intermediates 
 Iron-catalyzed trifluoromethyl azidation of cis- and trans-stilbenes 
Next, we compared the reactivity of both cis- and trans-stilbenes and observed that trans-stilbene 
3.13a is much more reactive than cis-stilbene 3.13b. Unlike the iron-catalyzed olefin diazidation, no cis–
trans isomerization was observed during the reaction (Scheme 3.5, eq 1).82 This experiment suggests that 
the C–CF3 bond forming step is irreversible and rate-limiting. Moreover, the cis-stilbene 
trifluoromethylation was evaluated in the absence of an iron catalyst (eq 2) and in the absence of TMSN3 
(eq 3): both cis-stilbene 3.13b and oxidant 3.1a were fully recovered under either conditions. However, in 
the presence of both iron catalyst and TMSN3, Togni’s reagent II 3.1a decomposed quickly to 2-
iodobenzoic acid even in the absence of an olefin substrate (eq 4). These experiments indicate that both an 
iron catalyst and TMSN3 are necessary to activate 3.1a to initiate the radical reaction. 
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Scheme 3.5  Iron-catalyzed trifluoromethyl-azidation of cis/trans-stilbene 
 Preformed catalytically active iron-azide complex 
 
Scheme 3.6 Preparation of catalytically active iron-azide complex 
Based upon these mechanistic insights, we suspect that a catalytically active iron-TMSN3 complex 
may be formed in situ and activate the oxidant (Togni’s reagent) thereafter. Therefore, we premixed 
Fe(OAc)2-based catalysts in the presence of stoichiometric amount of TMSN3 and we observed dark purple 
solution from both Fe(OAc)2–L1 and Fe(OAc)2–L6 complexes. Subsequent ether precipitation readily 
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afforded crystalline solids cat.2 and cat.3 respectively (Scheme 3.6). IR analysis revealed the presence of 
the azido group in both solid complexes. X-ray crystallographic analysis of the iron–bi-dentate ligand 
complex cat.3 proves challenging; however, we managed to obtain the crystal structure of the iron–tri-
dentate ligand complex cat.2. To our surprise, cat.2 exists as an oligomeric iron–azide complex with the 
formula of (Fe(L1)(N3)2)n (Figure 4.2).†††† Two type of azide species were observed in the crystal structure: 
a terminal iron–azide as well as a bridging iron–azide.  
 
Figure 3.3.2 X-ray crystal structure of (Fe(L1)(N3)2)n (cat.2) 
We further evaluated the reactivity of (Fe(L1)(N3)2)n (cat.2) in allyl benzene azido-
trifluoromethylation (Scheme 3.7). Surprisingly, it can activate 3.1a in the absence of TMSN3 and afford 
desired trifluoromethyl azidation product 3.3 with excellent mass balance (eq 1). As a control experiment, 
it also catalyzed allyl benzene azido-trifluoromethylation in the presence of TMSN3 and afforded 3.3 in 
good yield (eq 2). 
                                                 
†††† Crystal structures of the iron-azide complexes were obtained and analyzed with X-ray crystallography by Prof. 
Caleb Martin's group at Baylor University. 
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Scheme 3.7 (Fe(L1)(N3)2)n complex-catalyzed trifluoromethyl-azidation of allyl benzene 
Interestingly, by monitoring the reaction progress with IR technique, we observed that the azido 
group transferred from preformed iron-azide complex cat.3 to the desired product along the trifluoromethyl 
azidation reaction of allyl benzene (Figure 3.3). 
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Figure 3.3 IR-absorptions in the iron-azide complex-catalyzed allyl benzene trifluoromethyl-azidation 
Based on the collective evidence from the aforementioned control experiments, we proposed the 
mechanistic working hypothesis that is supported by the experimental data (Scheme 3.8). First, TMSN3 
activates Fe(OAc)2/ligand complex in situ: the azido group is transferred to iron center and a catalytically 
active iron–ligand–azide complex (intermediate A) is generated. During this process, the acetate counter 
ion is switched off from iron center and presumably forms TMSOAc. Next, Togni’s reagent II 3.1a is 
activated by intermediate A. The I-CF3 bond is reductively cleaved affording trifluoromethyl radical, which 
subsequently react with olefin substrate to form C-CF3 bond and carbo-radical species B. At the same time, 
0 min  
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N3 IR stretch: 2122 cm-1 
10 min  
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iron (II) complex A is oxidized to C and this high-valent iron species most likely may further oxidize carbo 
radical B through inner-sphere azido ligand-transfer to afford the desired trifluoromethyl-azidation product 
D. Throughout this process, the intermediate C is reduced to be a low-valent iron complex E. TMSN3 will 
abstract carboxylate group from iron center but transfer another equivalent of azido group to regenerate the 
catalyst A and complete the catalytic cycle. 
 
Scheme 3.8 Mechanistic working hypothesis for the iron-catalyzed olefin trifluoromethyl-azidation 
3.3 Experimental section 
 Materials and general information 
Materials:  Commercial reagents were purchased from Sigma Aldrich, Fluka, EM Science, and 
Lancaster and used as received. TMSN3 and all commercially available olefins were redistilled before use. 
All solvents were used after being freshly distilled unless otherwise noted. 
Instrumentation: Proton nuclear magnetic resonance (1H NMR) spectra, carbon nuclear magnetic 
resonance (13C NMR) spectra and fluorine nuclear magnetic resonance (19F NMR) were recorded on Bruker 
UltraShield-400 (400 MHz).  Chemical shifts for protons are reported in parts per million downfield from 
tetramethylsilane and are referenced to the NMR solvent residual peak (CHCl3: δ 7.26). Chemical shifts for 
carbons are reported in parts per million downfield from tetramethylsilane and are referenced to the carbon 
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resonances of the NMR solvent (CDCl3: δ 77.0). Chemical shifts for fluorine are reported in parts per 
million downfield and are referenced to the fluorine resonances of CFCl3. Data are represented as follows: 
chemical shift, multiplicity (br = broad, s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet), 
coupling constants in Hertz (Hz), and integration. When 19F NMR is used for quantitative purpose (dr 
determination), 30 degrees pulse and a longer delay time (d1 = 5 s) were employed and the receiver gain 
was manually set as 32. The mass spectroscopic data were obtained at the Georgia State University mass 
spectrometry facility using a Micromass Platform II single quadruple instrument. Infrared (IR) spectra were 
obtained using a Perkin Elmer Spectrum 100 FT-IR spectrometer. Data are represented as follows: 
frequency of absorption (cm-1) and absorption strength (s = strong, m = medium, w = weak).  
All reactions were performed in oven-dried or flame-dried round-bottom flasks and vials.  Stainless 
steel syringes and cannula were used to transfer air- and moisture-sensitive liquids. Flash chromatography 
was performed using silica gel 60 (230-400 mesh) from Sigma–Aldrich. 
 General procedure for iron-catalyzed trifluoromethyl-azidation reaction   
To a flame-dried sealable 2-dram vial (vial A) equipped with a stir bar were added Fe(OAc)2 (7.0 
mg, 0.04 mmol). After this vial was evacuated and backfilled with N2 twice, a stock solution of ligand L6 
in anhydrous CH2Cl2 (0.8 mL, c=0.05 M) and MeCN (0.1 mL) were added via a syringe and the mixture 
was stirred at room temperature for 10 min. TMSN3 (80 L, 0.6 mmol) was added to vial A and the mixture 
was stirred for additional 10 min. To a second flame-dried 3-dram vial (vial B) equipped with a stir bar was 
added 3.1a (152 mg, 0.48 mmol). Vial B was evacuated and backfilled with N2 twice and then anhydrous 
CH2Cl2 (1.1 mL) was added. Both solutions in vial A and vial B were degassed with brief evacuation and 
then backfilling with N2. Subsequently, freshly distilled olefin (0.4 mmol) was added to vial B followed by 
drop-wise addition of the catalyst solution in vial A at 0 °C. The reaction mixture was warmed up to 22 °C 
and kept stirring for 4 h until the olefin was consumed (monitored by TLC). Saturated Na2CO3 aqueous 
solution (0.4 mL) was added to quench the reaction and to remove any residue hydrazoic acid. The reaction 
mixture was further diluted with hexanes (5 mL) and stirred vigorously for 5 min to precipitate 2-
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iodobenzoic acid. The mixture was filtered through a short silica gel pad (ca. 1.5 cm long silica gel with 
cotton stopper in a regular Pasteur pipette) and washed with 20% Et2O in hexanes (10 mL).  After 
concentration in vacuo, the residue was subsequently purified through a silica gel column to afford the 
desired trifluoromethyl-azidation product. 
 General procedure for reduction and protection 
A: Pd/C, H2 reduction followed by Tosylation.  
To a 2-dram vial equipped with a stir bar was added Pd/C (10 wt%). After the vial was evacuated 
and backfilled twice with N2, a solution of vicinal trifluoromethyl azide product from last step (1.0 equiv) 
in 2 mL MeOH was added. The mixture was degassed with brief evacuation and backfilled three times with 
H2, and then vigorously stirred under H2 balloon at 22 °C until the reduction was complete (the reaction 
was monitored by TLC until the starting material was consumed). The solution was filtered through Celite 
and washed with MeOH (3 mL). To the filtrate was added a solution of TsOH·H2O (1.1 equiv) in MeOH 
(3 mL). The mixture was stirred for 5 min and concentrated in vacuo (to about 0.3 mL solvent left). The 
residue was diluted with Et2O (6 mL) and vigorously stirred for 20 min to get most of the product precipitate 
out. The white precipitates were collected by filtration, washed with Et2O (2 mL × 3) and dried in vacuo to 
afford the desired β-trifluoromethyl amminium salt. 
B: Staudinger reduction followed by Boc-protection.  
To a 3-dram vial equipped with a stir bar were added the vicinal trifluoromethyl azide product 
obtained from last step (1.0 equiv), THF (2 mL) and H2O (10 equiv). After the vial was evacuated and 
backfilled with N2 three times, a solution of PMe3 in THF (2.5 equiv) was added drop-wise at 0 °C. The 
mixture was warmed up to room temperature and stirred for 2 h (the reaction was monitored by TLC until 
the starting material was consumed). The mixture was then concentrated in vacuo and the residue was 
further dissolved in CH2Cl2 (2 mL). At 0 °C, to the above solution, Boc2O (2.0 equiv) in 1 mL CH2Cl2 was 
added drop-wise. The resulting mixture was warmed up to room temperature and kept stirring for additional 
2 h until the free amine was consumed. After the organic solvent was removed under reduced pressure, the 
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residue was purified through a silica gel flash column to afford the desired N-Boc-protected vicinal 
trifluoromethyl primary amine. 
 Procedures for selected vicinal trifluoromethyl amines syntheses 
A: Procedure for trifluoromethyl-azidation/reduction of allyl benzene.  
 
To a flame-dried sealable 2-dram vial (vial A) equipped with a stir bar were added Fe(OAc)2 (7.0 
mg, 0.04 mmol). After this vial was evacuated and backfilled with N2 twice, a stock solution of ligand L6 
in anhydrous CH2Cl2 (0.8 mL, c=0.05 M) and MeCN (0.1 mL) were added via a syringe and the mixture 
was stirred at room temperature for 10 min. TMSN3 (80 mL, 0.6 mmol) was added to vial A and the mixture 
was stirred for additional 10 min. To a second flame-dried 3-dram vial (vial B) equipped with a stir bar was 
added 3.1a (152 mg, 0.48 mmol). Vial B was evacuated and backfilled with N2 twice and then anhydrous 
CH2Cl2 (1.1 mL) was added.  Both solutions in vial A and vial B were degassed with brief evacuation and 
then backfilling with N2. Subsequently, freshly distilled allyl benzene (53 µL, 0.4 mmol) was added to vial 
B followed by drop-wise addition of the catalyst solution in vial A at 0 °C. The reaction mixture was 
warmed up to 22 °C and kept stirring for 4 h until the olefin was consumed (monitored by TLC). Saturated 
Na2CO3 aqueous solution (0.4 mL) was added to quench the reaction and to remove any residue hydrazoic 
acid. The reaction mixture was further diluted with hexanes (5 mL) and stirred vigorously for 10 min to 
precipitate 2-iodobenzoic acid. The mixture was filtered through a short silica gel pad (ca. 1.5 cm long 
silica gel with cotton stopper in a regular Pasteur pipette) and washed with 20% Et2O in hexanes (10 mL).  
After concentration in vacuo, the residue was subsequently purified through a silica gel column (100% 
hexanes) to afford the desired trifluoromethyl-azidation product 3.3 as colorless oil (79 mg, 86% yield). 
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2-Azido-4,4,4-trifluorobutyl benzene (3.3): IR νmax (neat)/cm-1: 3032 (w), 2119 (s), 1248 (s), 1142 (s), 
1114 (s), 748 (m), 699 (s); 1H NMR (400 MHz, CDCl3): δ 7.46–7.08 (m, 5H), 4.03–3.81 (m, 1H), 2.98–
2.86 (m, 2H), 2.46–2.19 (m, 2H); 13C NMR (100 MHz, CDCl3): δ 136.0, 129.3, 128.9, 127.4, 125.7 (q, J = 
277.2 Hz), 57.8 (q, J = 2.7 Hz), 41.0, 37.9 (q, J = 28.4 Hz); 19F NMR (376 MHz, CDCl3): δ -63.89 (t, J = 
10.4 Hz). 
To a 2-dram vial equipped with a stir bar was added Pd/C (8.0 mg, 10 wt%). After the vial was 
evacuated and backfilled twice with N2, a solution of 3.3 from last step (79 mg, 0.34 mmol) in 2 mL MeOH 
was added. The mixture was degassed with brief evacuation and backfilled three times with H2, and then 
vigorously stirred under H2 balloon at 22 °C until the reduction was complete (the reaction was monitored 
by TLC until 3.3 was consumed).  The solution was filtered through Celite and washed with MeOH (3 mL). 
To the filtrate was added a solution of TsOH·H2O (72 mg, 0.38 mmol) in MeOH (3 mL). The mixture was 
stirred for 5 min and concentrated in vacuo (to about 0.3 mL solvent left). The residue was diluted with 
Et2O (6 mL) and vigorously stirred for 20 min to get most of the product precipitate out. The white 
precipitates were collected by filtration, washed with Et2O (2 mL × 3) and dried in vacuo to afford the 
desired β-trifluoromethyl amminium salt 3.4 was obtained as a white solid (111 mg, 87% yield). 
4,4,4-Trifluoro-1-phenylbutan-2-aminium 4-methylbenzenesulfonate (3.4): IR νmax (neat)/cm-1: 3158 
(br), 2952 (w), 1535 (m), 1230 (m), 1117 (s), 1008 (s), 813 (s), 677 (s);  1H NMR (400 MHz, DMSO-d6): 
δ 8.11 (s, 3H), 7.48 (d, J = 7.2 Hz, 2H), 7.42–7.27 (m, 5H), 7.12 (d, J = 7.5 Hz, 2H), 3.86–3.72 (m, 1H), 
3.02 (dd, J = 13.8, 6.1 Hz, 1H), 2.88 (dd, J = 13.9, 7.5 Hz, 1H), 2.69–2.52 (m, 2H), 2.29 (s, 3H);  13C NMR 
(100 MHz, DMSO-d6): δ 145.4, 138.6, 135.7, 129.9, 129.2, 128.7, 127.7, 126.4 (q, J = 277.1 Hz), 126.0, 
47.0 (q, J = 2.5 Hz), 38.5, 35.4 (q, J = 28.3 Hz); 21.3;  19F NMR (376 MHz, DMSO-d6): δ -61.89 (t, J = 
11.3 Hz);  HRMS (ESI, m/z): calcd for C10H13F3N+, [M + H+], 204.0995, found 204.1004.  
B: procedure for trifluoromethyl-azidation/reduction of allyl acetate. 
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To a flame-dried sealable 3-dram vial (vial A) equipped with a stir bar were added Fe(OAc)2 (140 
mg, 0.8 mmol) and L6 (140.8 mg, 0.8 mmol). After the vial was evacuated and backfilled with N2 twice, 
anhydrous CH2Cl2 (6.0 mL) and MeCN (1.0 mL) were added via a syringe and the mixture was stirred at 
room temperature for 20 min. To another flame dried 50 mL round bottom flask (flask A) equipped with a 
stir bar was added 3.1a (3.03 g, 9.6 mmol). Flask A was evacuated and backfilled with N2 for twice and 
then anhydrous CH2Cl2 (9.0 mL) was added. Both solutions in vial A and Flask A were degassed with brief 
evacuation and then backfilling with N2. Subsequently, freshly distilled allyl acetate (817 L, 8.0 mmol) 
and TMSN3 (1.58 mL, 12.0 mmol) were added successively to flask A followed by drop-wise addition of 
the catalyst solution in vial A at 0 °C. The reaction was kept at this temperature for 30 min, then warmed 
up to 22 °C, and stirred for additional 3 h. Saturated Na2CO3 aqueous solution (10 mL) was added to quench 
the reaction. The organic layer was separated from the aqueous one, which was extracted with CH2Cl2 (10 
mL × 3). The combined organic layers were dried over anhydrous Na2SO4 and concentrated in vacuo (Note: 
the reaction mixture was concentrated in ice-water bath with care to minimize the loss of the volatile 
azidotrifluoromethylation product). The residue was purified through a silica gel column (hexanes/Et2O: 
from 50:1 to 10:1) to afford the desired trifluoromethyl-azidation product 3.5a as colorless oil (1.38 g, 82% 
yield). 
2-Azido-4,4,4-trifluorobutyl acetate (3.5a): IR νmax (neat)/cm-1: 2960 (w), 2121 (s), 1746 (s), 1220 (s), 
1137 (s), 1043 (s), 603 (m); 1H NMR (400 MHz, CDCl3): δ 4.24 (dd, J = 11.6, 4.3 Hz, 1H), 4.13 (dd, J = 
11.6, 6.8 Hz, 1H), 4.00–3.87 (m, 1H), 2.34 (qd, J = 10.4, 6.4 Hz, 2H), 2.12 (s, 3H); 13C NMR (100 MHz, 
CDCl3): δ 170.3, 125.3 (q, J = 276.9 Hz), 65.3, 65.3, 54.7, 54.6, 35.5 (q, J = 29.3 Hz), 20.6; 19F NMR (376 
MHz, CDCl3): δ -64.12 (t, J = 10.4 Hz). 
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To a 100 mL Schlenk flask equipped with a stir bar was added Pd/C (140 mg, 10 wt%) and 
TsOH·H2O (1.42 g, 7.47 mmol). After the flask was evacuated and backfilled twice with N2, a solution of 
the 3.5a from last step (1.37 g, 6.49 mmol) in 50 mL EtOAc was added. The mixture was degassed with 
brief evacuation and backfilled three times with H2, and then vigorously stirred under H2 balloon at 22 °C 
until the reduction completed (the reaction was monitored by TLC until 3.5a was consumed, ca. 2 h). The 
solution was then filtered through Celite and washed with MeOH (25 mL). The resulting solution was 
concentrated in vacuo (to about 4 mL solvent left) and diluted with Et2O (70 mL). The cloudy solution was 
vigorously stirred for 2 h to get most of the β-trifluoromethyl amminium salt precipitate out. The white 
precipitates were collected by filtration, washed with Et2O (10 mL × 3) and dried in vacuo to afford the 
desired β-trifluoromethyl amminium salt 3.5 as a white solid (2.1 g, 90% yield). 
1-Acetoxy-4,4,4-trifluorobutan-2-aminium 4-methylbenzenesulfonate (3.5): 1H NMR (400 MHz, 
DMSO) δ 8.28 (s, 3H), 7.50 (d, J = 8.1 Hz, 2H), 7.13 (d, J = 7.9 Hz, 2H), 4.27 (dd, J = 12.2, 3.4 Hz, 1H), 
4.13 (dd, J = 12.2, 5.9 Hz, 1H), 3.86 – 3.74 (m, 1H), 2.89 – 2.74 (m, 1H), 2.74 – 2.60 (m, 1H), 2.30 (s, 3H), 
2.08 (s, 3H); 13C NMR (100 MHz, DMSO) δ 170.5, 145.5, 138.6, 128.7, 126.1 (q, J = 276.7 Hz), 125.9, 
63.0, 44.8, 33.3 (q, J = 29.0 Hz), 21.2, 21.0; 19F NMR (376 MHz, DMSO) δ -62.38 (t, J = 11.4 Hz). 
C: procedure for trifluoromethyl-azidation/reduction of allyl N-Troc-amine. 
 
To a flame-dried sealable 3-dram vial (vial A) equipped with a stir bar were added Fe(OAc)2 (123 
mg, 0.65 mmol) and L6 (125 mg, 0.65 mmol). After the vial was evacuated and backfilled with N2 twice, 
anhydrous CH2Cl2 (6.0 mL) and MeCN (1.0 mL) were added via a syringe and the mixture was stirred at 
room temperature for 20 min. To another flame dried 50 mL round bottom flask (flask A) equipped with a 
stir bar was added 2,2,2-trichloroethyl allylcarbamate (1.0 g, 4.3 mmol) and 3.1a (1.6 g, 5.2 mmol). Flask 
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A was evacuated and backfilled with N2 twice and then anhydrous CH2Cl2 (14.0 mL) was added. Both 
solutions in vial A and flask A were degassed with brief evacuation and then backfilling with N2.  
Subsequently, freshly distilled TMSN3 (1.58 mL, 12.0 mmol) were added to flask A followed by drop-wise 
addition of the catalyst solution in vial A at 0 °C. The reaction was warmed up to 22 °C and stirred for 8h. 
Saturated Na2CO3 aqueous solution (10 mL) was added to quench the reaction. The organic layer was 
separated from the aqueous one, which was extracted with CH2Cl2 (10 mL × 3). The combined organic 
layers were dried over anhydrous Na2SO4 and concentrated in vacuo. The residue was purified through a 
silica gel column (hexanes/EtOAc: from 50:1 to 4:1) to afford the desired trifluoromethyl-azidation product 
3.6a as colorless oil (1.34 g, 91% yield). 
2,2,2-Trichloroethyl (2-azido-4,4,4-trifluorobutyl)carbamate (3.6a): IR νmax (neat)/cm-1: 3339 (m), 2957 
(w), 2125 (s), 1717 (s), 1524 (m), 1242 (s), 1131 (s), 723 (s);  1H NMR (400 MHz, CDCl3): δ 5.39 (s, 1H), 
4.75 (s, 2H), 4.03–3.86 (m, 1H), 3.60–3.45 (m, 1H), 3.35–3.20 (m, 1H), 2.44–2.25 (m, 2H);  13C NMR (100 
MHz, CDCl3): δ 154.7, 125.4 (q, J = 276.9 Hz), 95.2, 74.7, 56.43, 44.9. 36.4 (q, J = 29.1 Hz); 19F NMR 
(376 MHz, CDCl3): δ -63.88 (t, J = 10.4 Hz). 
To a 100 mL Schlenk flask equipped with a stir bar was added Pd/C (140 mg, 10 wt%) and 
TsOH·H2O (0.82 g, 4.3 mmol). After the flask was evacuated and backfilled twice with N2, a solution of 
3.6a from last step (1.34 g, 3.9 mmol) in 50 mL EtOAc was added. The mixture was degassed with brief 
evacuation and backfilled three times with H2, and then vigorously stirred under H2 balloon at 22 °C until 
the reduction completed (the reaction was monitored by TLC until 3.6a was consumed, ca. 4 h). The 
solution was filtered through Celite and washed with MeOH (25 mL). The resulting solution was 
concentrated in vacuo (to about 4 mL solvent left) and diluted with Et2O (70 mL). The cloudy solution was 
vigorously stirred for 2 h to get most of the product precipitate out. The white precipitates were collected 
by filtration, washed with Et2O (10 mL × 3) and dried in vacuo to afford the desired β-trifluoromethyl 
amminium salt 3.6 as a white solid (1.56 g, 82% yield). 
4,4,4-Trifluoro-1-(((2,2,2-trichloroethoxy)carbonyl)amino)butan-2-aminium 4-
methylbenzenesulfonate (3.6): IR νmax (neat)/cm-1: 3390 (br), 2990 (w),1722 (m), 1708 (m), 1514 (m), 
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1167 (s), 1123 (s), 1035 (s), 1010 (s), 812 (s), 677 (s); 1H NMR (400 MHz, Acetone) δ 8.42 (s, 2H), 7.74 
(d, J = 8.1 Hz, 2H), 7.49 (t, J = 5.7 Hz, 1H), 7.20 (d, J = 7.9 Hz, 2H), 4.74 (dd, J = 47.5, 12.3 Hz, 2H), 3.98 
(s, 1H), 3.88 – 3.62 (m, 2H), 3.09 – 2.93 (m, 1H), 2.93 – 2.81 (m, 2H), 2.35 (s, 3H); 13C NMR (100 MHz, 
DMSO) δ 155.5, 145.6, 138.4, 128.6, 126.2 (q, J = 276.8 Hz), 125.9, 96.4, 74.2, 45.7, 42.7, 34.1 (q, J = 
28.7 Hz), 21.3; 19F NMR (376 MHz, DMSO) δ -62.42 (t, J = 11.3 Hz). 
D: procedure for trifluoromethyl-azidation/reduction of geranyl acetate. 
 
To a flame-dried 3-dram vial (vial A) equipped with a stir bar were added Fe(OAc)2 (5.3 mg, 0.03 
mmol) and ligand L2 (7.1 mg, 0.03 mmol). After this vial was evacuated and backfilled with N2 twice, 
anhydrous CH2Cl2 (0.8 mL) and MeCN (0.2 mL) were added via a syringe and the mixture was stirred at 
room temperature for 10 min. To a second flame-dried 2-dram vial (vial B) was added 3.1a (76 mg, 0.24 
mmol). Vial B was evacuated and backfilled with N2 and then anhydrous CH2Cl2 (3.0 mL) was added to 
dissolve 3.1a. The solution in vial A was degassed with brief evacuation and then backfilling with N2 twice.  
At 0 °C, freshly distilled geranyl acetate (45 µL, 0.2 mmol) and TMSN3 (53 L, 0.4 mmol) were added 
successively to vial A. Subsequently, the solution in vial B was added to vial A using a syringe pump within 
2 h. The reaction mixture was then warmed up to 22 °C and kept stirring for additional 1 h until the olefin 
was mostly consumed (monitored by TLC). Saturated Na2CO3 aqueous solution (0.4 mL) was added to 
quench the reaction and to remove any residue hydrazoic acid.  The reaction mixture was further diluted 
with hexanes (5 mL) and stirred vigorously for 10 min to precipitate 2-iodobenzoic acid. The mixture was 
filtered through a short silica gel pad (ca. 1.5 cm long silica gel with cotton stopper in a regular Pasteur 
pipette) and washed with 30% Et2O in hexanes (10 mL). After concentration in vacuo, the residue was 
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subsequently purified through a silica gel column (hexanes/Et2O: from 100:1 to 20:1) to afford the desired 
trifluoromethyl-azidation product 3.14a as colorless oil (39 mg, 63% yield). 
7-Azido-3,7-dimethyl-6-(trifluoromethyl)oct-2-en-1-yl acetate (3.14a): IR νmax (neat)/cm-1: 2980 (w), 
2103 (s), 1737 (s), 1368 (m), 1228 (s), 1138 (s), 1092 (s);  1H NMR (400 MHz, CDCl3): δ 5.38 (t, J = 6.9 
Hz, 1H), 4.59 (d, J = 7.0 Hz, 2H), 2.31–2.20 (m, 1H), 2.17–2.09 (m, 1H), 2.09–1.99 (m, 4H), 1.84–1.63 
(m, 2H), 1.72 (s, 3H), 1.44 (s, 3H), 1.34 (s, 3H);  13C NMR (100 MHz, CDCl3): δ 171.0, 140.6, 127.4 (q, J 
= 281.8 Hz), 119.9, 62.0 (q, J = 1.3 Hz), 61.1, 50.6 (q, J = 23.6 Hz), 39.1 (q, J = 1.4 Hz), 25.9 (q, J = 2.4 
Hz), 23.9 (q, J = 2.3 Hz), 23.0 (q, J = 2.0 Hz), 21.0, 16.2;  19F NMR (376 MHz, CDCl3): δ -63.8 (d, J = 9.8 
Hz).   
To a 3-dram vial equipped with a stir bar were added 3.14a from last step (38 mg, 0.126 mmol), 
THF (3 mL) and H2O (24 µL, 1.3 mmol). After the vial was evacuated and backfilled with N2 three times, 
a solution of PPh3 (40 mg, 0.15 mmol) in THF (1.5 mL) was added drop-wise at 0 °C. The mixture was 
warmed up to 22 °C and stirred for 6 h (the reaction was monitored by TLC until 3.14a was consumed). 
The mixture was then concentrated in vacuo and the residue was purified through a silica gel column 
(hexanes/EtOAc: from 100:1 to 6:1) to afford the desired β-trifluoromethyl amine 3.14 as clear oil (29 mg, 
81% yield). 
7-Amino-3,7-dimethyl-6-(trifluoromethyl)oct-2-en-1-yl acetate (3.14): IR νmax (neat)/cm-1: 3225 (m), 
2946 (m), 2854 (w), 1721 (s), 1472 (m), 1245 (s), 1167 (s), 1156 (s), 740(m);  1H NMR (400 MHz, CDCl3): 
δ 5.36 (t, J = 6.8 Hz, 1H), 4.56 (t, J = 9.5 Hz, 2H), 2.30–2.21 (m, 1H), 2.10 (m, 1H), 2.04 (s, 3H), 1.99–
1.85 (m, 1H), 1.71 (s, 3H), 1.73–1.64 (m, 2H), 1.59 (s, 2H), 1.22 (d, J = 18.5 Hz, 6H); 13C NMR (100 MHz, 
CDCl3): δ 171.0, 141.0, 128.6 (q, J = 282.6 Hz), 119.6, 61.2, 52.6 (q, J = 21.9 Hz), 51.2 (q, J = 1.1 Hz), 
39.7 (q, J = 1.2 Hz), 29.4 (dq, J = 27.6, 2.1 Hz), 24.2 (q, J = 2.4 Hz), 22.6 (d, J = 55.6 Hz), 20.9, 16.3; 19F 
NMR (376 MHz, CDCl3): δ -63.4 (d, J = 10.3 Hz);  HRMS (ESI, m/z): calcd for C13H23F3NO2+, [M + H+], 
282.1681, found 282.1688. 
E: procedure for trifluoromethyl-azidation/reduction of indole. 
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To a flame-dried sealable 2-dram vial (vial A) equipped with a stir bar were added Fe(OAc)2 (10.5 
mg, 0.06 mmol) and the ligand L13 (14.2 mg, 0.06 mmol). After this vial was evacuated and backfilled 
with N2 twice, anhydrous CH2Cl2 (0.8 mL) and MeCN (0.1 mL) were added via a syringe and the mixture 
was stirred at room temperature for 10 min. TMSN3 (106 L, 0.8 mmol) was added to vial A and the mixture 
was stirred for additional 10 min. To a second flame-dried 3-dram vial (vial B) equipped with a stir bar was 
added 3.1a (190 mg, 0.6 mmol). Vial B was evacuated and backfilled with N2 twice and then anhydrous 
CH2Cl2 (1.1 mL) was added. Both solutions in vial A and vial B were degassed with brief evacuation and 
then backfilling with N2. Subsequently, N-Boc protected indole (78 L, 0.4 mmol) was added to vial B 
followed by drop-wise addition of the catalyst solution in vial A at 0 °C. The reaction mixture was warmed 
up to 22 °C and kept stirring for 8 h until the olefin was consumed (monitored by TLC). Saturated Na2CO3 
aqueous solution (0.4 mL) was added to quench the reaction and to remove any residue hydrazoic acid. The 
reaction mixture was further diluted with hexanes (5 mL) and stirred vigorously for 10 min to precipitate 
2-iodobenzoic acid. The mixture was filtered through a short silica gel pad (ca. 1.5 cm long silica gel with 
cotton stopper in a regular Pasteur pipette) and washed with 30% Et2O in hexanes (10 mL). After 
concentration in vacuo, the residue was subsequently purified through a silica gel column (hexanes/Et2O: 
from 100:1 to 20:1) to afford the desired trifluoromethyl-azidation product 3.15a as colorless oil (95 mg, 
72% yield, dr >20 :1). 
tert-Butyl-3-azido-2-(trifluoromethyl)indoline-1-carboxylate (3.15a):  IR νmax (neat)/cm-1: 2982 (w), 
2103 (s), 1718 (s), 1605 (w), 1481 (s), 1369 (s), 1150 (s), 753(m);  1H NMR (400 MHz, CD3CN): δ 7.77 
(d, J = 7.4 Hz, 1H), 7.49 (dd, J = 18.8, 7.7 Hz, 2H), 7.21 (t, J = 7.5 Hz, 1H), 5.12 (s, 1H), 5.00 (q, J = 7.3 
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Hz, 1H), 1.58 (s, 9H);  13C NMR (100 MHz, CD3CN): δ 151.5, 142.4, 131.0, 126.6, 125.4, 124.3 (q, J = 
282.5 Hz), 124.0, 117.3, 116.5, 83.0, 65.6 (q, J = 30.9 Hz), 59.6, 27.3;  19F NMR (376 MHz, CD3CN): δ -
76.73 (d, J = 6.7 Hz). 
To a 2-dram vial equipped with a stir bar was added Pd/C (10 mg, 10 wt%). After the vial was 
evacuated and backfilled twice with N2, a solution of 3.15a (95 mg, 0.29 mmol) in 2 mL MeOH was added.  
The mixture was degassed with brief evacuation and backfilled twice with N2 and then three times with H2.  
The reaction was vigorously stirred under H2 at room temperature until the reduction completed (the 
reaction was monitored by TLC until 3.15a was consumed). The solution was filtered through Celite and 
washed with MeOH (2 mL). The solution was concentrated and the residue was dissolved in CH2Cl2 (2 mL) 
and cooled to 0 °C. To the above solution, Boc2O (76 mg, 0.35 mmol) in 1 mL CH2Cl2 was added drop-
wise. The resulting mixture was warmed up to room temperature and kept stirring for additional 2 h until 
the free amine was consumed. After the organic solvent was removed under reduced pressure, the residue 
was purified through a silica gel flash column (hexanes/EtOAc: from 20:1 to 6:1) to afford the desired N-
Boc protected β-trifluoromethyl amine 3.15 as a white solid (101 mg, 86% yield, dr > 20:1).  
3.15 was recrystallized from EtOAc/hexanes, and its stereochemistry was confirmed by X-ray 
crystallographic analysis. (Figure 4.3) 
 
Figure 3.4 X-ray crystal structure of the β-trifluoromethyl-amine from indole 
tert-Butyl-3-((tert-butoxycarbonyl)amino)-2-(trifluoromethyl)indoline-1-carboxylate (3.15): IR νmax 
(neat)/cm-1: 3337 (m), 2980 (w),1714 (s), 1483 (m), 1369 (s), 1247 (m), 1154 (s), 752 (s); 1H NMR (400 
MHz, Acetone-d6): δ 7.7 (d, J = 4.1 Hz, 1H), 7.4 (ddt, J = 7.5, 1.4, 0.7 Hz, 1H), 7.4–7.3 (m, 1H), 7.1 (td, J 
= 7.5, 1.1 Hz, 1H), 6.9 (s, 1H), 5.2 (d, J = 8.0 Hz, 1H), 4.9 (qd, J = 7.5, 1.8 Hz, 1H), 1.6 (s, 9H), 1.4 (s, 
9H); 13C NMR (100 MHz, Acetone) δ 154.8, 151.7, 142.7, 130.1, 129.4, 127.8 (q, J = 282.5 Hz), 125.0, 
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123.6, 116.1, 81.9, 79.0, 66.4 (q, J = 33.2 Hz), 51.7, 27.6, 27.4; 19F NMR (376 MHz, Acetone-d6): δ -77.0 
(d, J = 7.1 Hz); HRMS (ESI, m/z): calcd for C19H25F3N2NaO4+, [M + Na+], 425.1659, found 425.1662.  
F: procedure for trifluoromethyl-azidation/reduction of 2,5-dihydropyrrole. 
 
To a flame-dried sealable 2-dram vial (vial A) equipped with a stir bar were added Fe(OAc)2 (17.4 
mg, 0.1 mmol). After this vial was evacuated and backfilled with N2 twice, a stock solution of ligand L6 in 
anhydrous CH2Cl2 (0.5 mL, c=0.2 M) and MeCN (0.1 mL) were added via a syringe and the mixture was 
stirred at room temperature for 10 min. TMSN3 (198 L, 1.5 mmol) was added to vial A and the mixture 
was stirred for additional 10 min. To a second flame-dried 3-dram vial (vial B) equipped with a stir bar was 
added 3.1a (316 mg, 1.0 mmol). Vial B was evacuated and backfilled with N2 twice and then anhydrous 
CH2Cl2 (0.5 mL) was added. Both solutions in vial A and vial B were degassed with brief evacuation and 
then backfilling with N2. Subsequently freshly purified 3.16 (88 L, 0.5 mmol) was added to vial B followed 
by drop-wise addition of the catalyst solution in vial A at 0 °C. The reaction mixture was kept stirring at 0 
°C for 4 h until the olefin was consumed (monitored by TLC). Saturated Na2CO3 aqueous solution (0.4 mL) 
was added to quench the reaction and to remove any residue hydrazoic acid. The reaction mixture was 
further diluted with hexanes (5 mL) and stirred vigorously for 10 min to precipitate 2-iodobenzoic acid. 
The mixture was filtered through a short silica gel pad (ca. 1.5 cm long silica gel with cotton stopper in a 
regular Pasteur pipette) and washed with 20% EtOAc in hexanes (10 mL). After concentration in vacuo, 
the residue was subsequently purified through a silica gel column (hexanes/EtOAc: from 100:1 to 10:1) to 
afford the desired trifluoromethyl-azidation product 3.17a as colorless oil (74 mg, 53% yield, dr> 20:1). 
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tert-Butyl (3R,4S)-3-azido-4-(trifluoromethyl)pyrrolidine-1-carboxylate (3.17a): 1H NMR (400 MHz, 
CDCl3) δ 4.21 (dd, J = 11.7, 5.6 Hz, 1H), 3.89 – 3.61 (m, 2H), 3.61 – 3.44 (m, 1H), 3.44 – 3.29 (m, 1H), 
2.97 – 2.78 (m, 1H), 1.45 (s, 9H);  13C NMR (100 MHz, CDCl3) δ 153.6, 125.6 (q, J = 278.1 Hz), 80.6, 
59.6, 50.4, 48.4, 43.9, 28.3;  19F NMR (376 MHz, CDCl3) δ -70.42. 
To a 2-dram vial equipped with a stir bar was added Pd/C (8 mg, 10 wt%). After the vial was 
evacuated and backfilled twice with N2, a solution of 3.17a (74 mg, 0.265 mmol) in 2 mL MeOH was 
added. The mixture was degassed with brief evacuation and backfilled twice with N2 and then three times 
with H2. The reaction was vigorously stirred under H2 at room temperature until the reduction completed 
(the reaction was monitored by TLC until 3.17a was consumed). The solution was filtered through Celite 
and washed with MeOH (2 mL). After concentration in vacuo, the residue was dissolved in CH2Cl2 (4 mL) 
and cooled to 0 °C. To the above solution, was added Et3N (74 µL, 0.53 mmol) and CbzCl (57 µL, 0.4 
mmol) in 1 mL CH2Cl2. The resulting mixture was warmed up to room temperature and kept stirring for 
additional 2 h until the free amine was consumed. After the organic solvent was removed under reduced 
pressure, the residue was purified through a silica gel flash column (hexanes/EtOAc: from 20:1 to 6:1) to 
afford the desired N-Cbz protected β-trifluoromethyl amine 3.17 as a white solid (91 mg, 88% yield, dr > 
20:1). The structure was confirmed by comparing published data.86 
tert-Butyl (3R,4S)-3-(((benzyloxy)carbonyl)amino)-4-(trifluoromethyl)pyrrolidine-1-carboxylate 
(3.17): 1H NMR (400 MHz, CDCl3) δ 7.42 – 7.27 (m, 5H), 5.39 (s, 1H), 5.09 (s, 2H), 4.37 (s, 1H), 3.78 
(dd, J = 11.5, 7.3 Hz, 1H), 3.66 (brs, 1H), 3.47 (brs, 1H), 3.26 (brs, 1H), 2.94 (brs, 1H), 1.44 (s, 9H); 13C 
NMR (100 MHz, CDCl3) δ 155.5, 136.0, 128.6, 128.4, 128.2, 125.9 (q, J = 277.0 Hz), 80.4, 67.1, 50.5(q, J 
= 59.8 Hz), 28.4; 19F NMR (376 MHz, CDCl3) δ -70.30 (brs). 
G: procedure for trifluoromethyl-azidation/reduction of (-)-β-pinene. 
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To a flame-dried sealable 2-dram vial (vial A) equipped with a stir bar were added Fe(OAc)2 (104 
mg, 0.6 mmol) and ligand L13 (142 mg, 0.6 mmol). After this vial was evacuated and backfilled with N2 
twice, anhydrous CH2Cl2 (5.0 mL) and MeCN (0.5 mL) were added via a syringe and the mixture was 
stirred at room temperature for 20 min. To a flame dried 50 mL round bottom flask (flask B) equipped with 
a stir bar was added 3.1a (2.28 g, 7.2 mmol). Flask B was evacuated and backfilled with N2 twice and then 
anhydrous CH2Cl2 (2.0 mL) was added. Both solutions in vial A and flask B were degassed with brief 
evacuation and then backfilling with N2. Subsequently, freshly distilled (−)-β-pinene (0.95 mL, 6.0 mmol) 
and TMSN3 (1.2 mL, 9.0 mmol) were added successively to flask B followed by slow addition of the 
catalyst solution in vial A using syringe pump within 1 h at 0 °C. The reaction was kept stirring at 0 °C for 
2 h and then quenched with saturated Na2CO3 solution (10 mL). The organic layer was separated from the 
aqueous one, which was extracted with CH2Cl2 (10 mL × 3). The combined organic layers were dried over 
anhydrous Na2SO4 and concentrated in vacuo. The residue was purified through a silica gel flash column 
(100% hexanes) to afford the desired trifluoromethyl-azidation product 3.8 as colorless oil (1.22 g, 82% 
yield, dr >20: 1). 
2-Azido-6,6-dimethyl-2-(2,2,2-trifluoroethyl)bicyclo[3.1.1]heptane (3.8): 1HNMR (400 MHz, CDCl3):  
δ 2.65–2.39 (m, 2H), 2.38–2.29 (m, 1H), 2.18 (t, J = 5.4 Hz, 1H), 2.05–1.86 (m, 5H), 1.44 (d, J = 10.5 Hz, 
1H), 1.30 (s, 3H), 1.03 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 125.6 (q, J = 278.6 Hz), 49.9, 43.6 (q, J = 
26.7 Hz), 39.9, 38.4, 28.3, 27.6, 27.2, 25.3, 23.1; 19FNMR (376 MHz, CDCl3): δ -60.03 (t, J = 10.8 Hz). 
To a 50 mL round bottle flask equipped with a stir bar and a three-way adapter was added Pd/C (10 
wt%, 0.12 g). After the flask was evacuated and backfilled twice with N2, a solution of 4.8 from last step 
(1.22 g, 4.93 mmol) in 15 mL MeOH was added. The mixture was degassed with brief evacuation and 
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backfilled three times with H2, and then vigorously stirred under H2 balloon at 22 °C until the reduction 
was complete (the reaction was monitored by TLC until 4.8 was consumed). The solution was filtered 
through Celite and washed with CH2Cl2 (20 mL). The mixture was then concentrated in vacuo and the 
residue was purified through a silica gel column (hexanes/EtOAc: from 100:1 to 4:1) to afford the desired 
β-trifluoromethyl amine 4.9 as white solid (830 mg, 76% yield). 
6,6-Dimethyl-2-(2,2,2-trifluoroethyl)bicyclo[3.1.1]heptan-2-amine (3.9): 1HNMR (400 MHz, CDCl3): δ 
2.54–2.30 (m, 2H), 2.28–2.18 (m, 1H), 2.00–1.81 (m, 5H), 1.72–1.60 (m, 1H), 1.57 (s, 2H), 1.37 (d, J = 
10.5 Hz, 1H), 1.25 (s, 3H), 1.00 (s, 3H); 13CNMR (100 MHz, CDCl3): δ 126.9 (q, J = 279.1 Hz), 54.2 (q, J 
= 1.7 Hz), 53.2 (q, J = 1.1 Hz), 46.2 (q, J = 24.2 Hz), 40.5, 38.5, 31.2 (q, J = 1.4 Hz); 27.7, 27.4, 25.2, 23.5; 
19FNMR (376 MHz, CDCl3): δ -58.64 (t, J = 11.5 Hz).  
For X-ray analysis purpose, N-Boc-protected β-trifluoromethyl amine 3.9a was prepared from 3.9 by 
following the general procedure B in 3.3.3 as a white solid (82% yield, dr > 20:1). After crystallization 
from EtOAc/hexanes, its stereochemistry was confirmed by X-ray crystallographic analysis (Figure 3.5). 
 
Figure 3.5 X-ray crystal structure of the β-trifluoromethyl-amine from (-)-β-pinene 
H: procedure for trifluoromethyl-azidation/reduction of (±)-citronellal. 
 
To a flame-dried sealable 2-dram vial (vial A) equipped with a stir bar were added Fe(OAc)2 (26.1 
mg, 0.15 mmol). After this vial was evacuated and backfilled with N2 twice, a stock solution of ligand L6 
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in anhydrous CH2Cl2 (1.0 mL, c=0.15 M) and MeCN (0.1 mL) were added via a syringe and the mixture 
was stirred at room temperature for 10 min. TMSN3 (198 mL, 1.5 mmol) was added to vial A and the 
mixture was stirred for additional 10 min. To a second flame-dried 3-dram vial (vial B) equipped with a stir 
bar was added 3.1a (380 mg, 1.2 mmol). Vial B was evacuated and backfilled with N2 twice and then 
anhydrous CH2Cl2 (3.9 mL) was added. Both solutions in vial A and vial B were degassed with brief 
evacuation and then backfilling with N2. Subsequently the freshly distilled (±)-citronellal (180 µL, 1.0 
mmol) was added to vial B followed by drop-wise addition of the catalyst solution in vial A at 0 °C. The 
reaction mixture was warmed up to 22 °C and kept stirring for 4 h until the olefin was consumed (monitored 
by TLC). Saturated NaHCO3 aqueous solution (0.4 mL) was added to quench the reaction and to remove 
any residue hydrazoic acid. The reaction mixture was further diluted with hexanes (5 mL) and stirred 
vigorously for 10 min to precipitate 2-iodobenzoic acid. The mixture was filtered through a short silica gel 
pad (ca. 1.5 cm × 1.5 cm silica gel in a filter funnel) and washed with 20% Et2O in hexanes (15 mL). After 
concentration in vacuo, the residue was subsequently purified through a silica gel column (hexanes/Et2O: 
from 50:1 to 10:1) to afford the desired trifluoromethyl-azidation product 3.18a as colorless oil (186 mg, 
70% yield, dr: 1:1). 
7-Azido-3,7-dimethyl-6-(trifluoromethyl)octanal (3.18a): IR νmax (neat)/cm-1: 2966 (w), 2926 (w), 2878 
(w), 2856 (w), 2136 (s), 2106 (s), 1722 (s), 1247 (m), 1151 (s), 1059 (m); 1H NMR (400 MHz, CDCl3) δ 
9.75 (t, J = 2.1 Hz, 1H), 2.47 – 2.37 (m, 1H), 2.33 – 2.21 (m, 1H), 2.13 – 1.95 (m, 2H), 1.76 – 1.47 (m, 
3H), 1.43 (s, 4H), 1.34 (s, 3H), 0.98 (dd, J = 6.7, 3.0 Hz, 3H); 13C NMR (100 MHz, CDCl3) diastereomer 
1: δ 202.2, 127.4 (d, J = 281.8 Hz), 62.1 (q, J = 2.3 Hz), 51.9 (q, J = 23.7 Hz), 50.9, 36.9 (q, J = 1.2 Hz), 
28.1, 26.0, 23.5 (q, J = 4.7, 2.3 Hz), 23.0 (q, J = 2.1 Hz), 19.8; diastereomer 2: 13C NMR (100 MHz, CDCl3) 
δ 202.2, 127.4 (q, J = 281.7 Hz), 62.1 (q, J = 2.3 Hz), 51.9 (q, J = 23.6 Hz), 50.5, 36.9 (q, J = 1.3 Hz), 28.1, 
26.0, 23.4 (q, J = 2.4 Hz), 23.0 (q, J = 2.1 Hz), 19.5; 19F NMR (376 MHz, CDCl3) diastereomer 1: δ -64.03 
(d, J = 9.9 Hz); diastereomer 2: δ -64.13 (d, J = 9.9 Hz). 
3.18a (100 mg, 0.37 mmol) was dissolved in anhydrous THF (3 mL) in a 10 mL flask equipped with a stir 
bar. The flask was cooled to 0 ºC and then LiAlH4 powder (29 mg, 0.76 mmol) was added in three portions. 
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The reaction mixture was warmed up to 22 ºC and monitored by TLC. After about 40 min, the reaction was 
quenched with saturated NH4Cl aqueous solution (2 mL). The mixture was filtered through a short Celite 
pad and concentrated in vacuo. The resting aqueous phase was extracted with EtOAc (3 mL × 3) and dried 
over anhydrous Na2SO4. After removal of the solvent, 3.18 was obtained as colorless oil without further 
purification (86 mg, 95% yield, dr:1:1) 
7-Amino-3,7-dimethyl-6-(trifluoromethyl)octan-1-ol (3.18): IR νmax (neat)/cm-1: 3291 (br), 2959 (m), 
2928 (m), 2875 (w), 1247 (s), 1147 (s), 1088 (s); 1H NMR (400 MHz, CDCl3) δ 3.81 – 3.48 (m, 3H), 1.94 
– 1.81 (m, 1H), 1.69 (brs, 3H), 1.64 – 1.46 (m, 5H), 1.46 – 1.31 (m, 2H), 1.18 (s, 6H), 0.97 – 0.85 (m, 3H); 
13C NMR (100 MHz, CDCl3) diastereomer 1: δ 128.70 (q, J = 282.4 Hz), 60.6, 53.8 (q, J = 21.7 Hz), 51.3 
(d, J = 3.0 Hz), 39.6, 37.8 (q, J = 1.1 Hz), 29.8, 29.3 (q, J = 2.1 Hz), 23.7 (q, J = 2.5 Hz), 19.6; diastereomer 
2: δ 128.7 (q, J = 282.4 Hz), 60.5, 53.8 (q, J = 21.7 Hz), 51.3 (d, J = 3.0 Hz), 39.4 (s), 37.7 (q, J = 1.1 Hz), 
29.7, 29.3 (q, J = 2.1 Hz), 23.6 (q, J = 2.6 Hz), 19.3; 19F NMR (376 MHz, CDCl3) diastereomer 1: δ -63.37 
(d, J = 10.4 Hz); diastereomer 2: δ -63.48 (d, J = 10.4 Hz). 
I: procedure for trifluoromethyl-azidation/reduction of 3-carene. 
 
To a flame-dried sealable 2-dram vial (vial A) equipped with a stir bar were added Fe(OAc)2 (26.1 
mg, 0.15 mmol). After this vial was evacuated and backfilled with N2 twice, a stock solution of ligand L6 
in anhydrous CH2Cl2 (1.0 mL, c=0.15 M) and MeCN (0.1 mL) were added via a syringe and the mixture 
was stirred at room temperature for 10 min. TMSN3 (198 mL, 1.5 mmol) was added to vial A and the 
mixture was stirred for additional 10 min. To a second flame-dried 3-dram vial (vial B) equipped with a stir 
bar was added 3.1a (380 mg, 1.2 mmol). Vial B was evacuated and backfilled with N2 twice and then 
anhydrous CH2Cl2 (3.9 mL) was added. Both solutions in vial A and vial B were degassed with brief 
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evacuation and then backfilling with N2. Subsequently the freshly distilled 3-carene (168 µL, 1.0 mmol) 
was added to vial B followed by drop-wise addition of the catalyst solution in vial A at 0 °C. The reaction 
mixture was warmed up to 22 °C and kept stirring for 8 h until the olefin was consumed (monitored by 
TLC). Saturated Na2CO3 aqueous solution (0.4 mL) was added to quench the reaction and to remove any 
residue hydrazoic acid. The reaction mixture was further diluted with hexanes (5 mL) and stirred vigorously 
for 10 min to precipitate 2-iodobenzoic acid. The mixture was filtered through a short silica gel pad (ca. 
1.5 cm × 1.5 cm silica gel in a filter funnel) and washed with 20% Et2O in hexanes (15 mL). After 
concentration in vacuo, the residue was subsequently purified through a silica gel column (100% hexanes) 
to afford the desired trifluoromethyl-azidation product 3.19a as colorless oil (193 mg, 78% yield, dr> 20:1).  
(1S,3R,4R,6R)-3-Azido-3,7,7-trimethyl-4-(trifluoromethyl)bicyclo[4.1.0]heptane (3.19a): 1H NMR 
(400 MHz, CDCl3) δ 2.04 (dd, J = 14.2, 9.7 Hz, 1H), 2.00 – 1.92 (m, 3H), 1.42 – 1.37 (m, 3H), 1.32 (ddd, 
J = 14.5, 5.5, 1.0 Hz, 1H), 1.03 (d, J = 2.6 Hz, 3H), 0.95 (s, 3H), 0.87 – 0.79 (m, 1H), 0.72 – 0.64 (m, 1H); 
13C NMR (100 MHz, CDCl3) δ 127.4 (q, J = 281.7 Hz), 60.3, 45.4 (q, J = 23.9 Hz), 34.2 (q, J = 1.1 Hz), 
28.4, 18.9, 18.6 (q, J = 2.1 Hz), 18.4, 18.3 (q, J = 3.2 Hz), 17.1, 14.9; 19F NMR (376 MHz, CDCl3) δ -66.57 
(d, J = 7.5 Hz). 
To a 2-dram vial equipped with a stir bar was added Pd/C (10 mg, 10 wt%). After the vial was 
evacuated and backfilled twice with N2, a solution of 3.19a from last step (192 mg, 0.78 mmol) in 3 mL 
MeOH was added. The mixture was degassed with brief evacuation and backfilled twice with N2 and then 
three times with H2. The reaction was vigorously stirred under H2 at room temperature until the reduction 
completed (the reaction was monitored by TLC until 3.19a was consumed). The solution was filtered 
through Celite and washed with MeOH (3 mL). The solution was concentrated and the residue was 
dissolved in CH2Cl2 (4 mL) and cooled to 0 °C.  To the above solution, Boc2O (255 mg, 1.17 mmol) in 2 
mL CH2Cl2 was added drop-wise. The resulting mixture was warmed up to room temperature and kept 
stirring for additional 2 h until the free amine was consumed. After the organic solvent was removed under 
reduced pressure, the residue was purified through a silica gel flash column (hexanes/EtOAc: from 20:1 to 
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6:1) to afford the desired N-Boc protected β-trifluoromethyl amine 3.19 as a white solid (213mg, 85% yield, 
dr > 20:1). 
tert-Butyl ((1S,3R,4R,6R)-3,7,7-trimethyl-4-(trifluoromethyl)bicyclo[4.1.0]heptan-3-yl)carbamate 
(3.19): 1H NMR (400 MHz, CDCl3) δ 4.49 (s, 1H), 3.07 (d, J = 8.4 Hz, 1H), 2.32 (d, J = 11.0 Hz, 1H), 2.04 
– 1.91 (m, 2H), 1.67 (dd, J = 15.0, 9.6 Hz, 1H), 1.40 (s, 9H), 1.26 (s, 3H), 1.04 (s, 3H), 0.99 (s, 3H), 0.78 
(td, J = 9.7, 5.4 Hz, 1H), 0.65 – 0.52 (m, 1H);  13C NMR (100 MHz, CDCl3) δ 154.2, 128.3 (q, J = 282.0 
Hz), 79.1, 52.6, 40.4, 31.9, 28.6, 28.4, 21.7, 19.6, 18.5, 18.2, 17.3, 15.3; 19F NMR (376 MHz, CDCl3) δ -
66.32 (d, J = 9.5 Hz). 
For X-ray analysis purpose, N-Ns-protected β-trifluoromethyl amine 3.19b was prepared from 3.19a by 
following the general procedure B in 3.3.3 as a white solid (70% yield, dr > 20:1). After crystallization 
from EtOAc/Hexanes, its stereochemistry was confirmed by X-ray crystallographic analysis (Figure 3.6). 
 
Figure 3.6 X-ray crystal structure of the β-trifluoromethyl-amine from 3-carene 
J: procedure for trifluoromethyl-azidation of substituted vinylcyclcopropane radical clock probe 
 
The radical clock substrate 3.10 was prepared according to a known procedure.84  
To a flame-dried sealable 2-dram vial (vial A) equipped with a stir bar were added Fe(OAc)2 (7.0 
mg, 0.04 mmol). After this vial was evacuated and backfilled with N2 twice, a stock solution of ligand L6 
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in anhydrous CH2Cl2 (0.8 mL, c=0.05 M) and MeCN (0.1 mL) were added via a syringe and the mixture 
was stirred at room temperature for 10 min. TMSN3 (80 L, 0.6 mmol) was added to vial A and the mixture 
was stirred for additional 10 min. To a second flame-dried 3-dram vial (vial B) equipped with a stir bar was 
added 3.1a (152 mg, 0.48 mmol). Vial B was evacuated and backfilled with N2 twice and then anhydrous 
CH2Cl2 (1.1 mL) was added. Both solutions in vial A and vial B were degassed with brief evacuation and 
then backfilling with N2. Subsequently the radical clock substrate 3.10 (94 L, 0.4 mmol) was added to vial 
B followed by drop-wise addition of the catalyst solution in vial A at 0 °C. The reaction mixture was kept 
stirring at 0°C for 3 h until the olefin was consumed (monitored by TLC). Saturated Na2CO3 aqueous 
solution (0.4 mL) was added to quench the reaction and to remove any residue hydrazoic acid. The reaction 
mixture was further diluted with hexanes (5 mL) and stirred vigorously for 10 min to precipitate 2-
iodobenzoic acid. The mixture was filtered through a short silica gel pad (ca. 1.5 cm long silica gel with 
cotton stopper in a regular Pasteur pipette) and washed with 20% EtOAc in hexanes (10 mL). After 
concentration in vacuo, the residue was subsequently purified through a silica gel column (hexanes/Et2O: 
from 100:1 to 20:1) to afford the desired trifluoromethyl-azidation product 3.11 as colorless oil (100 mg, 
77% yield, a mixture of two diastereomers, dr: 1:1). 
((1R,2S,E)-1-Azido-2-(tert-butoxy)-6,6,6-trifluorohex-3-en-1-yl)benzene (3.11): diastereomer 1 (less 
polar): 1H NMR (400 MHz, CDCl3) δ 7.37 – 7.27 (m, 5H), 5.72 (dd, J = 15.6, 6.2 Hz, 1H), 5.59 – 5.48 (m, 
1H), 4.48 (d, J = 5.3 Hz, 1H), 4.14 (t, J = 5.7 Hz, 1H), 2.89 – 2.72 (m, 2H), 1.09 (s, 9H);; 19F NMR (376 
MHz, CDCl3) δ -66.28 (t, J = 10.7 Hz);  
diastereomer 2 (more polar): 1H NMR (400 MHz, CDCl3) δ 7.37 – 7.28 (m, 3H), 7.24 – 7.18 (m, 2H), 5.53 
– 5.37 (m, 2H), 4.33 (d, J = 7.7 Hz, 1H), 4.14 (dd, J = 7.6, 5.3 Hz, 1H), 2.73 – 2.59 (m, 2H), 1.22 (s, 9H); 
13C NMR (100 MHz, CDCl3) δ 137.7, 136.8, 128.4, 128.2, 127.8, 125.7 (q, J = 276.7 Hz), 120.4 (q, J = 3.6 
Hz), 76.1, 75.6, 70.5, 36.9 (q, J = 29.8 Hz), 28.4; 19F NMR (376 MHz, CDCl3) δ -66.29 (t, J = 10.7 Hz).  
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3.4 Conclusion 
In conclusion, we have discovered a new iron-catalyzed olefin trifluoromethyl-azidation method 
for efficient synthesis of a wide variety of vicinal trifluoromethylated primary amines. This method tolerates 
a broad range of unfunctionalized olefins, monoterpenes and N-heterocycles, many of which have been 
challenging substrates for existing approaches. A readily available Togni’s Reagent II and the commercially 
available TMSN3 were used as source of CF3 and N3 functionalities. 
Additionally, a range of control experiments and crystallographic studies of the catalytically active 
iron-azide complex suggest that both oxidant activation and rapid azido-group transfer steps may proceed 
through an in situ formed iron-azide complex.  
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Appendix A. Representative NMR spectra and HPLC traces in CHAPTER 1  
Appendix A.1 NMR Spectra  
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The stereochemistry of 1.35 was determined through NOE analysis. There is a strong NOE between 
H(a) and H(b), while there is no NOE observed between H(a) and NH(c). (Note: on 1H NMR, H(b) and 
H(d) are partially overlapped and H(d) is in a distance away from H(a). 
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The stereochemistry of 1.36 was determined through NOE analysis. We observed strong NOEs 
between H(b) and H(e), as well as between H(d) and H(f). The results, together with the stereochemistry 
of the starting material, suggest that H(b) is at the axial position. Additionally, we observed either no NOE 
or a very weak NOE between H(a) and H(f) or H(d), which indicates that H(a) is at the equatorial position; 
therefore, the stereochemical relationship between the groups OR, NHBoc, and OTIPS are syn, anti. 
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Appendix A.2 HPLC traces of compound 1.7 
The ee of compound 1.7 was measured by Chiral HPLC analysis (Chiral S.S. Whelk, 1.0 mL/min, 254 
nm, 5% EtOH in hexanes, tr (minor) = 20.66 min, tr (major) = 24.88 min). 
Racemic sample
 
 
Enantio-enriched sample (81% ee) 
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Appendix A.3 HPLC traces of compound 1.10  
The ee of compound 1.10 was measured by Chiral HPLC analysis (Chiral S.S. Whelk, 1.0 mL/min, 210 nm, 
15% EtOH in hexanes, tr (minor) = 11.74 min, tr (major) = 17.97 min, 57% ee). 
Racemic sample 
 
  
Enantio-enriched sample (57% ee) 
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Appendix B. Representative NMR spectra and HPLC traces in CHAPTER 2  
Appendix B.1 NMR Spectra  
 
 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.08.59.0 ppm
4
.
8
6
5
7
.
5
0
0
7
.
5
0
5
7
.
5
1
9
7
.
5
3
5
7
.
5
4
0
7
.
6
5
5
7
.
6
5
8
7
.
6
6
1
7
.
6
7
3
7
.
6
7
7
7
.
6
8
1
7
.
6
9
5
8
.
1
1
5
8
.
1
1
8
8
.
1
2
3
8
.
1
3
6
8
.
1
3
9
8
.
6
8
1
2
.0
0
2
.0
0
1
.0
0
1
.9
6
0
.9
7
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
7
5
.
1
9
9
4
.
4
3
1
2
6
.
2
9
1
2
8
.
8
1
1
3
0
.
0
6
1
3
4
.
4
9
1
5
4
.
6
4
1
6
5
.
5
3
162 
 
 
 
  
9.5 9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 ppm
4
.
5
5
5
4
.
5
7
5
4
.
5
9
6
4
.
6
1
6
7
.
4
7
6
7
.
4
8
0
7
.
4
9
5
7
.
5
1
1
7
.
5
1
5
7
.
6
3
2
7
.
6
3
6
7
.
6
3
9
7
.
6
5
4
7
.
6
7
3
8
.
0
7
7
8
.
0
8
0
8
.
0
8
5
8
.
0
9
8
8
.
1
0
1
8
.
6
3
1
2
.0
1
1
.9
9
1
.0
0
1
.9
6
0
.9
7
2030405060708090100110120130140150160170180190 ppm
6
1
.
3
5
6
1
.
7
2
6
2
.
0
9
6
2
.
4
6
1
1
8
.
3
9
1
2
1
.
1
4
1
2
3
.
9
0
1
2
6
.
1
8
1
2
6
.
6
6
1
2
8
.
8
2
1
3
0
.
0
3
1
3
4
.
5
3
1
5
4
.
5
4
1
6
5
.
4
6
163 
 
 
  
9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
5
.
6
9
1
5
.
7
0
6
5
.
7
2
0
5
.
7
3
5
5
.
7
5
0
7
.
4
9
1
7
.
5
1
1
7
.
5
3
0
7
.
6
5
5
7
.
6
5
8
7
.
6
7
4
7
.
6
9
3
8
.
0
8
4
8
.
0
8
7
8
.
1
0
5
1
.0
0
2
.0
4
1
.0
3
2
.0
1
170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
6
7
.
6
9
6
8
.
0
4
6
8
.
3
9
6
8
.
7
4
6
9
.
0
9
1
1
6
.
0
0
1
1
8
.
7
7
1
1
8
.
8
0
1
2
1
.
5
8
1
2
1
.
6
1
1
2
4
.
4
1
1
2
5
.
7
7
1
2
8
.
8
7
1
3
0
.
0
7
1
3
4
.
7
3
1
5
2
.
6
3
1
6
5
.
0
7
164 
 
 
  
-40 -60 -80 -100 -120 -140 -160 -180 ppm
-
7
3
.
4
6
-
7
3
.
4
4
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
2
.
8
5
2
2
.
8
6
5
2
.
8
7
2
2
.
8
8
8
2
.
8
9
6
2
.
9
0
2
2
.
9
0
9
2
.
9
1
6
2
.
9
2
2
2
.
9
3
2
2
.
9
4
7
2
.
9
5
3
2
.
9
6
6
3
.
0
5
9
3
.
0
6
7
3
.
0
7
6
3
.
0
8
4
3
.
0
9
5
3
.
1
0
3
3
.
1
1
3
3
.
1
2
1
3
.
1
3
0
3
.
1
3
8
3
.
1
4
7
3
.
1
5
6
3
.
1
6
6
3
.
1
7
5
3
.
1
8
4
3
.
1
9
2
4
.
4
0
7
4
.
9
3
5
4
.
9
4
4
4
.
9
5
5
4
.
9
6
3
5
.
0
5
6
5
.
0
6
4
5
.
0
7
5
5
.
0
8
3
5
.
6
8
4
5
.
7
0
0
5
.
7
1
6
5
.
7
3
2
5
.
7
4
7
6
.
9
4
0
6
.
9
5
3
6
.
9
5
9
7
.
0
1
9
7
.
0
2
2
7
.
0
3
6
1
.0
6
1
.0
0
0
.9
7
1
.0
0
0
.9
9
1
.9
7
2
.9
7
165 
 
 
 
160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
4
6
.
9
9
4
7
.
2
3
6
7
.
1
3
6
7
.
4
7
6
7
.
8
2
6
8
.
1
6
6
8
.
5
0
9
1
.
5
3
9
3
.
2
6
1
1
6
.
3
6
1
1
9
.
1
6
1
2
1
.
9
7
1
2
4
.
7
9
1
2
5
.
3
9
1
2
5
.
4
6
1
2
8
.
7
9
1
2
9
.
1
3
1
2
9
.
1
4
1
3
6
.
1
8
1
3
6
.
3
8
1
5
2
.
6
9
-70 -80 -90 -100 -110 -120 -130 -140 -150 -160 -170 -180 -190 ppm
-
1
8
3
.
9
7
-
1
8
3
.
9
3
-
1
8
3
.
9
0
-
1
8
3
.
8
5
-
1
8
3
.
8
0
-
1
8
3
.
7
7
-
1
8
3
.
7
2
-
7
3
.
7
2
-
7
3
.
7
0
1
.0
0
5
.9
5
166 
 
 
 
  
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 ppm
1
.
0
6
6
1
.
4
1
7
1
.
4
3
3
1
.
4
5
4
1
.
4
7
0
1
.
4
9
4
1
.
5
1
0
1
.
5
3
2
1
.
7
3
4
1
.
7
5
4
1
.
7
7
2
1
.
7
9
2
1
.
8
1
1
1
.
8
3
0
3
.
1
3
5
3
.
1
4
7
3
.
1
5
4
3
.
1
5
9
3
.
1
6
6
3
.
1
8
3
3
.
1
9
6
3
.
2
0
2
3
.
2
7
3
3
.
2
8
0
3
.
2
9
1
3
.
2
9
7
3
.
3
4
5
3
.
3
5
2
3
.
3
6
3
4
.
5
7
9
4
.
5
8
4
4
.
5
9
6
4
.
6
0
2
4
.
7
0
2
4
.
7
0
7
4
.
7
1
9
4
.
7
2
4
5
.
2
2
1
5
.
5
9
9
5
.
6
1
5
5
.
6
3
0
5
.
6
4
6
5
.
6
6
1
7
.
3
7
3
7
.
3
7
8
7
.
3
8
8
7
.
3
9
4
7
.
4
0
6
7
.
4
1
3
7
.
4
2
1
7
.
4
2
4
7
.
4
4
1
7
.
4
5
7
7
.
5
9
7
7
.
6
0
1
7
.
6
1
7
7
.
6
3
0
7
.
6
3
3
7
.
6
4
9
9
.1
1
1
.1
0
1
.0
1
1
.0
2
1
.0
2
1
.0
0
0
.8
6
0
.9
8
6
.1
2
4
.1
8
160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
1
5
.
3
7
1
5
.
5
8
1
8
.
0
3
2
7
.
6
5
4
7
.
4
3
4
7
.
6
5
6
7
.
0
1
6
7
.
3
5
6
7
.
7
0
6
8
.
0
4
6
8
.
3
8
9
0
.
2
3
9
1
.
9
3
1
1
6
.
3
7
1
1
9
.
1
7
1
2
1
.
9
8
1
2
4
.
8
2
1
2
7
.
8
0
1
2
7
.
9
1
1
2
9
.
5
6
1
2
9
.
6
3
1
3
3
.
2
3
1
3
3
.
5
4
1
3
5
.
8
7
1
3
5
.
9
6
1
5
2
.
5
0
167 
 
 
 
-70 -80 -90 -100 -110 -120 -130 -140 -150 -160 ppm
-
1
6
9
.
5
4
-
1
6
9
.
5
3
-
1
6
9
.
4
9
-
1
6
9
.
4
8
-
1
6
9
.
4
5
-
1
6
9
.
4
1
-
1
6
9
.
4
0
-
1
6
9
.
3
7
-
1
6
9
.
3
6
-
1
6
9
.
3
2
-
7
3
.
6
7
-
7
3
.
6
2
1
.0
0
5
.9
2
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 ppm
1
.
0
4
6
1
.
0
5
6
1
.
0
7
0
1
.
0
8
4
1
.
0
9
5
1
.
1
0
8
1
.
1
2
3
3
.
3
3
6
3
.
3
4
3
3
.
3
5
6
3
.
3
6
0
3
.
3
7
2
3
.
3
8
0
3
.
3
9
1
3
.
4
0
2
3
.
4
0
7
3
.
4
2
0
3
.
4
2
6
3
.
4
3
9
3
.
5
5
3
3
.
5
6
1
3
.
5
7
1
3
.
5
7
9
3
.
5
9
0
3
.
5
9
8
3
.
6
0
8
3
.
6
1
6
3
.
6
2
2
3
.
6
3
0
3
.
6
4
0
3
.
6
4
8
3
.
6
5
9
3
.
6
6
7
3
.
6
7
7
3
.
6
8
5
4
.
2
9
8
5
.
0
0
1
5
.
1
2
3
5
.
4
5
8
5
.
6
4
7
5
.
6
6
2
5
.
6
7
8
5
.
6
9
3
5
.
7
0
9
5
.
7
6
9
5
.
7
8
4
5
.
8
0
7
5
.
8
2
3
5
.
8
3
9
5
.
8
4
3
5
.
8
4
8
5
.
8
5
9
5
.
9
5
6
5
.
9
6
3
5
.
9
7
2
5
.
9
8
0
6
.
0
0
2
6
.
0
1
0
2
2
.2
7
1
.0
4
1
.0
4
2
.0
2
1
.0
0
0
.9
4
1
.0
1
1
.0
9
1
.0
1
168 
 
 
 
170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
1
1
.
9
5
1
7
.
9
0
4
5
.
5
1
4
5
.
7
3
6
2
.
4
9
6
7
.
0
9
6
7
.
4
4
6
7
.
7
8
6
8
.
1
3
6
8
.
4
7
9
0
.
3
3
9
2
.
0
2
1
1
6
.
3
5
1
1
9
.
1
6
1
1
9
.
1
8
1
2
1
.
9
9
1
2
2
.
8
6
1
2
3
.
0
4
1
2
4
.
7
9
1
3
5
.
4
1
1
3
5
.
5
2
1
5
2
.
7
0
-60 -70 -80 -90 -100 -110 -120 -130 -140 -150 -160 -170 -180 ppm
-
1
8
1
.
7
0
-
1
8
1
.
6
8
-
1
8
1
.
6
6
-
1
8
1
.
6
5
-
1
8
1
.
6
4
-
1
8
1
.
6
3
-
1
8
1
.
6
1
-
1
8
1
.
6
0
-
1
8
1
.
5
9
-
1
8
1
.
5
8
-
1
8
1
.
5
7
-
1
8
1
.
5
5
-
1
8
1
.
5
4
-
1
8
1
.
5
3
-
1
8
1
.
5
2
-
7
3
.
7
1
1
.0
0
6
.0
6
169 
 
 
 
  
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0
.
8
9
2
0
.
9
2
5
1
.
3
1
3
1
.
3
5
4
1
.
4
0
3
1
.
4
1
5
1
.
4
5
3
1
.
4
7
2
1
.
4
7
8
1
.
4
9
0
1
.
5
0
6
1
.
5
2
6
1
.
5
3
8
1
.
5
5
0
1
.
5
6
3
1
.
5
8
6
1
.
5
9
1
1
.
6
1
1
1
.
6
2
3
1
.
6
4
6
1
.
6
6
8
1
.
6
7
8
1
.
6
9
1
1
.
7
0
8
1
.
7
1
7
1
.
7
2
9
3
.
3
1
6
3
.
3
2
0
3
.
3
3
3
3
.
3
4
0
3
.
3
4
6
3
.
3
5
2
3
.
3
6
5
3
.
3
6
9
3
.
3
8
2
3
.
3
8
9
3
.
4
0
1
3
.
5
3
0
3
.
5
3
6
3
.
5
4
7
3
.
5
5
4
3
.
6
0
3
3
.
6
1
0
3
.
6
2
1
3
.
6
2
7
4
.
5
3
2
4
.
5
4
1
4
.
5
5
0
4
.
6
5
5
4
.
6
6
3
4
.
6
6
7
4
.
6
7
4
5
.
4
3
8
5
.
6
7
2
5
.
6
8
7
5
.
7
0
3
5
.
7
1
8
5
.
7
3
4
3
.0
0
1
0
.5
7
1
.0
2
1
.0
2
1
.0
0
0
.8
7
0
.9
8
170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
1
3
.
9
8
2
2
.
4
9
2
4
.
6
3
2
4
.
6
8
2
8
.
9
5
3
1
.
5
6
3
1
.
9
9
3
2
.
1
9
4
5
.
3
7
4
5
.
5
8
6
7
.
0
8
6
7
.
4
3
6
7
.
7
7
6
8
.
1
2
6
8
.
4
6
9
1
.
8
2
9
3
.
5
1
1
1
6
.
3
7
1
1
9
.
1
9
1
2
1
.
9
7
1
2
4
.
7
7
1
5
2
.
7
7
170 
 
 
 
 
-50 -60 -70 -80 -90 -100 -110 -120 -130 -140 -150 -160 -170 -180 -190 ppm
-
1
8
6
.
6
5
-
1
8
6
.
6
4
-
1
8
6
.
6
0
-
1
8
6
.
5
8
-
1
8
6
.
5
6
-
1
8
6
.
5
2
-
1
8
6
.
5
1
-
1
8
6
.
4
8
-
1
8
6
.
4
7
-
1
8
6
.
4
5
-
1
8
6
.
4
3
-
1
8
6
.
4
0
-
1
8
6
.
3
9
-
1
8
6
.
3
5
-
7
3
.
6
8
-
7
3
.
6
7
-
7
3
.
6
5
-
7
3
.
6
4
-
7
3
.
6
3
1
.0
0
6
.1
8
9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 ppm
2
.
8
5
2
2
.
8
9
2
3
.
5
2
3
3
.
5
4
2
3
.
5
6
4
3
.
5
8
3
4
.
4
7
7
4
.
4
9
6
4
.
5
0
8
4
.
5
2
1
4
.
5
4
0
4
.
5
5
3
4
.
5
6
6
4
.
5
8
4
5
.
3
5
9
5
.
3
7
3
5
.
6
6
5
5
.
6
8
1
5
.
6
9
6
5
.
7
1
1
5
.
7
2
6
5
.
7
4
1
5
.
7
9
3
5
.
8
0
2
5
.
9
3
3
5
.
9
4
1
7
.
2
7
8
7
.
2
9
6
7
.
3
1
1
7
.
3
3
0
7
.
3
4
8
7
.
3
7
3
7
.
3
9
1
7
.
4
7
5
7
.
4
9
3
0
.9
5
1
.0
3
1
.0
1
0
.7
9
0
.9
6
1
.0
0
2
.0
0
1
.0
5
1
.0
0
171 
 
 
  
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
3
6
.
2
4
3
6
.
2
6
5
8
.
4
9
5
8
.
7
5
6
7
.
0
5
6
7
.
4
0
6
7
.
7
4
6
8
.
0
9
6
8
.
4
3
9
7
.
9
1
9
9
.
7
3
1
1
9
.
1
5
1
2
1
.
9
6
1
2
5
.
2
1
1
2
5
.
2
3
1
2
5
.
7
3
1
2
7
.
8
1
1
2
7
.
8
3
1
3
0
.
4
2
1
3
0
.
4
5
1
3
7
.
3
3
1
3
7
.
5
1
1
4
0
.
3
8
1
4
0
.
4
2
1
5
2
.
1
0
-50 -60 -70 -80 -90 -100 -110 -120 -130 -140 -150 -160 -170 -180 ppm
-
1
7
0
.
6
3
-
1
7
0
.
5
8
-
1
7
0
.
4
8
-
1
7
0
.
4
3
-
7
3
.
5
9
-
7
3
.
5
7
1
.0
0
6
.1
0
172 
 
 
 
  
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 ppm
2
.
9
8
7
2
.
9
9
7
3
.
0
0
8
3
.
0
1
8
3
.
0
2
6
3
.
0
3
5
3
.
0
4
7
3
.
0
5
7
3
.
3
5
0
3
.
3
6
9
3
.
3
8
9
3
.
4
0
8
4
.
4
6
8
4
.
4
8
1
4
.
4
9
0
4
.
5
0
2
4
.
5
1
0
4
.
5
2
2
4
.
5
3
0
4
.
5
4
3
4
.
5
5
0
4
.
5
6
3
4
.
5
7
1
4
.
5
8
3
4
.
5
9
2
4
.
6
0
4
5
.
6
6
6
5
.
6
7
8
5
.
6
9
6
5
.
7
1
1
5
.
7
2
7
5
.
7
4
2
5
.
7
5
7
5
.
8
1
1
5
.
8
2
3
7
.
3
0
7
7
.
3
2
5
7
.
3
4
2
7
.
4
0
6
7
.
4
1
0
7
.
4
2
5
7
.
4
3
1
7
.
4
4
1
1
.0
4
1
.0
7
1
.0
0
2
.9
0
1
.9
3
1
.0
1
1
.0
7
180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
3
6
.
4
0
5
4
.
2
4
5
4
.
4
3
6
7
.
1
6
6
7
.
5
0
6
7
.
8
5
6
8
.
1
9
6
8
.
5
4
9
3
.
0
2
9
4
.
7
9
1
1
9
.
2
0
1
2
2
.
0
1
1
2
5
.
2
5
1
2
5
.
2
8
1
2
6
.
4
9
1
2
6
.
5
2
1
2
7
.
6
9
1
2
7
.
7
3
1
2
8
.
8
9
1
3
0
.
5
9
1
3
1
.
2
0
1
3
1
.
2
4
1
3
6
.
7
9
1
3
6
.
9
4
1
4
2
.
1
9
1
4
2
.
2
4
1
5
2
.
3
9
173 
 
 
 
 
-50 -60 -70 -80 -90 -100 -110 -120 -130 -140 -150 -160 -170 -180 ppm
-
1
7
9
.
0
6
-
1
7
8
.
9
9
-
1
7
8
.
9
0
-
1
7
8
.
8
4
-
7
3
.
5
5
-
7
3
.
5
4
-
7
3
.
5
2
1
.0
0
5
.9
5
1.52.02.53.03.54.04.55.05.56.06.57.07.58.0 ppm
2
.
8
3
9
2
.
8
8
0
3
.
5
0
6
3
.
5
2
5
3
.
5
4
6
3
.
5
6
6
4
.
4
4
6
4
.
4
5
6
4
.
4
7
6
4
.
4
9
6
4
.
5
1
7
4
.
5
3
8
4
.
5
5
0
4
.
5
6
0
4
.
5
6
5
4
.
5
7
0
5
.
2
2
5
5
.
2
3
9
5
.
8
0
0
5
.
8
0
9
5
.
9
4
0
5
.
9
4
9
7
.
3
0
6
7
.
3
1
7
7
.
3
3
6
7
.
3
5
4
7
.
3
7
9
7
.
3
9
7
7
.
4
1
6
7
.
4
8
2
7
.
5
0
1
1
.0
3
0
.9
8
2
.9
5
1
.0
0
1
.0
0
1
.8
8
0
.9
6
0
.9
4
174 
 
 
 
160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
3
6
.
3
5
5
8
.
2
1
5
8
.
4
6
6
0
.
5
2
6
0
.
8
8
6
1
.
2
5
6
1
.
6
1
9
8
.
1
3
9
9
.
9
5
1
1
8
.
8
7
1
2
1
.
6
3
1
2
4
.
3
9
1
2
5
.
1
9
1
2
5
.
2
0
1
2
5
.
6
6
1
2
7
.
1
4
1
2
7
.
6
6
1
2
7
.
6
9
1
3
0
.
2
6
1
3
0
.
2
9
1
3
7
.
5
8
1
3
7
.
7
7
1
4
0
.
6
2
1
4
0
.
6
7
1
5
3
.
9
7
-70 -80 -90 -100 -110 -120 -130 -140 -150 -160 -170 ppm
-
1
7
1
.
0
7
-
1
7
1
.
0
2
-
1
7
0
.
9
2
-
1
7
0
.
8
7
-
7
4
.
2
7
-
7
4
.
2
5
-
7
4
.
2
3
1
.0
0
3
.0
4
175 
 
 
 
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
2
.
9
4
9
2
.
9
5
8
2
.
9
7
0
2
.
9
8
0
2
.
9
8
7
2
.
9
9
7
3
.
0
0
9
3
.
0
1
9
3
.
3
1
2
3
.
3
3
1
3
.
3
5
1
3
.
3
7
0
4
.
4
6
5
4
.
4
7
6
4
.
4
8
1
4
.
4
8
7
4
.
4
9
7
4
.
5
1
5
4
.
5
3
6
4
.
5
4
5
4
.
5
5
6
4
.
5
6
7
4
.
5
7
5
5
.
5
2
8
5
.
5
4
8
5
.
6
3
1
5
.
6
4
3
5
.
7
7
6
5
.
7
8
8
7
.
2
9
7
7
.
3
1
3
7
.
3
2
9
7
.
3
9
2
7
.
3
9
6
7
.
4
1
1
7
.
4
1
5
7
.
4
3
0
7
.
4
3
4
7
.
4
9
8
7
.
5
0
4
7
.
5
1
9
0
.9
9
1
.0
2
2
.9
4
0
.8
4
1
.0
0
1
.9
5
0
.9
9
0
.9
5
160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 ppm
3
6
.
4
9
5
3
.
9
7
5
4
.
1
6
6
0
.
5
9
6
0
.
9
5
6
1
.
3
2
6
1
.
6
8
9
3
.
1
9
9
4
.
9
6
1
1
8
.
9
2
1
2
1
.
6
8
1
2
4
.
4
3
1
2
5
.
2
2
1
2
5
.
2
5
1
2
6
.
4
6
1
2
6
.
4
8
1
2
7
.
1
9
1
2
7
.
5
6
1
2
7
.
6
0
1
3
1
.
0
5
1
3
1
.
0
9
1
3
7
.
0
5
1
3
7
.
2
1
1
4
2
.
4
6
1
4
2
.
5
1
1
5
4
.
2
2
176 
 
 
 
 
-70 -80 -90 -100 -110 -120 -130 -140 -150 -160 -170 ppm
-
1
7
9
.
1
6
-
1
7
9
.
1
0
-
1
7
9
.
0
1
-
1
7
8
.
9
4
-
7
4
.
2
6
-
7
4
.
2
4
-
7
4
.
2
1
1
.0
0
3
.0
0
8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 ppm
1
.
4
0
9
1
.
4
6
2
1
.
5
4
7
3
.
4
2
6
3
.
4
4
2
3
.
4
7
9
3
.
4
9
5
5
.
2
4
0
5
.
2
6
7
5
.
2
8
7
5
.
3
2
5
5
.
3
5
9
5
.
4
0
2
5
.
6
3
6
5
.
6
5
2
5
.
6
6
7
5
.
6
8
2
5
.
6
9
8
5
.
7
7
1
5
.
7
9
9
5
.
8
1
8
5
.
8
4
6
5
.
8
6
2
5
.
8
9
0
2
.9
7
2
.0
7
1
.0
0
0
.6
7
1
.0
5
0
.9
5
1
.0
9
177 
 
 
 
 
170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
2
2
.
6
2
2
2
.
8
6
4
8
.
8
5
4
9
.
0
8
6
7
.
1
1
6
7
.
4
5
6
7
.
7
9
6
8
.
1
4
6
8
.
4
8
9
4
.
3
8
9
6
.
1
0
1
1
5
.
9
5
1
1
6
.
0
6
1
1
6
.
4
0
1
1
9
.
1
9
1
2
1
.
9
9
1
2
4
.
8
0
1
3
6
.
9
1
1
3
7
.
1
3
1
5
3
.
0
0
-50 -60 -70 -80 -90 -100 -110 -120 -130 -140 -150 -160 ppm
-
1
5
5
.
5
5
-
1
5
5
.
5
0
-
1
5
5
.
4
4
-
7
3
.
6
7
-
7
3
.
6
5
1
.0
0
6
.1
7
178 
 
 
 
 
 
210 200 190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
1
7
.
9
8
1
8
.
0
1
4
2
.
3
9
4
2
.
6
1
9
3
.
1
0
9
4
.
8
2
1
1
3
.
5
4
1
1
3
.
6
4
1
2
6
.
9
4
1
2
8
.
6
6
1
3
1
.
7
1
1
3
4
.
1
7
1
4
0
.
5
0
1
4
0
.
6
7
1
6
7
.
6
0
179 
 
 
 
 
-90 -100 -110 -120 -130 -140 -150 -160 -170 -180 -190 -200 ppm
-
1
8
5
.
2
3
-
1
8
5
.
1
7
-
1
8
5
.
1
5
-
1
8
5
.
1
0
-
1
8
5
.
0
5
-
1
8
5
.
0
2
-
1
8
4
.
9
7
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
1
.
2
9
1
1
.
3
4
6
1
.
7
2
1
1
.
7
2
7
1
.
7
3
3
1
.
7
3
8
1
.
7
5
0
1
.
7
5
7
1
.
7
6
2
1
.
7
6
8
1
.
7
8
7
1
.
7
9
1
1
.
7
9
7
1
.
8
1
5
1
.
8
2
1
1
.
8
5
7
1
.
8
8
6
1
.
8
9
0
1
.
9
1
6
1
.
9
2
1
1
.
9
2
7
1
.
9
3
4
1
.
9
5
0
2
.
0
3
0
2
.
0
4
1
2
.
0
4
9
2
.
1
1
2
2
.
1
5
5
2
.
1
7
1
3
.
7
5
6
3
.
7
7
1
5
.
0
8
3
5
.
6
1
0
5
.
6
1
8
5
.
6
5
5
5
.
6
7
1
5
.
6
8
6
5
.
7
0
2
5
.
7
1
8
7
.0
9
3
.1
7
1
.9
3
1
.1
0
1
.9
3
0
.8
6
0
.9
5
1
.0
0
180 
2030405060708090100110120130140150160 ppm
2
3
.
3
1
2
3
.
3
6
2
3
.
7
4
2
3
.
9
9
2
4
.
5
8
2
4
.
8
3
2
6
.
2
8
2
6
.
3
5
2
6
.
8
2
4
3
.
2
3
4
3
.
4
5
4
7
.
2
6
6
6
.
9
6
6
7
.
3
0
6
7
.
6
4
6
7
.
9
9
6
8
.
3
3
9
6
.
5
1
9
8
.
1
6
1
1
9
.
2
5
1
2
2
.
0
5
1
2
3
.
3
2
1
3
3
.
4
3
1
5
2
.
6
0
-70 -80 -90 -100 -110 -120 -130 -140 ppm
-
1
4
1
.
2
1
-
1
4
1
.
1
7
-
1
4
1
.
1
5
-
1
4
1
.
1
2
-
1
4
1
.
0
9
-
1
4
1
.
0
6
-
1
4
1
.
0
3
-
1
4
1
.
0
0
-
1
4
0
.
9
7
-
1
4
0
.
9
4
-
7
3
.
6
5
-
7
3
.
6
4
1
.0
0
6
.0
2
181 
 
 
 
 
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 ppm
1
.
5
5
8
1
.
5
8
6
1
.
6
1
1
1
.
6
1
9
1
.
6
2
6
1
.
6
3
6
1
.
6
5
5
1
.
6
6
1
1
.
6
9
2
1
.
6
9
6
1
.
7
0
8
1
.
7
1
7
1
.
7
2
4
1
.
7
3
3
1
.
7
4
0
1
.
7
4
9
1
.
7
5
9
1
.
7
6
5
1
.
7
7
7
1
.
7
8
2
1
.
8
0
0
2
.
0
3
9
2
.
0
5
6
3
.
4
3
3
3
.
4
4
8
3
.
4
8
1
3
.
4
9
2
3
.
4
9
5
3
.
5
0
9
5
.
0
4
1
5
.
0
5
9
5
.
0
7
6
5
.
2
8
7
5
.
3
1
4
5
.
3
5
4
5
.
3
5
5
5
.
3
9
7
5
.
6
2
8
5
.
6
4
4
5
.
6
5
9
5
.
6
6
5
5
.
6
7
5
5
.
6
9
2
5
.
7
0
8
5
.
7
1
8
5
.
7
3
6
5
.
7
4
6
5
.
7
6
1
5
.
7
8
9
8
.0
9
1
.9
6
2
.0
0
1
.0
8
1
.8
7
1
.0
9
2
.0
2
160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
1
7
.
5
9
2
1
.
5
7
2
1
.
6
1
2
5
.
6
3
3
6
.
1
7
3
6
.
3
9
4
7
.
9
4
4
8
.
1
6
6
7
.
0
7
6
7
.
4
1
6
7
.
7
6
6
8
.
1
0
6
8
.
4
4
9
6
.
5
0
9
8
.
2
6
1
1
6
.
6
7
1
1
6
.
7
9
1
1
9
.
1
7
1
2
2
.
0
0
1
2
2
.
9
9
1
3
2
.
5
9
1
3
5
.
4
4
1
3
5
.
6
6
1
5
2
.
9
5
182 
-70 -80 -90 -100 -110 -120 -130 -140 -150 -160 ppm
-
1
6
6
.
0
5
-
1
6
6
.
0
2
-
1
6
5
.
9
9
-
1
6
5
.
9
7
-
1
6
5
.
9
4
-
1
6
5
.
9
1
-
1
6
5
.
8
8
-
7
3
.
6
7
-
7
3
.
6
6
-
7
3
.
6
4
1
.0
0
6
.2
1
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 ppm
1
.
2
8
3
1
.
3
3
7
1
.
7
1
7
1
.
7
3
8
1
.
7
6
8
1
.
8
1
7
1
.
8
5
8
1
.
9
0
0
1
.
9
3
2
2
.
0
9
0
2
.
1
0
6
2
.
1
4
4
3
.
9
2
8
3
.
9
4
2
3
.
9
6
6
3
.
9
8
3
4
.
0
0
3
4
.
0
2
4
4
.
0
4
1
5
.
6
4
6
6
.
2
1
3
7
.
2
6
0
7
.
4
1
0
7
.
4
2
9
7
.
4
4
7
7
.
4
7
9
7
.
4
9
8
7
.
5
1
6
3
.1
3
3
.2
8
3
.1
8
3
.0
6
2
.0
7
1
.0
0
0
.9
8
2
.1
7
1
.0
9
2
.0
5
183 
190 180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
2
3
.
4
5
2
3
.
5
0
2
3
.
7
6
2
4
.
0
1
2
4
.
6
0
2
4
.
8
4
2
6
.
3
4
2
6
.
4
1
2
7
.
2
3
4
3
.
3
5
4
3
.
5
7
4
5
.
4
4
9
6
.
6
1
9
8
.
2
6
1
2
2
.
4
9
1
2
6
.
8
9
1
2
8
.
6
0
1
3
1
.
4
7
1
3
4
.
5
5
1
3
4
.
6
4
1
6
7
.
4
2
-105 -110 -115 -120 -125 -130 -135 -140 -145 -150 -155 -160 -165 -170 -175 ppm
-
1
4
1
.
0
0
-
1
4
0
.
9
7
-
1
4
0
.
9
5
-
1
4
0
.
9
1
-
1
4
0
.
8
9
-
1
4
0
.
8
6
-
1
4
0
.
8
3
-
1
4
0
.
8
0
-
1
4
0
.
7
7
-
1
4
0
.
7
4
184 
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
2
.
5
1
8
2
.
5
3
0
2
.
5
4
7
2
.
5
5
3
2
.
5
6
9
2
.
5
8
2
2
.
6
0
1
2
.
6
2
3
2
.
6
3
8
2
.
6
5
0
2
.
6
6
5
2
.
6
8
4
2
.
6
9
2
2
.
7
1
1
2
.
7
2
1
2
.
7
2
9
2
.
7
4
7
2
.
7
6
6
3
.
7
7
7
3
.
7
9
1
3
.
8
0
5
4
.
4
2
5
4
.
4
4
6
4
.
4
6
8
4
.
4
8
9
4
.
8
7
7
5
.
3
7
6
5
.
3
8
8
5
.
3
9
6
5
.
4
0
7
5
.
4
9
4
5
.
5
0
7
5
.
5
1
4
5
.
5
2
6
5
.
5
4
3
5
.
5
5
7
5
.
5
7
2
5
.
5
8
2
5
.
5
9
6
5
.
6
0
9
5
.
6
2
1
5
.
6
3
6
5
.
6
5
3
5
.
6
7
5
5
.
6
9
2
7
.
3
0
0
7
.
3
1
9
7
.
3
3
2
7
.
3
4
9
7
.
3
6
4
7
.
3
8
3
2
.3
3
1
.9
2
2
.0
0
0
.8
8
1
.2
0
2
.0
3
4
.8
0
160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
3
9
.
8
6
4
0
.
1
0
4
3
.
0
0
6
0
.
3
9
6
0
.
7
5
6
1
.
1
1
6
1
.
4
8
9
2
.
7
1
9
4
.
4
3
1
2
1
.
7
2
1
2
4
.
4
8
1
2
5
.
4
8
1
2
5
.
5
5
1
2
7
.
6
3
1
2
7
.
6
8
1
2
8
.
4
4
1
2
8
.
4
5
1
2
8
.
4
9
1
2
9
.
1
9
1
3
9
.
4
7
1
3
9
.
6
6
1
5
4
.
2
0
185 
 
 
 
 
-70 -80 -90 -100 -110 -120 -130 -140 -150 -160 -170 ppm
-
1
7
5
.
0
4
-
1
7
4
.
9
9
-
1
7
4
.
9
4
-
1
7
4
.
9
2
-
1
7
4
.
8
7
-
7
4
.
3
5
-
7
4
.
3
3
-
7
4
.
3
1
1
.0
0
3
.0
8
8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 ppm
0
.
9
2
0
0
.
9
3
8
0
.
9
8
7
1
.
0
0
4
1
.
2
0
4
1
.
2
6
0
1
.
9
2
4
1
.
9
4
1
1
.
9
4
9
1
.
9
5
8
1
.
9
6
6
1
.
9
7
6
1
.
9
8
4
1
.
9
9
3
2
.
0
0
1
2
.
0
1
8
3
.
4
1
8
3
.
4
2
6
3
.
4
3
2
3
.
4
4
3
3
.
4
6
6
3
.
4
8
0
3
.
4
8
7
3
.
5
0
4
5
.
3
3
9
5
.
6
5
6
5
.
6
7
1
5
.
6
8
7
5
.
7
0
2
5
.
7
1
8
5
.9
5
3
.0
7
0
.9
6
2
.1
0
0
.8
1
1
.0
0
186 
 
 
 
160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
1
6
.
4
6
1
6
.
5
1
1
7
.
3
0
1
7
.
3
4
1
7
.
4
2
1
7
.
5
4
3
3
.
8
3
3
4
.
0
4
4
7
.
5
4
4
7
.
7
5
6
7
.
1
1
6
7
.
4
5
6
7
.
8
0
6
8
.
1
4
6
8
.
4
9
9
8
.
2
3
9
9
.
9
3
1
1
6
.
4
0
1
1
9
.
2
0
1
2
2
.
0
3
1
2
4
.
8
3
1
5
3
.
0
1
-70 -80 -90 -100 -110 -120 -130 -140 -150 ppm
-
1
5
3
.
3
7
-
1
5
3
.
3
4
-
1
5
3
.
3
1
-
1
5
3
.
2
8
-
1
5
3
.
2
6
-
1
5
3
.
2
3
-
1
5
3
.
2
0
-
1
5
3
.
1
7
-
7
3
.
6
8
-
7
3
.
6
6
1
.0
0
6
.4
5
187 
 
 
 
  
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 ppm
0
.
9
5
7
0
.
9
7
5
1
.
2
9
4
1
.
3
4
9
1
.
3
7
1
1
.
4
2
7
1
.
9
2
1
1
.
9
3
7
1
.
9
5
4
1
.
9
7
0
1
.
9
8
6
2
.
0
0
3
3
.
2
3
8
3
.
2
5
5
3
.
2
7
2
3
.
2
8
9
3
.
3
0
6
3
.
3
6
7
3
.
3
7
9
3
.
3
8
3
3
.
3
9
5
3
.
4
0
2
3
.
4
1
3
3
.
4
1
8
3
.
4
2
9
5
.
3
8
2
5
.
6
4
7
5
.
6
6
3
5
.
6
7
9
5
.
6
9
4
5
.
7
1
0
3
.1
4
6
.1
8
0
.9
8
0
.9
6
1
.0
0
0
.9
3
1
.0
1
170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
1
3
.
5
8
1
3
.
6
6
2
2
.
2
8
2
2
.
5
3
2
6
.
2
2
2
6
.
4
7
4
2
.
2
8
4
2
.
4
9
4
3
.
7
3
4
3
.
7
7
6
6
.
9
1
6
7
.
2
5
6
7
.
5
9
6
7
.
9
3
6
8
.
2
7
9
7
.
7
6
9
9
.
4
1
1
1
6
.
4
6
1
1
9
.
2
6
1
2
2
.
0
7
1
2
4
.
8
7
1
5
2
.
6
8
188 
 
 
 
-70 -80 -90 -100 -110 -120 -130 -140 ppm
-
1
3
8
.
6
5
-
1
3
8
.
6
3
-
1
3
8
.
6
2
-
1
3
8
.
6
0
-
1
3
8
.
5
9
-
1
3
8
.
5
7
-
1
3
8
.
5
6
-
1
3
8
.
5
4
-
1
3
8
.
5
4
-
1
3
8
.
5
1
-
1
3
8
.
5
0
-
1
3
8
.
4
9
-
1
3
8
.
4
8
-
1
3
8
.
4
5
-
1
3
8
.
4
4
-
1
3
8
.
4
3
-
1
3
8
.
4
2
-
1
3
8
.
3
9
-
1
3
8
.
3
8
-
7
3
.
7
0
-
7
3
.
6
9
-
7
3
.
6
8
1
.0
0
6
.1
7
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0.0 ppm
0
.
5
7
2
0
.
5
9
0
3
.
7
2
8
3
.
7
3
7
3
.
7
4
6
3
.
7
5
4
3
.
7
6
3
3
.
7
6
8
3
.
7
7
2
3
.
7
7
7
3
.
7
8
5
3
.
7
9
4
3
.
8
0
5
3
.
8
1
4
3
.
8
2
3
3
.
8
2
8
3
.
8
3
1
3
.
8
3
6
3
.
8
4
5
3
.
8
5
4
3
.
8
6
2
3
.
8
7
1
4
.
4
6
9
4
.
4
9
0
5
.
0
9
6
5
.
1
0
4
5
.
2
1
5
5
.
2
2
4
5
.
7
1
3
5
.
7
2
9
5
.
7
4
5
5
.
7
6
1
5
.
7
7
6
5
.
7
9
2
5
.
8
0
8
6
.
9
7
8
6
.
9
8
9
6
.
9
9
7
7
.
0
0
7
7
.
0
2
0
7
.
0
3
4
7
.
0
4
5
7
.
0
5
3
2
.9
4
1
.0
1
0
.9
5
1
.0
0
1
.0
1
5
.1
2
189 
170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
1
6
.
9
7
1
7
.
0
0
5
1
.
7
8
5
2
.
0
1
6
6
.
8
9
6
7
.
2
3
6
7
.
5
8
6
7
.
9
2
6
8
.
2
7
9
4
.
0
2
9
5
.
7
9
1
1
6
.
3
4
1
1
9
.
1
2
1
2
1
.
9
3
1
2
4
.
7
9
1
2
5
.
5
4
1
2
5
.
6
1
1
2
8
.
5
3
1
2
8
.
8
2
1
3
6
.
1
1
1
3
6
.
3
2
1
5
1
.
9
4
-50 -60 -70 -80 -90 -100 -110 -120 -130 -140 -150 -160 -170 -180 -190 ppm
-
1
9
8
.
3
7
-
1
9
8
.
3
0
-
1
9
8
.
2
4
-
1
9
8
.
1
8
-
7
3
.
6
6
-
7
3
.
6
5
-
7
3
.
6
4
1
.0
0
6
.1
1
190 
 
 
 
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 ppm
0
.
6
1
2
0
.
6
2
9
3
.
7
9
5
3
.
8
1
3
3
.
8
2
5
3
.
8
3
0
3
.
8
3
6
3
.
8
4
2
3
.
8
4
7
3
.
8
5
3
3
.
8
6
0
3
.
8
6
5
3
.
8
7
2
3
.
8
7
8
3
.
8
8
3
3
.
8
8
9
3
.
8
9
5
3
.
9
0
1
3
.
9
1
3
3
.
9
3
0
4
.
2
6
5
4
.
2
7
6
4
.
2
9
8
4
.
7
6
2
4
.
7
7
4
4
.
8
7
8
4
.
8
8
9
5
.
5
9
6
5
.
6
1
1
5
.
6
2
7
5
.
6
4
3
5
.
6
5
9
6
.
9
7
2
6
.
9
8
7
6
.
9
9
1
7
.
0
3
1
7
.
0
5
0
7
.
0
6
9
7
.
0
8
5
7
.
0
9
0
2
.9
1
1
.0
8
1
.0
2
1
.0
0
1
.0
0
5
.2
9
160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0 ppm
1
6
.
9
7
1
7
.
0
1
5
1
.
7
8
5
2
.
0
1
6
6
.
8
8
6
7
.
2
3
6
7
.
5
7
6
7
.
9
1
6
8
.
2
6
9
4
.
0
2
9
5
.
7
9
1
1
6
.
3
1
1
1
9
.
1
1
1
2
1
.
9
2
1
2
4
.
7
5
1
2
5
.
5
4
1
2
5
.
6
1
1
2
8
.
5
3
1
2
8
.
8
2
1
3
6
.
1
1
1
3
6
.
3
2
1
5
1
.
9
4
191 
  
-80 -90 -100 -110 -120 -130 -140 -150 -160 -170 -180 ppm
-
1
8
9
.
9
4
-
1
8
9
.
8
9
-
1
8
9
.
8
2
-
1
8
9
.
7
7
-
7
3
.
6
8
-
7
3
.
6
7
1
.0
0
6
.1
2
192 
Appendix B.2 HPLC traces of compound 2.6e 
The ee of compound 2.6e-anti was determined by Chiral HPLC analysis (Chiralcel OD-H column, 5% 
isopropanol in hexanes, flow rate = 1.0 mL/min, UV detection at 210 nm). tr (minor) = 23.5 min, tr (major) 
= 16.7 min, 84% ee.  
Racemic sample
  
Enantio-enriched sample (84% ee) 
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The ee of compound 2.6e-syn was determined by Chiral HPLC analysis (Chiralpak AD-H column, 15% 
EtOH in hexanes, flow rate = 1.0 mL/min, UV detection at 210 nm). tr (minor) = 12.2 min, tr (major) = 8.02 
min, 84% ee. 
Racemic sample 
 
 
 
Enantio-enriched sample (84% ee) 
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Appendix B.3 HPLC traces of compound 2.20  
The ee of compound 2.20 was determined by Chiral HPLC analysis (Chiralcel OD-H column, 10% 
isopropanol in hexanes, flow rate = 0.6 mL/min, UV detection at 254 nm). tr (major) = 32.5 min, tr (minor) 
= 34.4 min, 91% ee.  
Racemic sample 
 
 
Enantio-enriched sample (91% ee) 
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Appendix C. Representative NMR spectra in CHAPTER 3 
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